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This thesis describes investigations directed towards developing a novel synthetic route to the 
natural products perophoramidine and the communesins, with particular emphasis placed on 
the formation of the two vicinal all-carbon quaternary centres contained in these molecules.   
 
Chapter 1 introduces perophoramidine and the communesin group of natural products and 
explains how they are related to the calycanthaceous alkaloids.  The isolation of 
perophoramidine and the communesins is outlined and their biosynthesis is discussed.  
Specific structural features of these natural products are highlighted before established 
synthetic strategies are reviewed.  Chapter 1 concludes by proposing a novel synthetic route 
for the synthesis of perophoramidine and the communesins that involves a Claisen 
rearrangement in the indolo[2,3-b]quinoline system as a key step.   
 
Chapter 2 describes model studies on the proposed Claisen rearrangement in an attempt to 
form a quaternary centre in the indolo[2,3-b]quinoline system.  These initial studies did not 
result in the generation of the desired quaternary centre.  However, a detailed understanding 
of the reactions that occur leads to the design of a new model substrate.   
 
Chapter 3 describes studies on the revised model system that result in the formation of the 
desired quaternary centre using a Claisen rearrangement.  The differences between the two 
systems are discussed before an investigation into the scope of the rearrangement is 
described.  Chapter 3 concludes by describing an investigation into a protecting group 
strategy that would by required with this synthetic route.   
 
Chapter 4 describes investigations into the formation of the second vicinal quaternary centre 
using a model system.  The synthetic routes investigated lead to two separate methods for the 
formation of the desired quaternary centre.   
 
Chapter 5 describes investigations into the effect a C-10 substituent has on the Claisen 
rearrangement.  Additionally, an asymmetric version of the Claisen rearrangement is 
examined.  Chapter 5 culminates in the preparation of an intermediate relevant to an 
asymmetric synthesis of the communesins.   
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Chapter 1: Introduction 
 
 
1.1 The alkaloids  
 
Due to their diverse biological properties, the alkaloids have been utilised as medicines and 
poisons throughout history.1  From ancient times the alkaloids have been used in the form of 
crude extracts from their natural sources.  Only relatively recently has it become possible to 
isolate these naturally occurring compounds and to determine their precise molecular 
structures.  An early example is the structural elucidation of the morphine alkaloids through 
the degradation studies conducted by Robinson and Gulland.2  By determining their 
molecular structures, it became apparent that the structures of many alkaloids contain the 
indole ring system.  These indole alkaloids have received a great amount of attention from 
the scientific community due to the remarkable biological properties many of these 
compounds display.3  However, it is often not simply the biological properties of natural 
products that fascinates the synthetic chemist.  The synthesis of natural products plays an 
integral part in gaining an understanding of chemical reactivity and in the development of 
new synthetic methodology.  Furthermore, the total synthesis of a natural product is one of 
the most rigorous tests of a proposed molecular structure.  The isolation, structural 
determination and synthesis of the indole alkaloids continues to pose new challenges to the 
chemist.   
 
 
1.2 The calycanthaceous alkaloids  
 
Following the structural determination of the natural product calycanthine, it was postulated 
that calycanthine represents one of the five structural isomers, 1, 2, 3, 4 and 5, that can be 
feasibly derived, through bis-aminal formation, from the hypothetical intermediate 6 
(Scheme 1).4  This intermediate 6 can be produced by hydrolysis of indolenine 7, which can 
























































Scheme 1. The possible structural arrangements for the calycanthaceous alkaloids.   
 
Before 1993 only three of these structural arrangements 1, 3 and 4 were represented by, for 
example, the known natural products calycanthine4,5, chimonanthine6,7 and iso-calycanthine8 
respectively.  Structural arrangements 2 and 5 were unknown in nature at that time.  
However, various natural products representing 5 have recently been discovered (natural 
examples of structural arrangement 2 are currently still unknown).  First, the natural products 
communesin A (9) and communesin B (10) were isolated from a strain of Penicillium fungus 
found attached to the marine alga Enteromorpha intestinalis (Figure 1).9  Later, 
communesins C (11) and D (12) were isolated from a strain of Penicillium fungus found 
living on the marine sponge Axinella verrucosa.10  Subsequently, terrestrial sources also 
yielded natural products with the communesin parent structure.  Communesin D (12) along 
with the novel communesins E (13) and F (14) were isolated from the soil inhabiting fungus 
Penicillium expansum,11 and communesins A (9) and B (10) have been independently 
reported to be present in this fungus.12  Most recently, communesins G (15) and H (16) were 
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10 B CH3  
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Figure 1. The communesin family of natural products.   
 
The eight known members of the communesin group of natural products show structural 
variation at the three positions R1, R2 and the oxidation state at the isoprene motif.  All the 
communesins other than communesin F (14), which displays an unoxidised alkene of the 
isoprene derived motif, have a C-21-C-22 epoxide.  A methyl substituent is present on the 
indolic nitrogen N-5 in all the communesin structures except in communesin C (11) and E 
(13), which are unsubstituted at this position (R1 = H), and communesin D (12), which has an 
N-5 formyl group (R1 = CHO).  Four different R2 substituents have been observed in the 
communesins.  In communesin A (9), E (13) and F (14) R2 is a methyl group.  Whereas in 
communesins G (15) and H (16), R2 is a saturated ethyl or propyl aliphatic chain.  Finally, 
























(original proposed structure)  
Figure 2. The structure of perophoramidine and the proposed structure of nomofungin.   
 
Moreover, structural arrangement 5 is not exclusive to the communesin family of natural 
products (Figure 2).  The natural product perophoramidine (17), isolated from the Philippine 
ascidian Perophora namei,14 represents an oxidised version of structure 5 and the natural 
product nomofungin (18), isolated from an unidentified fungus found on the bark of Ficus 
microcarpa, represents an appended version of structure 5.15   
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Interestingly, communesin B (10) and nomofungin (18) display striking similarities in their 
proposed structure, reported spectral data (their NMR chemical shifts and coupling constants 
are essentially identical) and biological properties.  These similarities led to the proposal that 
communesin B (10) and nomofungin (18) are in fact the same compound.16  Initially, in an 
attempt to determine which structure correctly represented the natural product, a comparison 
of the 13C and 1H NMR chemical shifts of C-6 and H-6 with similar aminal and hemiaminal 
containing compounds suggested the aminal functionality present in the communesin B 
structure (10) was the most likely representation of the natural product(s) in question.16,17  
Furthermore, partial synthesis of both the nomofungin (18) and the communesin core 
structures by the research group of Stoltz,16,17 and later by the group of Funk,18 provided 
corroborating evidence in favour of the communesin B structure (10).  The observation that 
there is no feasible biosynthetic pathway to nomofungin, as there is in the case of 
communesin B 10, was also instrumental in the rejection of the proposed nomofungin 
structure (18).16,17  Whilst the paper describing the isolation, structural determination and 
biological properties of nomofungin (18) was withdrawn in response to the publication of 
these refuting investigations, the contribution made by the authors in regard to the relative 
and absolute stereochemistry, and their finding on the biological properties of 
nomofungin/communesin B should not be ignored.19   
 
 
1.3 Structural features of the communesins and perophoramidine  
 
The communesins (9-16) and perophoramidine (17) all possess architecturally intriguing 
structures with the same core hexacyclic structure containing vicinal all-carbon quaternary 
stereocentres.  The communesins, in contrast to perophoramidine (17), possess an additional 
azapine ring system.  Perophoramidine (17) displays halogen substitution at C-3, C-12 and C-
14, whereas the aromatic ring system of the communesins is substituted at C-12a with, 
presumably, an isoprene derived unit that is oxidised in most cases.  The relative 
stereochemistry of perophoramidine (17), which was determined using NMR techniques,14 is 
opposite to that displayed at the vicinal quaternary centres in the communesin structure: in 
perophoramidine the two 2C units are trans whereas in the communesins the two 2C units are 
cis.  The first isolation report of the communesins A (9) and B (10) assigned the relative 
stereochemistry at all the stereocentres, other than at C-21, to be that as shown in Figure 1 
using 1H-1H nOe correlations.9  The later isolation of the communesins C to H prompted 
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reinvestigation of the substructure's relative stereochemistry and corroborated the initial 
findings for communesin A (9) and B (10), therefore showing that all the communesins have 
the same relative stereochemistry.10,11,13  The later investigations also assigned the relative 
configuration at C-21 using Murata's J-based configurational analysis20 and proposed that the 
C-21 configuration is as depicted in Figure 1.  The relative stereochemistry assigned to the 
communesins by all of these investigations is consistent with the independent stereochemical 
assignments made for nomofungin (18) (communesin B (10)).15  In addition, the 
investigations leading to the proposed nomofungin structure (18) addressed the question of 
this compound's absolute stereochemistry and conclude, by use of the circular dichroism 
exciton chirality method,21,22 that the absolute configuration is 11S, 7R, 6S, 9S, 8R, 21R 
(Figure 2).15  However, considering that the original structural assignment of nomofungin 
(18) was incorrect, it is necessary to treat this assignment of absolute stereochemistry with 
caution.  Despite the fact that naturally occurring perophoramidine (17) is reported to have an 
optical rotation, the absolute stereochemistry of perophoramidine has not been assigned.14   
 
 
1.4 Biological properties of the communesins and perophoramidine  
 
Communesin A (9) and, to a greater extent, communesin B (10) have been reported to exhibit 
cytotoxic activity against P-388 lymphocytic leukaemia cells (ED50 = 7.7 µM and 0.9 µM 
respectively).9  It is proposed that the cytotoxic effect of communesin B (10) is achieved by 
disruption of the microfilament network in mammalian cells,15 a property shared with the 
fungal metabolite cytochalasin D.23  The communesins A (9), B (10), D (12), E (13), and F 
(14) have been shown to display insecticidal activity, when assayed against the larvae of 
silkworms, and again communesin B (10) showed the highest activity.11  perophoramidine 
(17) has been shown to be cytotoxic to the HCT116 colon carcinoma cell line (IC50 = 60 µM) 
and induces apoptosis via PARP cleavage.14  The communesins G (15) and H (16) have been 
tested in various antimicrobial, antiviral and anticancer assays but failed to show significant 







1.5 Biosynthesis of the communesins and perophoramidine  
 
Presumably, the communesins and perophoramidine (17), given their structural similarities, 
are formed via similar biosynthetic pathways.  Various synthetic studies have demonstrated 
the feasibility of a calycanthaceous alkaloid biosynthesis involving the oxidative union of 
two moles of tryptamine followed by bis-aminal formation.16,17,24  Of greatest relevance to 
the biosynthesis of the communesins and perophoramidine is the observation, made before 
the isolation of these natural products, that reductive cyclisation of 19 with lithium 
aluminium hydride in refluxing tetrahydrofuran affords 20 (yield not reported) that displays 




















19 20  
Scheme 2. Compound 20 is the only product reported from the reductive cyclisation of 19.25   
 
Surprisingly, reductive cyclisation of 21, the C2-symmetric diastereoisomer of 19, is reported 
to afford 22 and not structural arrangement 5 with the communesin relative stereochemistry 
(Scheme 3).25  However, as the yield of 22 is not reported, it is not possible to draw the 
conclusion that structural arrangement 5 with the communesin relative stereochemistry 
cannot be formed by the reduction of 21.  Nonetheless, the observation that 20 can be formed 
from 19 supports the hypothesis that structural arrangement 5 can arise from the dimerisation 
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Specifically in the case of communesin biosynthesis, it has been suggested that the union of 
the penicillium fungal alkaloid aurantioclavin (23) with an oxidised tryptamine derivative, 
such as 24, in a Diels-Alder type process would give the polycyclic cycloadduct 25 (Scheme 
4).16,17  The highly strained lactam of 25 would be easily opened by the primary amine to 
give 26 that following reduction and aminal closure would afford the communesin 



































Scheme 4. A proposed biosynthetic pathway to the communesins.16   
 
Synthetic studies have been presented in support of this hypothesis.16,17  They involve the use 
of a hetero-Diels-Alder reaction between N-Boc protected aurantioclavin 28 and the quinone 
methide imine 29, generated from 30, to form 31 as a mixture of diastereoisomers (Scheme 
5).  This study was also used to refute the nomofungin structure by comparison of H-6 and C-
6 NMR chemical shifts of 32, after the removal of the tosyl group from 31, with those 
reported for communesin B (10)/nomofungin (18).16,17 
 
Results from a recent detailed investigation into the biosynthesis of communesin A (9) and B 
(10), involving the addition of radio labelled precursors to microbial fermentation broths, 
support the hypothesis of a synthesis involving the dimerisation of two tryptamine based 
units, but do not support the idea that the construction of the isoprene unit, present in 







































Scheme 5. The hetero-Diels-Alder reaction between N-Boc protected aurantioclavin 28 and quinone methide 
imine 30 demonstrates the feasibility of a similar biosynthetic pathway.16   
 
It was found that when [2-13C]-tryptophan was added during fermentation, the isolated 
communesins showed enrichment of the 13C NMR signals associated with C-20 and C-17.26  
Not only is this consistent with a biosynthesis from two tryptophan derived moieties, but it 
also confirms the precise orientation of these units.  Furthermore, the observation that 14C-
tryptophan and 3H-methionine were incorporated into the communesins throughout 
production at a constant ratio suggested that these precursors were involved at approximately 
the same time.  The incorporation of radio labels derived from 3H-mevalonate and 14C-
tryptophan, however, did not show this constant ratio of incorporation throughout 
communesin production.  Early in the fermentation process a high preference for tryptophan 
incorporation was observed, but later a preference for mevalonate was observed.  These 
observations signify the early build up of a tryptophan based intermediate with addition of 
the isoprene based moiety, from mevalonate, occurring later in the biosynthesis.  These 
results are in contrast to the hypothesis that reaction of tryptamine with aurantioclavin is an 
early step in communesin biosynthesis.  Whilst it has been shown that methylation, with 3H-
methionine, and tryptamine dimerisation occur at approximately the same time, it has been 
suggested that dimerisation precedes methylation, based on the observation that methylation 
is not a crucial step in the synthesis of all the communesins.26  However, the possible 
involvement of a demethylation step in the biosynthesis of communesin C (11) and D (13) 
has been ignored when drawing this conclusion.  Indeed, the presence of the N-formyl group 
found in communesin D (12) could be considered as evidence for oxidative demethylation.   
Chapter 1 9
1.6 Approaches to the total synthesis of the communesins and perophoramidine  
 
The communesin parent structure and perophoramidine (17) pose challenging synthetic 
targets.  It is the two vicinal all-carbon quaternary centres, with a trans configuration in 
perophoramidine (17) and a cis configuration in the communesins, that are expected to be the 
most challenging aspect of any synthesis of these compounds.  Generally, establishing all-
carbon quaternary centres, particularly in an asymmetric manner, remains one of the key 
challenges of synthetic chemistry.27-30   
 
Since the discovery of the communesins and perophoramidine (17) there have been numerous 
synthetic studies directed at the synthesis of these natural compounds.  The first synthetic 
studies were not primarily concerned with the development of a total synthesis, but were 
mainly directed at elucidating the communesin B (10)/nomofungin (18) structure and 
investigating proposed biosynthetic pathways.  This chapter will now outline these studies 
with particular attention being given to the key steps involved in the synthesis of the two 
vicinal quaternary centres.  Many of these synthetic efforts can be described as biomimetic as 
they involve the union of tryptamine based moieties in either an inter- or an intramolecular 
fashion.   
 
The first synthetic studies on the communesins were those published by Stoltz et al. detailing 
the reaction of Boc-protected aurantioclavin 28 with a quinone methide imine 29.16,17  As 
already stated, these studies were directed at providing corroborating evidence for the 
proposed biosynthetic pathway and demonstrating that the proposed nomofungin structure 
(18) was incorrect as well as developing a method for the synthesis of the natural products.  
As these studies have already been discussed (page 7) no further consideration will be given 
to them here.   
 
Similar biomimetic approaches, reported by Funk et al., have been applied to the synthesis of 
both perophoramidine (17) and the communesins, and have resulted in the first total synthesis 
of racemic perophoramidine (17).31 The key step in Funk's synthesis of perophoramidine 
involves the coupling of 3-bromoindoline-2-one 33 and TIPS protected tryptophol 34 to form 
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36 37  
Scheme 6. Key steps in the synthesis of racemic perophoramidine (17).31 NCS = N-chlorosuccinimide, Boc = 
tert-butoxycarbonyl, TIPS = triisopropylsilyl.   
 
After conversion of 35 to the Boc-derivative, reduction of the azide moiety causes a cascade 
sequence involving a transamidation and attack of the resulting Boc-protected aniline onto 
the indolenine ring to afford 36.  The electron rich aromatic ring of 36 was then chlorinated 
ortho- and para- to the indolic nitrogen to give 37.  Racemic perophoramidine (17) was then 
synthesised in eight more steps from 37.  The overall yield of perophoramidine (17) (twelve 






































Scheme 7. Two alternative mechanisms have been suggested for the formation of 35 from 33 and 34.  TIPS = 
triisopropylsilyl.33   
 
It has been proposed that the coupling of 33 with 34 proceeded by the initial in situ formation 
of the indole-2-one intermediate 38, and two alternative mechanisms were suggested for the 
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subsequent formation of 35 (Scheme 7).31  Either, a cycloaddition reaction occurs between 
34 and 38 to form cycloadduct 39 that subsequently undergoes ring opening to form 
intermediate 40, or a conjugate addition of 34 to 38 could directly form intermediate 40.  This 
second mechanism is presumably also possible in the case of the coupling of 28 with 29 
(Scheme 5) that is reported by Stoltz et al. to proceed via a Diels-Alder type process.16,17   
 
In model studies directed towards the synthesis and structural assignment of the 
communesins, Funk et al. describe an intramolecular hetero-Diels-Alder reaction used to 
form the core ring system and the C-7 quaternary centre (Scheme 8).18 Thermolysis of 
carbonate 41 in dichlorobenzene gave 42 in good yield as a single diastereoisomer, 


























Scheme 8. An intramolecular hetero-Diels-Alder reaction is used to form the core ring system and the C-7 
quaternary centre present in the communesins.18   
 
In line with the study by Stoltz et al., after hydrolysis of the carbamate moiety in 42, a 
comparison of the C-6 and H-6 NMR chemical shifts with those of C-6 and H-6 of 
communesin B (10)/nomofungin (18) provided further evidence that the nomofungin 
structure (18) was incorrect.  Currently, this synthetic route is not easily applicable to a total 
synthesis of the communesins as functionalisation of 42 at C-11, C-9 and C-8 is non-trivial.   
 
To address this issue, a modification of this intramolecular hetero-Diels-Alder methodology 
was later published by Funk that involved the generation of the aza-ortho-xylylene by the 
ring opening of 2-(2-acylaminophenyl)aziridines (Scheme 9).32  This method is reported to 
be preferable to that used previously as it allows for incorporation of a substituent at C-9 that 
can be used for the formation of the second aminal functionality present in the communesin 
structure.  Additionally, in this synthesis an acetylene moiety is present at C-12a that gives a 
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handle for the preparation of the isoprene unit.  These synthetic studies culminate in the 
preparation of the advanced communesin intermediate 43.  Following preliminary studies on 
simplified substrates, it was discovered that treatment of the β-(trimethylsilyl)ethoxycarbonyl 
(TEOC) protected aniline 44 with tetrabutylammonium fluoride (TBAF) gave cycloadduct 45 
via aza-ortho-xylylene 46.  Cycloadduct 45 was then converted to 47 using a gold catalysed 
intramolecular hydroamination.33  Hydrolysis of the ester 47 to the corresponding acid 48 
followed by mixed anhydride formation and treatment with sodium azide afforded 43 via a 
Curtius rearrangement that occurred with retention of configuration at C-9.  It is envisaged 
that the C-8 quaternary centre will be formed by a C-H insertion reaction, directed from the 











































































Scheme 9. The synthesis of an advanced intermediate 43 in synthetic studies directed at the total synthesis of 
the communesins.32  TBAF = tetrabutylammonium fluoride, Tf = trifluoromethanesulfonyl, 
DIPEA = N,N-diisopropylethylamine.   
 
In model studies directed at developing a route to the communesins and perophoramidine 
(17), Qui et al. use an intramolecular cyclopropanation as a key step to construct the core 
indolo[2,3-b]quinoline ring system and the C-7 quaternary centre (Scheme 10).34  This 
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approach can be, broadly speaking, classed as biomimetic as the synthesis of 49 originates 
from the two indole fragments tryptamine and isatin.  The diazo decomposition of 49 in the 
presence of copper (I) triflate afforded the stable cyclopropane intermediate 50 as a mixture 
of diastereoisomers.  Sodium borohydride reduction of the azide of 50 gave 51 after opening 
of the cyclopropane ring of 52 and subsequent addition of the resulting aniline functionality 
to the iminium ion present in 53.  The pentacycle 51 was formed as a mixture of 
diastereoisomers but with retention of stereochemistry at C-7.  Although it is not reported, the 
C-8 quaternary centre is presumably formed by alkylation of the enolate derived from 51 by 
















































Scheme 10. A cyclopropanation strategy for the formation of a perophoramidine and communesin core 
structure.34  Tf = trifluoromethanesulfonyl. 
 
An intermediate very similar to 51 is prepared, also from tryptamine and isatin but using a 
different route, in the total synthesis of racemic dehaloperophoramidine (54) (Figure 3) 
recently published by Rainier et al.35  Whilst dehaloperophoramidine (54) has not been 
isolated from natural sources, the synthesis of 54 by the dehalogenation of naturally 
occurring perophoramidine (17), under ammonium formate catalytic transfer hydrogenolysis 








Figure 3. Dehaloperophoramidine (54) is not a known natural product, but it has been synthesised by the 
dehalogenation of naturally occurring perophoramidine (17).14   
 
In Rainier's synthesis, which utilises thioindoles as key intermediates, the indolo[2,3-
b]quinoline ring system and the C-7 quaternary centre are formed via the cyclisation of 55 
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Scheme 11. Key steps in the total synthesis of dehaloperophoramidine published by Rainier et al.35  Boc = tert-
butoxycarbonyl, Ms = methanesulfonyl, DBU = 1,8-diazabicyclo[5.4.0]undec-7-ene.   
 
Starting with the reaction of 56 with 57 and subsequent treatment of the product with 
benzenesulfenyl chloride, 58 is formed in excellent yield.  After reduction of ketone 58, 
alcohol 59 is treated with mesyl chloride.  The thus formed mesylate 55 undergoes 
spontaneous cyclisation, indicating the highly nucleophilic nature that the thioether imparts 
upon the indole, to give 60 as a 1:1 mixture of diastereoisomers.  Closure of the indolo[2,3-
b]quinoline ring by treatment of this diastereoisomeric mixture 60 with base afforded 61 in 
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good yield as a single diastereoisomer (the base also causes equilibration at C-8).  The C-8 
quaternary centre was then formed by alkylation of 61 with allyl iodide and potassium tert-
butoxide.  X-ray crystallographic analysis established that the single diastereoisomer 62 thus 
generated had the perophoramidine relative stereochemistry.  Dehaloperophoramidine (54) 
was synthesised in another twelve steps from 62.  The overall yield of 54 (eighteen steps 
from 56) was 11%.   
 
Weinreb et al. envisaged formation of the C-7 quaternary centre using a tandem 
intramolecular Heck/carbonylation sequence and initially explored this in model studies.36  
These model investigations were mainly directed at the synthesis of perophoramidine and the 
feasibility of a halogen-selective tandem Heck/carbonylation was examined.  It was expected 
that a preferential reaction with the iodine atom in the presence of the two chlorine atoms in 
63 would be possible (Scheme 12).  Indeed, this reaction was found to proceed with a high 
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Scheme 12. The possibility of synthesising perophoramidine (17) using a halogen-selective tandem 
Heck/carbonylation reaction was explored by Weinreb et al. in a model system.36  Tol = tolyl 
(methylphenyl), DMA = dimethylacetamide, DMF = dimethylformamide, MOM = 
methoxymethyl.   
 
The relative stereochemistry at C-7 and C-8 in 64 is the result of a syn addition of the aryl 
palladium intermediate and carbon monoxide across the E-alkene of 63.  Removal of the silyl 
protecting group of 64 followed by heating of the resulting alcohol under acidic conditions 
afforded lactone 65 as a single diastereoisomer.  Installation of the C-8 quaternary centre was 
achieved by allylation of the lactone enolate derived from 65 to give 66 as a single 
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diastereoisomer in moderate yield.  Using nOe experiments (of particular note was the H-1 to 
H-18 enhancement), the relative stereochemistry of 66 was assigned to be that present in 
perophoramidine (17).   
 
On the basis of the observed stereochemistry of 66, a total synthesis of perophoramidine (17) 
was initiated.37  Using a synthetic protocol similar to that used for the preparation of 66, the 
suitably functionalised intermediate 67 (Figure 4) was prepared in low yield as a single 
diastereoisomer.  Surprisingly, structural analysis using X-ray crystallography revealed that 












Figure 4. A low yielding preparation of 67 was achieved using methodology similar to that used for the 
preparation of 66.37  MOM = methoxymethyl.   
 
This unexpected observation led to the re-examination of compound 66 by conversion to 
hydroxyamide 68 allowing for an unambiguous stereochemical assignment using X-ray 
crystallographic analysis that had not been possible for 66 (Scheme 13).37  This demonstrated 
that the original stereochemical assignment of 66 had been incorrect and that 66 actually had 
the communesin relative stereochemistry.  Now, realising that it was the communesin 
stereochemistry that was generated by alkylation of the lactone enolate, studies towards the 
synthesis of perophoramidine (17) were discontinued and efforts towards developing a total 

























Scheme 13. X-ray crystallographic analysis of 68 demonstrated that the first stereochemical assignment of 66 
was incorrect.37  MOM = methoxymethyl.   
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In attempts to adapt this methodology to suit a synthesis of the communesins, it was 
discovered that the presence of a nitro group at C-4a, which could be reduced to the 
corresponding amine to close the indolo[2,3-b]quinoline ring, caused a reduction in yield of 
the desired Heck/carbonylation product.  A solution to this problem was to synthesise 69 that 
contains a protected hydroxymethyl substituent at C-4a that would allow for a late 
installation of the required nitrogen (Scheme 14).  Additionally, in contrast to the attempted 
synthesis of perophoramidine, a substituent at C-12a was required for the construction of the 

















































Scheme 14. The synthetic approach to perophoramidine (17) was adapted for the beginning of a communesin 
synthesis.37  MOM = methoxymethyl, DMF = dimethylformamide, PMP = p-methoxyphenyl.   
 
During attempts to allylate 69, it was discovered that the allylation of this lactone enolate did 
not proceed by direct C-alkylation, but by a two step process involving O-allylation to form 
70 followed by a Claisen rearrangement to give the C-alkylated products 71 and 72.37  It was 
found that isolation of the O-alkylation product 70 and subsequent separate rearrangement to 
71 and 72 gave better yields than the one pot procedure used in the synthesis of 66.  In 
contrast to the allylation of 65, the rearrangement of 70 was found to give mixtures of 
diastereoisomers 71 and 72 in a ratio that varied with different solvents. Toluene was found 
to give the greatest selectivity in favour of 71.   
 
Whilst many of the synthetic approaches discussed here have the potential to be developed 
into an asymmetric synthesis, the issue of asymmetry has not been addressed directly.  The 
recent asymmetric allylation reported by Trost et al., although not presented as a synthetic 
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strategy for the synthesis of the communesins and perophoramidine (17), has the potential to 
be used as a tool for the asymmetric synthesis of these compounds.38  In this procedure, 
which was applied to various indole substrates, it was found that the anthracene derived 
ligand 73 in combination with a bulky borane derivative, derived from the hydroboration of 
1-hexene with 9-BBN, gave the highest selectivity for C- versus N-allylation and also the 
highest enantiomeric ratios (Scheme 15).  When a pendant nucleophile was present in the 
substrate it was found that this cyclised on to the imine under the reaction conditions to give 
a cis-fused ring system.  Specifically, the indolo[2,3-b]quinoline ring system with a C-7 
quaternary centre in 74 was generated from 75, via 76, in a 91% yield and in an 
enantionmeric ratio of 93:7.  In the context of a communesin and perophoramidine synthesis, 
the fact that this methodology requires an electron rich indole for high enantiomeric ratios to 
be obtained, with best results being obtained with a C-12 electron donating substituent, 
would have to be considered.  Additionally, there is no obvious handle for the generation of 






























Scheme 15. The asymmetric allylation reported by Trost et al. could be used as the basis of an asymmetric 
synthesis of the communesins or perophoramidine (17).38  Boc = tert-butoxycarbonyl, dba = 
dibenzylideneacetone, BBN = borabicyclo[3.3.1]nonane.   
 
 
1.7 A novel approach to the synthesis of perophoramidine and the communesins 
 
The following four chapters of this thesis describe efforts to develop a new synthetic route 
that is applicable to the total synthesis of both perophoramidine (17) and the communesin 
natural products.  As there have been no prior methodological studies related to this current 
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research by the Westwood group, the investigations described in this thesis have not aimed to 
synthesise any particular one of the natural products, but have aimed to develop an 
understanding of the key synthetic steps, particularly those involved with the construction of 
the vicinal quaternary centres, that would be used as part of a total synthesis.   
 
Due to their significant structural differences, it was not the intention that the communesins 
and perophoramidine would be formed from a common intermediate.  Of the structural 
differences between the communesins and perophoramidine that have been taken into 
account when attempting to develop a general strategy, the differences in the aromatic rings 
substituents and the relative stereochemistry at the quaternary centres C-7 and C-8 have 
received the greatest consideration.  Whilst it is considered that the amidine and aminal units 
of perophoramidine (17) and the communesin could be constructed using similar chemistry 
from suitably functionalised precursors, it would be necessary to use precursors with 
opposing relative stereochemistry for the different natural products.  For example, the 
construction of the amidine unit in 77, for a perophoramidine (17) synthesis, will require a 
precursor with trans 2C units and suitably halogenated aromatic rings such as in 78, or a 
















77 78  
Scheme 16. Construction of the amidine functionality in perophoramidine requires trans 2C units.  R1 = 
protecting group.   
 
On the other hand, construction of the aminal functionality in 79, for a communesin 
synthesis, would require a precursor with cis 2C units and a substituent R2, which would 
allow construction of the isoprene based moiety and the azepine ring, such as in 80 or a 

















Scheme 17. Construction of the aminal functionality in the communesins requires cis 2C units.  R1 = protecting 
group.   
 
In general, it was intended that the C-8 quaternary centre would be formed by the alkylation 
of a compound with a suitably acidic H-8, such as 81 for a perophoramidine (17) synthesis 
(Scheme 18).  It was expected that the alkylation would be highly stereoselective, probably 
affording the configuration shown in 82, and therefore allylation would only be suitable for a 
synthesis of perophoramidine.  In this synthetic plan the allyl groups are considered as 
protected 2C units that could be developed through, preferably concurrent, oxidative 





























Scheme 18. It was expected that allylation would give trans allyl groups and that oxidative cleavage would 
therefore give trans 2C units suitable for a perophoramidine (17) synthesis.  R1 = methyl or a 
protecting group.   
 
Based upon the expected approach of the electrophile opposite to the C-7 allyl group when 
forming the C-8 quaternary centre, a communesin synthesis would require alkylation of a 
compound such as 83 with a 1C electrophile, for example formaldehyde, to give 84 (Scheme 
19).  Homologation of the aldehyde moiety of 84, after protection of the primary alcohol, into 
the C-8 2C unit of 85 could then be achieved using, for example, a Wittig reaction with a 
(methoxymethyl)triphenyl phosphonium ylide.  The substituent R1 would be either the 
substituent present in the final natural product (for example, a methyl group for communesin 




















Scheme 19. The formation of the cis 2C units in the communesins would require alkylation of 83 with a 1C 
electrophile followed by independent manipulation of the C-8 pendant groups  R1 = methyl or a 
protecting group, R2 = substituent that would give a handle for the construction of the isoprene 
unit and the azapine ring, P = protecting group.   
 
Of course it is possible that alkylation at C-8 will not be trans selective and that the cis 2C 
relationship present in the communesins will result from allylation.  Indeed, it was one of the 
aims of this research to establish the configuration of the C-8 stereocentre that was generated 
by alkylation.   
 
It was planned that for a synthesis of both perophoramidine (17) and the communesins, the 
aldehyde that renders H-8 acidic in general structures 81 and 83 would be formed by 






























Scheme 20. Reterosynthetic plan showing the communesin natural product numbering and, in parentheses, the 
indolo[2,3-b]quinoline numbering system that will be used in subsequent chapters of this thesis.   
 
Introduction of the ketone and the C-7 quaternary centre of 86 should be possible in a single 
step from allyl ether 87 using a Claisen rearrangement.  It must be noted that the use of a 
Claisen rearrangement to generate the C-7 quaternary centre potentially allows for an 
asymmetric synthesis of the natural products, as asymmetric induction using the Claisen 
rearrangement is well known for suitably substituted allyl ethers (see Chapter 5, section 4).  It 
was expected that allyl ether 87 would be accessible from the appropriately substituted 
indolo[2,3-b]quinolone 88.  The substituent R1 to R5 required in the indolo[2,3-b]quinoline 
ring system will vary with the natural product being synthesised.  Whereas a synthesis of 
perophoramidine would require the appropriate halogen substituents at R3, R4 and R5, a 
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synthesis of the communesins would require a substituent at R2 that will allow construction 
of the isoprene based motif.  For example, a bromine substituent at C-2 would allow for 
construction of this motif late in the synthesis using palladium based chemistry.   
 
Due to the indolo[2,3-b]quinoline ring system being the core of various biologically 
important molecules and natural products, such as the alkaloid cryptoteckieine 89 (Figure 5), 
there are various procedures reported in the literature for the preparation of this ring 












Figure 5. Structure of the natural product cryptoteckieine showing the numbering system conventionally used 
for the indolo[2,3-b]quinoline ring system.   
 
However, there are fewer procedures reported regarding the synthesis of the required 
indolo[2,3-b]quinoline-11-one,45 and there are no reports regarding the synthesis of the 
required functionalised systems.  Additionally, the proposed Claisen rearrangement of the 
type 87 to 86 (Scheme 20) in the indolo[2,3-b]quinoline system has not been reported.  Due 
to this limited information on the synthesis of substituted indolo[2,3-b]quinoline-11-one 
systems, in combination with the lack of information regarding the proposed Claisen 
rearrangement, synthetic studies were initially conducted in a model unfunctionalised 
indolo[2,3-b]quinoline system.   
 
Throughout this chapter the numbering system that is conventionally used for the complex 
communesin natural product structure was adopted.  As the following chapters describe 
studies on relatively simple indolo[2,3-b]quinoline structures, the atoms in this ring system 
are numbered using the system that is conventionally used in this ring system.  Specifically, 
from this point on in the thesis, the quaternary centres at C-7 and C-8 in the natural product 





1.8 Summary  
 
In this chapter the natural products perophoramidine (17) and the communesins have been 
introduced.  The isolation, biological properties, structural features and biosynthesis of these 
indole alkaloids have been outlined.  It has been explained how perophoramidine (17) and the 
communesins are related to the calycanthaceous alkaloids through their biosynthetic origin.  
A review of the literature regarding approaches to the total synthesis of perophoramidine (17) 
and the communesins has been presented, which includes many papers published since the 
research described in this thesis was initiated.  Finally, a novel synthetic approach to these 
compounds was proposed that involves a Claisen rearrangement in the indolo[2,3-b]quinoline 
system as a key step.  Chapter 2 will describe initial investigations into this proposed 




Chapter 2: Investigating the Claisen Rearrangement in a Model System 
 
 
2.1 Introduction  
 
Chapter 1 concluded by proposing a synthetic plan for a new approach to perophoramidine 
17 and the communesin natural products.  It was proposed that this synthetic route would 
initially be investigated in a model system.  This chapter focuses on the preparation of 90 and 
on initial attempts to form the C-10b quaternary centre present in 91 using a Claisen 












Scheme 21. The Claisen rearrangement of 90 to 91 is a key transformation in the proposed new synthesis of 
perophoramidine 17 and the communesins.   
 
The conversion of 90 to 91 involves the rearrangement of an aromatic substrate to give a 
partially dearomatised product.  Whilst there are no published examples of such Claisen 
rearrangements in the indolo[2,3-b]quinoline system, there are examples of all-carbon 
quaternary centre formation by the Claisen rearrangement of similar heteroaromatic 
substrates.  Of particular relevance are the numerous reports of 2-allyloxyindoles undergoing 
Claisen rearrangements to give the corresponding 2-oxindole with a C-3 all-carbon 
quaternary centre.  These rearrangements, which have been extensively studied by the group 
of Kawasaki, have been used in the synthesis of various hexahydropyrrolo[2,3-b]indole 
containing structures46 including the natural products flustramine A-C,47,48 flustramide A and 
B,48 and pseudophrynaminol.49  As an example, Scheme 22 shows the Claisen rearrangement 
used as a key step in the synthesis of flustramine C (92).47  In this one pot procedure, 
treatment of 93 with cyanomethylphosphonate forms 94 that, after isomerisation under the 
reaction conditions to 95, undergoes a Claisen rearrangement to give oxindole 96 in 73% 
yield.  Reduction followed by alkylation of the resulting pyrrolo[2,3-b]indole furnished the 
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Scheme 22. Key steps in the synthesis of flustramine C (92).47  Red-Al = sodium bis(2-
methoxyethoxy)aluminiumhydride, Ac = acetyl.   
 
A similar one pot protocol is used for the generation of a series of spirocyclic oxindoles 97 
from 2-halo indoles 98 (Scheme 23).50  After using an intramolecular Ullmann coupling to 
generate the pyranoindoles 99 from 98, the pyranoindoles 99 are rearranged, under thermal 





















Scheme 23. A series of spirocyclic oxindoles is formed using a one pot procedure involving an intramolecular 
Ullmann coupling followed by a Claisen rearrangement.50  DME = 1,2-dimethoxyethane.   
 
Claisen rearrangements in the quinoline system that have led to the isolation of products with 
a disrupted aromatic system and an all-carbon quaternary centre are far less common.  The 
only report of such a dearomatisation found in the literature describes the heating of 
quinoline 100 in xylenes and isolating 101 in low yield (the exact isolated yield is not 
reported).51  Further heating transforms 101 to 102 via a Cope rearrangement of the 


































Scheme 24. It is reported that 101 has been isolated from the thermal rearrangement of 100.51   
 
In light of the literature precedent for the use of the Claisen rearrangement to form an all-
carbon quaternary centre at the desired position in both the indole and the quinoline system, a 
synthesis of the 11-allyloxyindolo[2,3-b]quinoline Claisen substrate 90 was initiated.   
 
 
2.2 Synthesis of 11-allyloxy-5-methyl-5H-indolo[2,3-b]quinoline 
 
Two alternative methods for the preparation of the required indolo[2,3-b]quinoline-11-one 
system have been published.45  As it was anticipated that gram quantities of 90 would be 
required, the method that appeared to be most amenable to multigram preparation was used.  
The alternative method involves heating of 2,4-dichloroquinoline (104) with benzotriazole 
(104) to give a mixture of regioisomers 106 and 107.  This mixture of isomers is treated with 
hot polyphosphoric acid and the desired isomer 108 is separated by crystallisation after 
treatment with acetic anhydride.  Removal of the acetyl group with aqueous hydrochloric 
acid to give 109 and treatment with water in hot dimethyl sulfoxide affords the indolo[2,3-
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Scheme 25. Low yielding route to indolo[2,3-b]quinoline-11-one 110. Ac = acetyl, DMSO = dimethyl 
sulfoxide.45   
 
This route to the indolo[2,3-b]quinoline-11-one system was considered unacceptable as it is 
intrinsically low yielding due to the low regiochemical selectivity of the coupling of 105 with 
104.   
 
The higher yielding published route to the indolo[2,3-b]quinoline-11-one system involves the 
coupling of indoles with anilines to form the corresponding 2-aminoindoles that are 
subsequently cyclised to the indolo[2,3-b]quinoline-11-one products.45  It was this route that 
was used in the current investigation.  The synthesis of 110 started with the coupling of 
indole-3-carboxylic acid methyl ester (111) with aniline to form 2-aminoindole 112 (Scheme 
26).  The literature report of the synthesis of 112 describes the use of chromatography to 
purify 112.45  However, so as to avoid the use of chromatography, 112 was purified by 















Scheme 26. Preparation of 2-aminoindole 112 according to the literature procedure.  DMP = N,'N-
dimethylpiperazine, NCS = N-chlorosucinimide, TCA = trichloroacetic acid. 
 
As the coupling of indole-3-carboxylic acid methyl ester (111) with anilines was used 




formed is shown in Scheme 27.52  In this mechanism it is proposed that the reaction of 111 
with N-chlorosuccinimide (NCS) in the presence of N,'N-dimethylpiperazine (DMP) leads to 
the in situ generation of the highly reactive chloroindolenine 113.  Nucleophilic attack by 
aniline at C-2 of 113 gives 114 that subsequently eliminates hydrogen chloride to form the 2-
aminoindole product 112.  Presumably, if addition of aniline is syn to the chlorine, 
elimination of hydrogen chloride will be via an E2 mechanism as opposed to an E1 process 





























Scheme 27. The proposed mechanism for the coupling of nucleophiles with indole-3-carboxylic acid methyl 
ester.52  DMP = N,'N-dimethylpiperazine, NCS = N-chlorosucinimide, TCA = trichloroacetic acid.   
 
Cyclisation of 112, with the loss of methanol, in refluxing diphenyl ether afforded 110 in 
excellent yield after filtration and washing with ether (Scheme 28).45  The insolubility of 110 
in most common solvents made purification of this compound impractical.  However, crude 
110 synthesised by this method, using crystallised 112, was found to be of high purity (as 
determined by 1H NMR) and could be used directly in the subsequent reaction.  Initially 
when considering the synthesis of 110, it was intended that the 11-allyloxy moiety would be 
installed by O-allylation of 110, or an N-functionalised derivative of 110.  However, it soon 
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Treatment of 110 with refluxing phosphorus oxychloride afforded chloride 109 in high yield 
and could be carried out on a multigram scale after modification of the literature procedure.45  
As was the case with 110, purification of the highly insoluble chloride 109 was unfeasible 
and therefore crude 109, of satisfactory purity, was used in the subsequent transformation.   
 
The advantages of converting 110 to 109, in regard to a synthesis of 90, are twofold.  First, 
with only one acidic proton present, the indolic nitrogen (N-6) of 109 was methylated using 
an excess of reagents to give novel compound 115, now sufficiently soluble to allow 
chromatographic purification, in good yield (Scheme 29) (the position of the methyl group 
was determined after conversion of 115 to 90).  Despite the insolubility of 109 in 
tetrahydrofuran, tetrahydrofuran was found to be a satisfactory solvent for the methylation of 
109 due to the increased solubility of the corresponding anion in this solvent.  Whilst there 
have been reports in the literature of mixed products from the alkylation of similar 
substrates,53 the methylation of 109 with sodium hydride and methyl iodide was found to be 
highly regioselective (no other methylated products were detectable by 1H NMR).  This high 
degree of selectivity is presumably due to the localisation of the negative charge on N-6 


























Scheme 29. Preparation of novel compounds 115 and 90.   
 
The second advantage of converting 110 to 109 was that the allyloxy moiety in 90 could be 
installed by displacement of the chlorine atom of 115 in an addition-elimination process.  
After two days at 70 °C, complete displacement of the chlorine in 105 with sodium allyloxide 
had occurred and 90 was isolated in good yield after purification by chromatography and 
crystallisation, which was required to achieve high purity (determined by elemental analysis 
and 1H NMR).   
 
The position of the methyl group in 90 could now be unequivocally assigned using a 1H-13C 
HMBC NMR experiment: a correlation was observed between the methyl protons and C-6a.  




1 to H-4), the protons in ring D (H-1 to H-4) were assigned using correlations to C-11, and C-
11 was assigned on the basis of a correlation to the allylic protons.  A selection of instructive 
correlations are shown in Figure 6.   
 
 
Figure 6. HMBC spectrum of 90 showing selected correlations that were used to determine the position of the 
methyl group.   
 
 
2.3 Attempts to form the C-10b quaternary centre using a Claisen rearrangement  
 
With 90 in hand, formation of a quaternary centre at C-10b by rearrangement of 90 was 
examined.  In summary, all attempts to rearrange 90 in a variety of different solvents 
(including tetrahydrofuran, methanol, toluene, and trifluoroacetic acid) and at different 
temperatures to the desired compound 91 were unsuccessful.  The only compound that could 
be isolated from the thermal rearrangement of 90 was a compound, more polar than 90, with 
spectroscopic data consistent with structure 116, resulting from the formal migration of the 
allyl group from O-11 to N-5 (Scheme 30).  Of particular note for structural determination 
was the presence of a low field (173.3 ppm) quaternary (determined using the PENDANT 
pulse sequence) carbon signal in the 13C NMR spectrum associated with 116, consistent with 




associated with 116 revealed a mutual correlation of the α-allylic protons with C-5a and C-5a 
with the methyl protons, thereby indicating the close proximity of the allyl and methyl 
groups.  In refluxing toluene, the transformation of 90 to 116 was complete after four days 


















Scheme 30. In refluxing toluene the transformation of 90 to 116 was found to be complete after four days.   
 
The formation of 116 was not wholly unexpected in light of various previously published 
observations.  For example, in addition to the formation of 101 (Scheme 24) and its 
subsequent Cope rearrangement to 10251 that has already been discussed on pages 25-26, a 













Scheme 31. The formation of 118 from 117 is reported to proceed via a two step intramolecular process with 
119 as an intermediate.54   
 
It is reported that when 117 is heated without solvent, 118 is formed in near quantitative 
yield.  Whilst it is proposed, with supporting experimental evidence gained from the 
rearrangement of analogues of 117, that the transformation of 117 to 118 proceeds via 119 in 
a two step intramolecular process, a direct one step intermolecular migration is also possible.  
Indeed, intermolecular 1,3-migrations of alkyl groups from oxygen to nitrogen have been 
observed. For example, the rearrangement of 2-methoxypyridine to N-methyl-2-pyridone has 





The rearrangement of 90 to 116 can also be rationalised by either of two mechanistic 
pathways.  First, this rearrangement could be a two step intramolecular process, Claisen 
rearrangement followed by an aza-Cope rearrangement,56,57 with 91 as an intermediate.  It 
must be noted that an intramolecular mechanism involving a Claisen rearrangement to form 
the C-11a substituted intermediate followed by an aza-Cope rearrangement is also possible 
but, as this would involve breaking the aromaticity of a benzene ring, is considered unlikely.  
Second, a mechanism involving cleavage of the ether bond and the consecutive 
intermolecular allylation of N-5, not involving the formation of 91, can be envisaged.  As 
only one of these mechanisms implies the existence, albeit transient, of desired 91, it was 
considered important to understand the mechanisms involved in the transformation of 90 to 
91.   
 
 
2.4 Investigating the allyl migration mechanism  
 
When 90 was rearranged to 116 at a range of starting concentrations no change in rate was 
observed (Table 1).  This suggested that the reaction followed first order kinetics consistent 







Table 1. The effect of concentration on the rate of O-11 to N-5 allyl migration.   
 
In an attempt to gain further corroborating evidence for an intramolecular mechanism, a 
crossover experiment was devised.  In such an experiment the "migrating" group and "fixed" 
group are independently labelled, thereby allowing the origin of the migrating group to be 
traced.  It was intended that the crossover experiment would use the two structurally isomeric 
compounds 120 (Scheme 32) and 121 (Scheme 33).  The preparation of 120 (Scheme 32) 
followed the same procedure that had been used to prepare 115 from 109, but using ethyl 
iodide to form 122 from 109 (Scheme 29). 
 
Rearangement of 90 to 116 in refluxing toluene 




* Calculated from integration of CH3 peaks in the crude 1H NMR 





















Scheme 32. Preparation of 120.      
 
It was found that the low yielding preparation of 121 from 115 (Scheme 33) required a lower 
temperature and a longer reaction time, due to the rapid rearrangement of 121 at a higher 
temperature, than was required to form 90 from 115 (Scheme 29).  No attempt was made to 








THF, 55 °C, 65h, 16%
Na, 2-butene-1-ol
115 121  
Scheme 33. Low yielding preparation of 121.   
 
It was intended that the crossover experiment would involve the thermal rearrangement of 
120 in the presence of 121 and that, due to the isomeric nature of 121 and 120, any change in 
the molecular weight of the components in the reaction mixture would be indicative of the 
intermolecular transfer of the allyl or butenyl groups.  That is to say, it was intended that after 
heating a mixture of 120 and 121 until significant rearrangement of both compounds had 
occurred, analysis of the crude reaction mixture by mass spectrometry would rapidly identify 
the presence of any crossover products with molecular weights of 316 and 288.   
 
However, the greatly accelerated rate of rearrangement that was observed for 121 (Scheme 
34) in relation to that of 120 invalidated the planned crossover experiment as only trace 
amounts of 120 would have rearranged in the time that it would take for all of 121 to be 



















Scheme 34. The rate of rearrangement of butenyl ether 121 to 123 is faster than that observed for the 
corresponding allyl ether.   
 
Despite this failure of the crossover experiment, two useful pieces of information that suggest 
an intramolecular mechanism involving a Claisen followed an aza-Cope rearrangement, but 
do not conclusively refute an intermolecular mechanism, were gained from the rearrangement 
of 121 (Scheme 34).  First, it was observed that the only product formed from the thermal 
rearrangement of 121 was 123 and not the alternative regioisomer 124 that could be formed 
from an intermolecular alkylation of N-5, albeit at the more sterically hindered end of the π-
allyl system.  The E-geometry of the alkene moiety in 123 was demonstrated by 1H NMR 
spectroscopy.  The alkene protons coupling constant (3J =15.8 Hz) was measured after 
irradiating at the methyl proton's resonance frequency, in a homonuclear decoupling 
experiment, so as to simplified these signals that appear as multiplets in the standard 1H 
NMR spectrum.   
 
Furthermore, the observation that the rate of rearrangement of the butenyl ether 121 is 
considerably greater than that of the allyl ether 90 also suggests an intramolecular mechanism 
involving a Claisen followed an aza-Cope rearrangement.  This acceleration of rate is 
consistent with the previously documented observation that electron donating substituents at 
the γ-allylic position accelerate the rate of the Claisen rearrangement.58  This effect has been 
rationalised in light of experimental evidence that bond breaking precedes bond 
formation.59,60  Electron donating substituents at the γ-allylic position of the allyl vinyl ether 
125 should lower the energy of the transition state 126 by facilitating cleavage of the C-O 
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Scheme 35. The rate accelerating effect that electron donating groups have at the γ-allylic position has on the 
Claisen rearrangement has been rationalised by considering how such substituents should facilitate 
bond cleavage.  EDG = electron donating group.   
 
 
2.5 Detection of the intermediate species 91 
 
Although an intermolecular allyl migration could not be completely ruled out, the proposed 
intermediacy of 91, in the transformation of 90 to 116, was now tenable and consideration 
was given to whether 91 was sufficiently stable to permit detection.  Generally, the 
intermediate species in two step consecutive reactions reaches the highest concentration early 
in the reaction progress.  Based on this assumption, it was reasoned that detection of 91 
would be most likely early in the reaction progress before large amounts of 90 had been 
consumed.   
 
After heating 90 for one hour at 100 °C, detailed analysis of the 1H NMR spectrum 
associated with the crude reaction mixture indicated the presence of a trace quantity 
(approximately 0.5% in comparison to 90) of a third compound that was neither 90 nor 116 
(Figure 7).  It was reasoned that if this additional compound was 91 it should be possible to 
detect a signal for C-11 of the carbonyl group at approximately 200 ppm in the 13C NMR 
spectrum.  Due to the low concentration of this compound in relation to 90 the sensitive 
HMBC experiment was used.  Indeed, this analysis did indicate the presence of a carbon with 
a chemical shift of 195 ppm that correlated with a signal at 8.00 ppm in the 1H dimension, 
presumed to be H-1 of 91.  Not only did this give further support to the proposed 
intermediacy of 91, it also demonstrated that 91 was a relatively stable and long lived 






Figure 7. After heating 90 in toluene-d8 for one hour, 1H NMR and 1H13C HMBC spectra indicate the presence 
of 91.  The major peaks in the 1H dimension correspond to the protons of 90.   
 
Being encouraged by these investigations, consideration was given as to how the 
concentration of this intermediate could be increased to an isolable level.  A potential 
solution to this problem was reached by considering this two step process in terms of the 
relative rates (or activation energies) of the two steps involved.  For 91 not to accumulate in 
the reaction mixture, the rate of the aza-Cope rearrangement must be significantly greater 
than that of the Claisen rearrangement (Figure 8).  That is to say, the free energy of 
activation for the Claisen rearrangement of 90 (∆G‡1) must be significantly greater than the 
















reaction coordinate  
Figure 8. For intermediate 91 not to accumulate ∆G‡1 must be greater than ∆G‡2.   
 
By rationalising the two-step process in this way it can be seen that if the relative magnitudes 
of the activation energies for the two steps were to be reversed so that the rate of the Claisen 
rearrangement is competitive with that of the aza-Cope rearrangement (either by accelerating 
the first step or retarding the second) the desired intermediate with a C-10b quaternary centre 











Figure 9. If ∆G‡2 were to be greater than ∆G‡1 the intermediate species would accumulate in the reaction 
mixture.   
 
Initially it was proposed that the activation energy of the aza-Cope rearrangement could be 
increased in relation to that of the Claisen rearrangement by positioning a sterically 
demanding group at N-6 instead of the methyl group in 90.  Attempts were made to 
synthesise an analogue of 90 with a bulky triphenylmethyl group at N-6.  However, as 
alkylation of 109 with chlorotriphenylmethane could not be achieved this approach was 
abandoned.   
 
Next, consideration was given to how the activation energy to the Claisen rearrangement 
could be reduced.  It was proposed that a reversal of the rates could be achieved by using the 




90, from N-6 to N-5.  It was expected that this would have the effect of lowering the 
activation energy for the Claisen rearrangement whilst leaving the activation energy for the 
aza-Cope rearrangement essentially unchanged.  The preparation and rearrangement of 129 is 









Figure 10. It was proposed that rearrangement of the modified substrate 129 would allow isolation of the 
intermediate Claisen product with the C-10b quaternary centre 
 
 
2.6 Summary and conclusions  
 
The aim of the investigations described in this chapter was to determine the expediency of 
the Claisen rearrangement that is a key step in the proposed new synthesis of 
perophoramidine and the communesins.  The synthesis of the model Claisen substrate 90 and 
attempts to form the C-10b quaternary centre, present in 91, by rearrangement of this 
compound were described.  It was found that rearrangement of 90 did not give 91 but led to 
the formation of 116, the result of the formal migration of the allyl group from O-11 to N-5.  
After an investigation into the mechanism of this allyl migration, it was concluded that the 
observed rearrangement was a two step consecutive, Claisen followed by aza-Cope 
rearrangement, intramolecular process involving the intermediate 91.  Intermediate 91 was 
detected using a 1H-13C HMBC experiment and a rationalisation as to why 91 does not form 
was made based on the relative activation energies of the two steps.  A modified structure 
129 for the Claisen structure was proposed.  Chapter 3 outlines the preparation and 
rearrangement of 129 before discussing the differences in chemical behaviour between 129 
and 90.   
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Chapter 3: A Redesigned Model System 
 
 
3.1 Introduction  
 
Chapter 2 described the preparation and rearrangement of allyl ether 90.  Whilst it was found 
that 90 did undergo a Claisen rearrangement to form the desired compound 91, 91 did not 
accumulate to an isolable quantity in the reaction mixture (Scheme 36).  The only product 
that could be isolated from the rearrangement of 90 was 116, resulting from the subsequent 














Scheme 36. Claisen rearrangement and subsequent aza-Cope rearrangement of allyl ether 90.  
 
Chapter 2 concluded by proposing that if the rate of the Claisen rearrangement could be 
accelerated in relation to the rate of the aza-Cope rearrangement the desired intermediate 
would accumulate in the reaction mixture.  It was further proposed that rearrangement of the 
modified substrate 129 should facilitate accumulation of the desired intermediate.  First, this 
chapter focuses on the preparation of 129 and its subsequent rearrangement to 130 (Scheme 
37).  Next, an exploration into the effect that substituents at the α- and γ-allylic positions 
have on the Claisen and aza-Cope rearrangements is described.  Finally, a limited 










Scheme 37. It was expected that the C-10b quaternary centre in 130 could be formed by rearrangement of the 
modified substrate 129.   
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3.2 Synthesis of 11-allyloxy-6-methyl-6H-indolo[2,3-b]quinoline (129)  
 
Using the previously reported procedure, known indolo[2,3-b]quinoline-11-one 131 was 
prepared in three steps from indole-3-carboxylic acid methyl ester (111) (Scheme 38).45  
Whilst the previous synthesis of 90 required methylation at N-6 after formation of the 
indolo[2,3-b]quinoline ring system, synthesis of 131 allowed the N-5 methyl substituent to be 
present from the beginning of the synthesis by using N-methyl aniline.  Coupling of 111 with 
N-methylaniline afforded 132 that was subsequently cyclised in refluxing diphenyl ether to 
give 131.  Both these steps proceeded in good yield and were amenable to multigram scale 
preparation.  Although the literature describes the use of chromatography to purify 132, it 
was found that 132 could be prepared in batches of up to twenty grams when crystallisation 
was used as the purification method and 131 required no purification other than washing with 

























Scheme 38. Preparation of 5,6-dihydro-5-methylindolo[2,3-b]quinoline-11-one (131) acording to the literature 
procedure.  DMP = N,'N-dimethylpiperazine, NCS = N-chlorosucinimide, TCA = trichloroacetic 
acid.   
 
Treatment of 131 with refluxing phosphorus oxychloride afforded novel chloride 133 in 
excellent yield (Scheme 39).  Displacement of the chlorine atom in 133 with allyl alcohol 
and sodium at ambient temperature afforded the desired allyl ether 129, again in excellent 
yield.  Both 133 and 129 were initially purified by chromatography and it is the purified 
yields that are shown in Scheme 39.  However, when a large scale preparation of 129 was 
later required, it was found that both steps could be conducted without purification if 131 was 






















Scheme 39. Preparation of novel compounds 133 and 129.   
 
It is interesting to note that, unlike the 6-methyl derivatives 115 and 90, 129 (dark yellow) 
and 133 (bright orange) are both highly coloured compounds, presumably due to their 
extensive π-electron systems delocalised over all four rings.  Additionally, an interesting 
observation regarding colour was made during the isolation of 133 (Scheme 40).  When 133 
was a suspension in aqueous acid, after quenching any remaining phosphorus oxychloride 
with water, 133 was observed as a yellow solid.  However, when this aqueous suspension of 
133 was basified with sodium bicarbonate prior to isolation (either by extraction into 
dichloromethane or, for larger scale preparation, by filtration) a dramatic colour change to 
bright orange was observed.  A rationalisation for this striking colour change is presented in 
Scheme 40.  Protonation of 133, with the π-electrons delocalised throughout all four rings, 
gives 134 with the π-electrons localised in two isolated conjugated systems similar to that of 













Scheme 40. The extended conjugated system of 133 appears orange whereas the two isolated conjugated 
systems of 134 give a yellow colour.   
 
A further experimental observation of interest is that the formation of 129 from 133 required 
a lower temperature and shorter reaction time than was required for the formation of 90 from 
115 (page 29).  To rationalise this mechanistically, if the energies of the two intermediates 
(135 and 136, Figure 11) in these addition-elimination processes are assumed to be 
approximately equal, an increased ground state energy of 133 would explain its greater 
lability.  Presumably this difference in ground state energy is due to the stable quinoline 
aromaticity present in 115, which is broken when forming 136, that is not present in 133.  
Encouragingly, this observation suggested that a similar destabilisation of 129, in relation to 
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90, would potentially increase the rate of the Claisen rearrangement and facilitate the 








135 136  
Figure 11. The two intermediate species generated by the addition of sodium allyloxide to 133 or 115 are 
assumed to be of approximately equal stability.   
 
 
3.3 Rearrangement of 11-allyloxy-6-methyl-6H-indolo[2,3-b]quinoline (129) 
 
Expecting a more facile rearrangement than had been observed for 90 (page 31), 129 was 
heated in refluxing methanol (Scheme 41).  After nineteen hours complete consumption of 
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Scheme 41. The attempted Claisen rearrangement of 129 in methanol afforded two unexpected compounds.   
 
The more polar of the two was an orange compound that was assigned the structure of known 
compound 137.53 The structural assignment of 137 was based mainly on observations of the 
1H NMR spectrum that showed, in relation to 129, a loss of the allyl group, the presence of 
an additional O-methyl group and only minor changes in the aromatic proton signals.  The 
less polar yellow compound, which was isomeric with 129, was assigned the structure of 
indolo[2,1-b]quinazolin-12-one 138 using 1H-13C HMBC and 1H-1H nOe experiments.  Of 
particular value for structural determination was the observed nOe between the α-allylic and 
methyl protons.  The structure of 138 was later confirmed by X-ray crystallography (Figure 











Figure 12. X-ray structure of 138.   
 
It was reasoned that the formation of 137 and 138 was a function of the nucleophilicity of 
methanol.  However, the mechanism of formation of 138 from 129 is not as obvious as the 
addition-elimination process with loss of allyl alcohol that gives rise to 137.  It was believed 
that 138 was formed by the methanol catalysed rearrangement of 130, generated in situ from 
129, and the following series of mechanistic events were proposed (Scheme 42).  After initial 
rearrangement of 129 to 130, nucleophilic attack by methanol at C-11 causes the breaking of 
the C-10b-C-11 bond.  Subsequent rotation about the N-5-C-5b bond of 139 and 
intramolecular attack of the indole nitrogen at the ester, causing the loss of methanol, gives 

































Scheme 42. Proposed mechanism for the formation of 138.   
 
The use of a non-nucleophilic solvent, with a similar boiling point to that of methanol, for the 
rearrangement of 129 was expected to prevent the formation of both the undesired 
compounds, 137 and 138.  Indeed, after 4.5 days in refluxing tetrahydrofuran, 129 was found 
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to have undergone complete transformation to the desired product 130 with a quaternary 
centre at C-10b.  Subjecting 90 to these same reaction conditions was shown to form only 
trace amounts of 116, suggesting that the rate of the Claisen rearrangement for 129 had been 
significantly increased in relation to that of 90.  The use of refluxing toluene, however, for 
the transformation to 129 to 130 was later considered preferable as the time for complete 
rearrangement was reduced to five hours and only a small reduction in yield was observed 
due to the subsequent aza-Cope rearrangement.  Under these conditions 130 was isolated in 














Scheme 43. High yielding formation of the quaternary centre at C-10b using a Claisen rearrangement.    
 
Evidence that the desired compound 130 had been formed was gained from the 1H NMR 
spectrum associated with this compound that showed the diagnostic well separated signals 
corresponding to the diastereotopic α-allylic protons.  In the 13C NMR spectrum, recorded 
using the PENDANT pulse sequence, the quaternary carbon signal associated with C-10b 
was readily distinguished at 66.2 ppm and the low field signal associated with the carbonyl 
carbon C-11 was observed at 192.9 ppm.  Additionally, 13C-1H HMBC and 1H-1H nOe 
correlations, were consistent with structure 130.  Finally, the structure of 130 was confirmed 








Figure 13. X-ray structure of 130.  
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Now that 130 could be isolated, it was confirmed that 138 had arisen from the methanol 
catalysed rearrangement of 130.  Indeed, when 130 was heated in methanol at reflux a 
complete transformation to 138 was observed in less than twelve hours and 138 was isolated 














Scheme 44. Methanol catalysed rearrangement of 130 to 138.   
 
Regarding the rearrangement of 130 to 138, it is interesting to note that there is only one 
report of C-10b substituted 5-methyl-10bH-indolo[2,3-b]quinolin-11-ones, similar to 130, 
found in the literature.61  These compounds are reported to have a thiomethyl substituent 
replacing the allyl group at C-10b of 130.  However, it was later demonstrated that the 
structural assignment made in this report was incorrect and that the compounds in question 
were in fact the corresponding indolo[2,1-b]quinazolin-12-ones, similar to 138.62  It is 
possible that a rearrangement similar to 130 to 138 had also occurred in this case but was not 
detected by the authors.61 
 
Further heating of 130 in refluxing toluene for four days caused the expected aza-Cope 
rearrangement to 140 that was isolated in 72% yield.  A minor product 141, resulting from a 
Cope rearrangement of the allyl group to C-1, was also isolated in 12% yield (Scheme 45).  It 
was shown that the times required for complete conversion of 129 to 140 and 90 to 116 are 
approximately equal, requiring about four days in refluxing toluene.  This suggests that the 
rate of the aza-Cope rearrangements in each case are approximately equal and it is only the 
rate of the Claisen rearrangements that are significantly different.  Heating 130 without 
solvent at 180 °C reduced the time for complete rearrangement to 1.5 hours, whilst also 
increasing the quantity of 141 formed.  The separation of 140 from 141 proved to be 
troublesome requiring chromatography using methanol-chloroform mixtures to prevent co-
elution of these compounds.  It was noted that if the yield of 141 could be increased, this 
method of functionalising C-10 of the indolo[2,3-b]quinoline system could potentially be 
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Scheme 45. Aza-Cope and Cope rearrangements of 130.   
 
 
3.4 Rationalising the difference between the two systems   
 
In Chapter 2 it was rationalised that the intermediate 91 did not accumulate because the rate 
of the aza-Cope rearrangement was significantly greater than the rate of the Claisen 
rearrangement, and it was proposed that by moving the methyl group from the indolic (N-6) 
to the quinolic (N-5) nitrogen the relative magnitudes of the two rates would be reversed.  
Now that a comparison of the two systems could be made and it was clear that the rate of the 
Claisen rearrangement had been significantly increased for 129 in comparison to that of 90 
(pages 30-31), the following rationalisation was made.  Whilst both 129 and 90 can be 
considered as complete aromatic (4n + 2) systems of 18-π-electrons (n = 4, including the 
nitrogen lone pair), suggesting that there is no difference in stabilisation, it is the individual 
aromatic components of the ring systems that are of greater importance to stability and the 
degree of isolated double bond character within these components must be considered.   
 
Generally, the propensity of aromatic systems to undergo dearomatisation by a Claisen 
rearrangement can be considered as evidence for the isolated double bond character of the 
participating aromatic double bond.  For example, the indole aromatic systems already 
discussed at the beginning of Chapter 2 undergo Claisen rearrangements with a breaking of 
the complete indole aromaticity but with preservation of the more stable benzene π-electron 
system.  A further example of this is illustrated by a Claisen rearrangement in the aromatic 
naphthalene system (Scheme 46).63,64  Rearrangement of 142 affords almost exclusively 143, 
with disrupted naphthalene aromaticity, in preference to 144 with the intact naphthalene π-
system.   
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Scheme 46. Claisen rearrangement of naphthalene 142 preferentially forms the product with disrupted 
naphthalene aromaticity.   
 
This, at first sight surprising, preference for the formation of the dearomatised product can be 
rationalised when the individual aromatic components are considered during the two step 
process that forms 144 from 142 (Scheme 47).  Claisen rearrangement of 142 to give 
intermediate 145 requires the breaking of the benzene aromatic system and is less favourable 
than formation of 143.  This shows the isolated double bond character of the naphthalene 
system and that the individual aromatic components must be considered when rationalising 
chemical behaviour.   
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Scheme 47. The formation of 144 necessitates an intermediate 145 with disrupted benzene aromaticity.   
 
This rationalisation implies a hierarchy of aromatic stabilisation with the quinoline π-system 
of 129 conferring a greater degree of stabilisation than that of the complete 18-π-electron 
system in 90.  That is to say, 90 is more aromatic than 129 and therefore 90 is at a lower 
ground state energy than 129.  When the intermediates 91 and 129 are considered to be of 
similar ground state energy this destabilisation of 129 in relation to 90 is fundamental.  A 
computational comparative investigation of these two system gives an interesting insight into 







3.5 Extending the scope of the Claisen rearrangement    
 
Having established a method for the formation of the desired quaternary centre at C-10b in 
the indolo[2,3-b]quinoline system, it was considered interesting to attempt to form this 
quaternary centre from analogues of 129 with methyl substituents on the allyl group.  This 
was investigated through the preparation and rearrangement of 146, 147 and 148 (Scheme 
48, Scheme 49 and Scheme 50 respectively).  The rearrangement of each of these three 
compounds, which were prepared from 133 using methodology analogous to that used for the 
synthesis of 129, will be described individually.  However, in all three cases it was found that 
the Claisen rearrangement was significantly accelerated in relation to that observed for 129 
and required only a few hours in refluxing tetrahydrofuran were required for complete 
consumption of the allyl ethers.  Moreover, this acceleration of rate prevented the isolation of 
pure samples of 146, 147 and 148 due to their rearrangement, albeit slow, at room 
temperature.  This acceleration of the Claisen rearrangement rate can be attributed to the 
electron donating effect of the methyl substituents at either the α- or γ-allylic positions (see 
pages 34-35,).58  The reaction conditions presented in Scheme 48, Scheme 49 and Scheme 
50 are those that were optimised for the rearrangement of 148 as this was considered the most 
synthetically useful transformation.   
 
Crude 146 was synthesised from 133 using trans-2-butene-1-ol (Scheme 48).  It was found 
that high yields of the Claisen product 149 could not be obtained by rearrangement of 146 
without considerable quantities of 150 also being formed.  This indicated that, in comparison 
to 129, there was a disproportionate increase in the rate of the aza-Cope rearrangement in 
relation to the rate of the Claisen rearrangement.  This additional acceleration of the aza-
Cope rearrangement can be rationalised by considering the increase in steric strain that 
occurs on transformation of 146 to 149 and the release of steric strain that occurs on 
transformation of 149 to 150.  After crude 146 was heated in refluxing tetrahydrofuran for 
2.5 hours, 149 was isolated in 40% yield as a single diastereoisomer.  Whilst the relative 
stereochemistry of 149 could not be determined directly, it was assumed to be as depicted 
based on the premise that the Claisen rearrangement of 146 had proceeded via a chair 
transition state with the methyl group occupying an equatorial position.  The signals 
associated with the alkene protons of 150 appear as multiplets in the 1H NMR spectrum.  
However, selective irradiation at the methyl proton's resonance frequency (homonuclear 
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decoupling) allowed the 3J coupling constant between the alkene protons of 150 to be 




















Scheme 48. Synthesis and rearrangement of 146.     
 
Crude 147 was synthesised from 133 using 3-methyl-2-butene-1-ol (Scheme 49).  Whilst 
inspection of the 1H NMR spectra associated with the crude reaction mixtures from the 
preparation and rearrangement of 147 did show traces of what was believed to be 151, it was 
not possible to isolated this transient compound.  Indeed, it was found that the only 
compound that could be isolated from the rearrangement of 147 was 152.  For example, after 
2.5 hours at reflux 152 was isolated in a 88% yield.  In this case, the disproportionate 
increase in the rate of the aza-Cope rearrangement in relation to the rate of the Claisen 
rearrangement was even more pronounced than with 146 and this is presumably due to the 





















Scheme 49. Preparation and rearrangement of 147.   
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The rearrangement of 148, formed from 133 and 3-butene-2-ol (153), proved to be of greater 
synthetic value than the rearrangement of 146 or 147 (Scheme 50).  Indeed, 154 could be 
formed in high yield without any significant aza-Cope rearrangement product being 


















Scheme 50. Preparation of 148 using 3-butene-2-ol (153) and rearrangement to 154.  
 
Of particular note is that only E-alkene 154 was observed and not the possible Z-isomer.  As 
before the alkene geometry was determined from the 3J coupling constant of the alkene 
protons (15.2 Hz) after homonuclear decoupling of the methyl protons.  This selectivity for 
the E-alkene is important as it suggests that the Claisen rearrangement is proceeding via an 
ordered transition state, most likely a chair, in which the methyl group occupies an equatorial 
position (if the methyl group occupies an axial position the Z-alkene will result).  
Furthermore, this implies that the stereochemical information embedded in the chiral centre 
of 148 has been transferred to the newly formed chiral centre in 154.  Of course, in this 
racemic mixture such a chirality transfer could not be assessed.  However, the fact that 
chirality transfer has occurred becomes significant when an enantiomerically enriched 
substrate is rearranged and this is the subject of section 4 in Chapter 5.    
 
 
3.6 Protecting groups 
 
The results reported in this section were obtained in collaboration with Helmut Kraus as part 
of his M. Chem. Research Project,  Specifically, attempts at benzyl deprotection of 161 and 
the preparation of 170, 172, 174, and 176 were carried out in collaboration with Helmut 
Kraus.   
 
As the Claisen rearrangement used to form the C-10b quaternary centre requires a substituent 
on the quinolic nitrogen N-5, and neither perophoramidine nor the communesins have a 
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substituent at this position, it was clear that an N-5 substituent that could be removed later in 
the synthesis was required.  Whilst the development of a protection group strategy was not a 
primary aim of this project, some consideration was given to this matter and the synthesis of 
N-5 protected analogues of 130 were investigated. 
 
Considering it desirable not to change the synthetic route that had already been developed, a 
protecting group that was stable to the reaction conditions used and that could be introduced 
at the beginning of synthesis as the appropriate N-substituted aniline was required.  
Specifically, to allow introduction at the beginning of the synthesis, the protecting group 
must not reduce the nucleophilic character of the aniline as would be the case with, for 
example, an amide protecting group.  Furthermore, not only must the high temperature 
cyclisation in refluxing diphenyl ether be tolerated, but so must the potentially strongly acidic 
conditions of the phosphorus oxychloride reaction and the nucleophilic/basic nature of the 
sodium allyloxide.  Taking these factors into account a choice was made in favour of benzyl 
and methoxy-substituted benzyl protecting groups.  Whilst there is limited information 
reported in the literature regarding amidine protection,65 there are numerous examples of 
amine, amide and alcohol protection strategies using these groups.66   
 
Initially considering the introduction of benzyl and p-methoxybenzyl (PMB) protecting 
groups, the methodology used for the preparation of 132 was modified to incorporate the 
appropriate N-substituted aniline.  Whereas N-benzylaniline was commercially available, N-
(p-methoxybenzyl)aniline (155) was synthesised in good yield by the sodium borohydride 







rt, 12 h, 93%
155156  
Scheme 51. Reduction of N-(p-methoxybenzylidine)aniline (156) to N-(p-methoxybenzyl)aniline (155).   
 
It was found that 157 and 158 could both be prepared in good yield from 111 (Scheme 52).  
As was the case with 132, 157 could be purified by crystallisation whereas 158 required 

















0 °C to rt, 4 h
Ar = Ph 157 (67%)
Ar = p-C6H4OMe 158 (85%)
Ar = Ph 159 (83%)
Ar = p-C6H4OMe 160 (0%)
111
 
Scheme 52. Preparation of 159 and attempted preparation of 160.  DMP = N,'N-dimethylpiperazine, NCS = N-
chlorosucinimide, TCA = trichloroacetic acid.   
 
Whilst the high temperature cyclisation of 157 proceeded smoothly to give 159 in high yield 
and satisfactory purity, a clean transformation of 158 to 160 could not be achieved with 
mixtures of compounds resulting (Scheme 52).  The 1H NMR spectrum associated with the 
crude ether insoluble portion of this mixture showed features consistent with loss of the PMB 
group: two NH signals were present at 12.30 ppm and 11.65 ppm and only traces of the 
signals associated with the benzyl protons of the PMB group were present.  It was therefore 
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Scheme 53. Indolo[2,3-b]quinoline-11-one 159 was converted to 161 in an overall yield of 76%, using reaction 
conditions identical to those used previously.   
 
Using a reaction sequence analogous to that used for the preparation of 130 from 132, 159 
was converted to 161 in three steps in an overall yield of 76%, via 162 and 163 (Scheme 53).  
The yields shown in Scheme 53 are those involving chromatographic purification at each 
step.  However, for large scale preparation of 161, chromatographic purification could be 
carried out in the last step only if 157 was of high purity.   
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Attempts were made to remove the benzyl group from 161 using a variety of reagents 
(including aluminium trichloride,68 boron trifluoride etherate,69 vinyl chloroformate,70 and 
hydrogenation with a palladium catalyst71) in combination with various solvents at different 
temperatures.  In summary, all attempts at benzyl deprotection of 161 resulted in either 
recovery of 161 or cleavage of the allyl group to afford 159.   
 
Having failed to remove the benzyl group from 161, the use of the p-methoxybenzyl (PMB) 
protecting group, and later the 3,4-dimethoxybenzyl (3,4-DMB) protecting group, was 
reconsidered.  Whilst it was clear that incorporation of these groups prior to the high 
temperature cyclisation would not be possible, it was reasoned that a selective N-5 alkylation 
of 110 after formation of the indolo[2,3-b]quinoline-11-one ring system could be achieved.  
This proposal was based on the assumed differences in stability of the two possible mono-
anions generated by deprotonation of 110 with one equivalent of base (Scheme 54).  
Removal of H-5 or H-6 from 110 gives two different anions 164 and 165 that would appear 
to be of approximately equal stability.  However, the resonance form 166 is presumably less 
stable than resonance form 167, due to the formation of the aromatic quinoline system, 























Scheme 54. It was expected that selective N-5 alkylation could be achieved via the presumably more stable 
anion 165/167.   
 
The two different electrophiles that were used for the alkylation of 110 were p-
methoxybenzyl chloride (PMBCl), which was commercially available, and 3,4-
dimethoxybenzyl bromide (3,4-DMBBr, 168) that was prepared from 3,4-dimethoxybenzyl 
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Scheme 55. Preparation of 3,4-dimethoxybenzyl chloride (168).   
 
Treatment of 110 with one equivalent of sodium hydride in tetrahydrofuran and quenching 
the resulting anion with either PMBCl or 3,4-DMBBr resulted in the formation of mixtures of 
products that could not be purified, other than by washing with ether, due to their insolubility 
in most solvents (Scheme 56).  Analysis by 1H NMR indicated that each of these mixtures 

























Ar = p-C6H4OMe 170 
Ar = 3,4-C6H3(OMe)2 171
Ar = p-C6H4OMe 176 (60%)
Ar = 3,4-C6H3(OMe)2 177 (73%)
Ar = p-C6H4OMe 174 (93%)
Ar = 3,4-C6H3(OMe)2 175 (94%)
Ar = p-C6H4OMe 172
(45%, 2 steps)














Scheme 56. Preparation of PMB and 3,4-DMB protected substrates 176 and 177.  PMBCl = p-methoxybenzyl 
chloride, 3,4-DMBBr = 3,4-dimethoxybenzyl bromide.   
 
Treatment of these mixtures with phosphorus oxychloride afforded the diagnostically orange 
coloured N-5 alkylated product chlorides 172 and 173 in reasonable yield, following 
chromatographic purification.  Chloride 172 and 173 were then converted to allyl ethers 174 
and 175 respectively using sodium and allyl alcohol.  Claisen rearrangement to form the C-
10b quaternary centre in 176 and 177 proceeded as before.   
 
Chapter 3 55
The cleavage of PMB and the more labile 3,4-DMB groups from nitrogen and oxygen is well 
documented.74-78  In addition to the general methods that have been used to cleave 
unsubstituted benzyl groups, PMB and 3,4-DMB groups have also been cleaved from 
heteroatoms under oxidative conditions using 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ) 
or ceric ammonium nitrate (CAN).   
 
Attempts were made to remove the PMB and 3,4-DMB groups from 176 and 177 
respectively, using the reagents trifluoroacetic acid, DDQ or CAN.  However, in all cases no 
evidence could be found for removal of the protecting groups.  As was seen with attempts to 
remove the benzyl group from 161, either deallylation, recovery of the starting material, or 
the formation of complex mixtures of unidentifiable products was observed.   
 
In light of these failed attempts to remove any of the N-5 protecting groups, and in particular 
the frequently observed deallylation of the substrates, it was considered that removal of a 
protecting group may be more successful later in the synthesis.  No further investigations 
regarding a protecting group strategy were carried out.   
 
 
3.7 Summary and conclusions  
 
In Chapter 2 a modified model substrate 129 for the Claisen rearrangement was proposed.  In 
this chapter the synthesis of 129 was outlined and it was shown that 130 containing the 
desired C-10b quaternary centre could successfully be formed in high yield by rearrangement 
of this substrate.  The differences in chemical behaviour of the two allyl ethers 129 and 90 
was rationalised and it was concluded that the differences in the rates of the Claisen 
rearrangements was due to an increased isolated double bond character of the participating 
aromatic bond in 129.   
 
An investigation into the effect of methyl substituents on the allyl group was then described 
and it was shown that the relative rates of the consecutive Claisen and aza-Cope 
rearrangements is dependent on these substituents.  Furthermore, it was shown that the 
rearrangement of 148 gave a single E-alkene product 153, indicating that a potentially 
synthetically useful chirality transfer had taken place.  Finally, the preparation of a series of 
N-5 protected analogues of 130 and attempts at deprotection were outlined.   
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Chapter 4 describes efforts to form the C-11 quaternary centre in the indolo[2,3-b]quinoline 
system.  For these studies the model compound 130 was chosen as it could be prepared on a 
multigram scale.   
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Chapters 2 and 3 described investigations into the formation of the C-10b quaternary centre 
in the indolo[2,3-b]quinoline system using a Claisen rearrangement.  These investigations 
resulted in the successful formation of the C-10b quaternary centre in substrates with an N-5 
substituent.  The investigations described in this chapter are concerned with the formation of 
the second, adjacent quaternary centre at C-11 of the indolo[2,3-b]quinoline system.  In 
general, the formation of vicinal all-carbon quaternary centres presents a significant 
challenge27-30 and is certainly one of the most difficult aspects of a communesin or 
perophoramidine (17) synthesis.  When constructing the C-11 quaternary centre the relative 
stereochemistry of the C-10b and C-11 has to be considered in light of the relative 
configurations of the natural products.  As discussed in Chapter 1, perophoramidine has trans 
2C units and the communesins have cis 2C units at these stereocentres.  It was expected that 
the configuration at the C-10b quaternary centre would strongly influence the relative 
stereochemical outcome of transformations used to manipulate the functionality at C-11.  
With this in mind, one of the aims of the investigations described in this chapter was to 
understand how the configuration at C-10b affects the relative configuration at C-11 so as to 
determine the chemistry that would be required to form the correct relative stereochemistry 
for each of the natural products. 
 
First, this chapter describes attempts at forming the C-11 quaternary centre using a route 
based on the alkylation of an aldehyde formed from the C-11 ketone.  A modification of this 
procedure that results in the formation of the C-11 quaternary centre by alkylation of an ester 
is then described.  Next, a brief investigation into the formation of the C-11 quaternary centre 
by opening an epoxide with organometalic reagents is outlined.  Finally, formation of the C-
11 quaternary centre by alkylation of a nitrile, formed from the C-11 ketone using the 
TosMIC reagent, is described.   
 
All the investigations described in this chapter were conducted on the model compound 130 
as this compound could be prepared in good yield on a multigram scale.  Additionally, the 
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presence of the N-5 methyl group, as opposed to a benzyl group, aided structural 
determination by reducing the amount of coincidental peaks in the aromatic region of 1H and 
13C NMR spectra.   
 
 
4.2 Attempts to form the C-11 aldehyde 
 
In Chapter 1 it was proposed that the ketone resulting from the Claisen rearrangement could 
be manipulated in such a way so as to form a compound with an acidic hydrogen at C-11 that 
could be deprotonated and the resulting anion alkylated with a suitable electrophile (Scheme 
57).  Initially it was planned that conversion of the C-11 ketone of 130 to aldehyde 178 
would be suitable for this purpose.  It was expected that it should then be possible to alkylate 

















Scheme 57. Initial plan for the formation of the C-11 quaternary centre.  E = electrophile.   
 
A Wittig reaction using the phosphorane derived from (methoxymethyl)triphenyl 
phosphonium chloride has frequently been used to form aldehydes from ketones, via the 
corresponding easily hydrolysed enol ethers.  For example, Scheme 58 shows the high 
yielding conversion of ketone 180 to aldehyde 181 using this phosphorane as part of a recent 














1) Ph3PCH2OMeCl, KHMDS, THF
2) acidic hydrolysis, 89%
181180  
Scheme 58. The phosphorane derived from (methoxymethyl)triphenyl phosphonium chloride is used to convert 
ketones to aldehydes.79  HMDS = hexamethyldisilazide.   
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In an attempt to form the enol ether 182 that could be subsequently hydrolysed to the 
corresponding aldehyde 178, 130 was treated with (methoxymethyl)triphenyl phosphonium 
chloride and the base potassium hexamethyldisilazide (KHMDS) in tetrahydrofuran or 
toluene (Scheme 59).  The only product that could be isolated from this reaction, however, 
was not the expected enol ether 182, but the rearrangement product 138 in 74% yield with 
19% of 130 remaining.  Analogous results were obtained when the phosphorane derived from 














THF, 0 °C to rt, 22h, 74% 182130 138
 
Scheme 59. An attempt to form enol ether 182 from ketone 130 using the phosphorane derived from 
(methoxymetyl)triphenyl phosphonium chloride.  HMDS = hexamethyldisilazide.   
 
In contrast to the previously proposed mechanism for formation of 138 from 130 in refluxing 
methanol (page 43), it is presumably the phosphorane that attacks the ketone and is then 
regenerated on formation of 138.  However, regardless of the mechanism by which 138 
forms, it was clear that an alternative synthetic route was required.   
 
From the mechanism shown in Scheme 42 (page 43) it can be seen that if the amidine of 130 
was to be reduced to the corresponding aminal, the rearrangement of 130 to 138 would not be 
possible.  Attempts were made to prevent this unwanted rearrangement by the selective 
reduction of the amidine functionality present in 130 prior to reaction with the phosphorane.  
Whilst a selective reduction of the amidine was achieved by methylation with methyl triflate 
followed by brief treatment with sodium borohydride,80 the product was found to be unstable 
and could not be satisfactorily purified.  Alternative methods to avoid the rearrangement of 
130 to 138 were considered.    
 
The acid catalysed rearrangement of epoxides to aldehydes and ketones is a known and 
frequently utilised transformation.81  Rearrangement is often accomplished under Lewis 
acidic conditions and, mechanistically, involves the coordination of the Lewis acid to the 
epoxide followed by a 1,2-hydride migration.  Boron trifluoride is a commonly used reagent 
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for this transformation.  Epoxide 183, for example, was transformed to aldehyde 184 in 












Scheme 60. Epoxide 183 is converted to aldehyde 184 in excellent yield under Lewis acidic conditions.82   
 
Whilst many epoxides have been formed from ketones in one step using sulfur ylides,83 
treatment of 130 with dimethyloxosulfonium methylide afforded only 138.  With the C-11 
aldehyde 178 still being the synthetic target, alternative transformations on 130 were 
investigated in an attempt to gain an understanding of the requirements for rearrangement to 
138.  Fortunately, it was found that the reaction of 130 with sodium borohydride, Grignard or 
organolithium reagents did not cause rearrangement to 138 and gave the normal alcohol 





















Scheme 61. Reduction or the addition of methyl lithium to 130 gave the expected alcohol containing products.    
 
Indeed, the addition of methyl lithium to 130 afforded tertiary alcohol 185 in quantitative 
yield as a single diastereoisomer, and the reduction of 130 with sodium borohydride afforded 
alcohol 186 in high yield, also as a single diastereoisomer.  The relative stereochemical 
assignment of 186, which demonstrates that hydride attack had occurred on the opposite face 
to the allyl group, was based on X-ray crystallographic analysis (Figure 14).  Whilst the 
relative stereochemistry of 185 was not determined directly, it was assumed that addition of 
the methyl nucleophile had also occurred on the opposite face to the allyl group to give the 
relative configuration shown.  This proposed stereochemistry in 185 is also based on the 









Figure 14. X-ray structure of 186.   
 
It is difficult to rationalise why the nucleophilic addition of the organolithium reagents, or the 
addition of hydride, to the carbonyl of 130 does not cause breakage of the C-10b-C-11 bond 
in the same way that nucleophilic attack by methanol or ylides do.  One possible explanation 
is that C-10b-C-11 bond cleavage is prevented by prior coordination of a Lewis acidic 
lithium cation to the carbonyl oxygen in the case of methyl lithium, or by the coordination of 
boron in the case of the sodium borohydride reduction.   
 
Having observed that 185 could be formed from 130 using methyl lithium without the 
formation of 138, it was expected that a synthetically useful transformation involving similar 
chemistry would provide a route to the desired C-11 aldehyde via epoxidation of 130.   
 
A method for generating epoxides from ketones or aldehydes using an organolithium reagent 
has been reported in the literature (Scheme 62).84  This procedure involves treating a mixture 
of the ketone 187 and chloroiodomethane with n-butyllithium or methyllithium at -78 °C.  To 
isolate the epoxide 188, the reaction mixture is warmed to room temperature after the 
addition of the alkyl lithium and quenched once the lithium alkoxide intermediate 189 has 
undergone ring closure.  Alternatively, if the reaction is quenched immediately after 


















Scheme 62. Epoxide formation using the highly reactive chloromethyllithium (190).   
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As all the components are mixed together, the success of this epoxide formation is indicative 
of the rate relationship between several fast reactions.  That is to say, lithium-iodine 
exchange must be faster than the attack of the alkyl lithium species at the carbonyl and the 
attack of the chloromethyllithium (190) at the carbonyl must be faster than the previously 
reported facile decomposition of 190.85,86  It is reported that using methyllithium-lithium 
bromide complex for this epoxide formation has the advantage of increasing the rate of 
epoxide ring closure and reducing the amount of side products resulting from attack of the 








THF, -78 °C, 0.5 h
rt, 12 h, 88%
MeLi-LiBr, ClCH2I
130 191  
Scheme 63. High yielding conversion of ketone 130 to epoxide 191 using chloromethyllithium.   
 
Applying the epoxidation condition described above to 130 led to a clean transformation to 
epoxide 191, as a single diastereoisomer (Scheme 63).  Crystallisation of 191 by the slow 
evaporation of ether produced large (up to 3 mm), cubic, colourless crystals and allowed for 
multigram preparation of 191 without the use of chromatography.  The relative 
stereochemistry of 191, determined by X-ray crystallography (Figure 15), indicated that 
nucleophilic attack at the carbonyl had occurred, as expected, from the opposite side to the 
allyl group.  This high degree of selectivity is presumably due to steric interactions between 







Figure 15. X-ray structure of epoxide 191.    
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With epoxide 191 in hand, attempts were made to form aldehyde 178 using an acid catalysed 
rearrangement.81  The transformation of 191 to 178 was attempted using a variety of Lewis 
and protic acids (including MgBr2, F3CO2H, F3B-OEt2), in the solvents tetrahydrofuran or 
dichloromethane and using various workup procedures.  In summary, aldehyde 178 could not 
be reproducibly prepared in satisfactory purity or yield under any of these conditions.  The 
best results were obtained using an excess of boron trifluoride etherate in tetrahydrofuran at -
25 °C (Scheme 64).  However, even under these conditions only low yields of an impure 
compound, showing a diagnostic aldehyde proton doublet signal at 8.98 ppm in the 1H NMR 
spectrum, could be isolated.  This aldehyde, which rapidly decomposed to a complex mixture 
of compounds, was shown to have structure 178a by reduction of a small sample with sodium 
borohydride to the corresponding alcohol.  This impure alcohol was found to have a mass and 
















191 192178a  
Scheme 64. Impure samples of the unstable aldehyde 178a ware prepared from 191.  Additional evidence that 
178a had been prepared was gained by reduction of a small sample of this impure material to 192.   
 
A crystal of this alcohol was grown from chloroform-hexane and analysed by X-ray 
crystallography thereby confirming the structure to be that of 192 (Figure 16).  The 









Figure 16. X-ray structure of 192.   
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It is interesting to note that aldehyde 178a is formed with retention of stereochemistry at C-
11.  One possible explanation for this is that the coordination of boron trifluoride to oxygen 
leads to the formation of a tertiary cationic centre at C-11 prior to a 1,2-hydride shift rather 
than the alternative concerted mechanism that would be expected to lead to inversion of 
configuration at C-11.  The preference for the 1,2-hydride shift to take place syn to the allyl 
group to form 193 can be explained by the intermediate 194 adopting a conformation that 
places the oxygen in a sterically less demanding position, anti to the allyl group (Scheme 
















193194 178a  
Scheme 65. After formation of the tertiary carbocation centre at C-11 a 1,2-hydride shift takes place syn to the 
allyl group with the oxygen adopting the less sterically demanding position.   
 
An alternative explanation relies on the fact that 178a is the thermodynamic product and 
178a results from equilibration of a mixture of diastereoisomeric aldehydes, or from the 
epimerisation of the single C-11 epimer of 178a under the reaction conditions.   
 
Attempts were made to deuterate and alkylate impure 178a using lithium diisopropylamide in 
combination with methanol-d4 or methyl iodide respectively.  However, this led to the 
formation of complex mixtures of compounds that could not be separated and that no longer 
showed an aldehyde proton signal in the associated 1H NMR spectrum.  As aldehyde 178a 
could not be prepared reproducibly, was found to decompose rapidly and could not be 
alkylated, alternative synthetic routes to form the C-11 quaternary centre were investigated.  
Initially, two routes using epoxide 191 were considered.  First, it was considered that an ester 
functionality at C-8 would impart greater stability than the aldehyde and a synthetic sequence 
for the preparation of such a compound was investigated.  Later, direct formation of the 





4.3 Synthesis of ester 197 
 
As aldehyde 178a was found to be unsuitable as a synthetic intermediate it was considered 
that an oxidised analogue of this compound may have greater stability and would allow 
alkylation at C-11.  Additionally, it was considered that the isolation of the aldehyde 
intermediate could be avoided by reductive opening, rather than rearrangement, of epoxide 
191 to give the corresponding primary alcohol 195 (Scheme 62).  It was expected that 195 
would be a more stable intermediate compared to 178a.  That is to say, a synthetic sequence 
involving reductive opening of epoxide 191 to form the primary alcohol 195 followed by 
oxidation to the corresponding acid, involving only transient formation of aldehyde 178, and 
subsequent esterification was proposed.  It has been reported that the reduction of epoxides 
using sodium cyanoborohydride in combination with boron trifluoride etherate gives 
predominantly the less substituted alcohol.87  Initial attempts to reductively open epoxide 191 
using sodium cyanoborohydride in combination with sub-stoichiometric or stoichiometric 
amounts of boron trifluoride etherate resulted in the recovery of 191.  Treatment of epoxide 
191 with sodium cyanoborohydride and an excess boron trifluoride etherate in 
tetrahydrofuran gave complex reaction mixtures.  Attempts to separate 195 by 
chromatography resulted in the co-elution of compounds, but it was found that primary 














Scheme 66. A low yielding conversion of epoxide 191 to primary alcohol 195.   
 
The structure of 195, which is epimeric at C-11 with 192, was determined by X-ray 
crystallography (Figure 17) and indicated that the reduction of 191 to 195 had proceeded 









Figure 17. X-ray structure of primary alcohol 195.   
 
Two mechanisms leading to inversion of configuration at C-11 can be envisaged (Figure 18).  
A mechanism that involves formation of the tertiary cationic centre at C-11 followed by 
attack of hydride, an SN1-like process, preferentially from the less sterically encumbered 
face, anti to the allyl group, would lead to inversion of configuration.  Alternatively, a 
mechanism involving initial polarisation, but not actually breaking, of the C-O bond by boron 
trifluoride that facilitates an SN2-like attack by hydride at C-11 would also lead to an 
inversion of configuration that is independent of the adjacent stereocentre.  The well 
documented observations that the opening of epoxides with nucleophiles under acidic 
conditions frequently leads to inversion of configuration supports the latter of these two 
mechanisms.81,88  However, it seems reasonable that the stereochemical outcome is a result of 
the configuration at both C-11 and C-10b and that the true mechanism is something between 












SN2-like mechanism SN1-like mechanism
11 11
 
Figure 18. The two extreme mechanisms possible for the Lewis acid catalysed reductive opening of epoxide 
191 will both give inversion of configuration at C-11.   
 
The attempt to oxidise alcohol 195 to the corresponding aldehyde under the mild conditions 
described by Dess and Martin led to complex mixtures of products and the same problems 
that had been encountered previously in isolating aldehyde 178a.89  This suggested that it was 
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aldehyde 178 that was intrinsically unstable rather than the method of preparation that was 
problematic.   
 
Now that the stable alcohol 195 could be prepared, oxidation to the corresponding carboxylic 
acid 196 was attempted (Scheme 67).  Treatment of an acetone solution of 195 with chromic 
acid afforded carboxylic acid 196 that showed a diagnostic broad signal at 11.1 ppm in the 
associated 1H NMR spectrum.  Due to the potential zwitterionic nature of 196, no attempt 
was made to purify this compound.  Crude 196 was converted to the corresponding methyl 
ester 197 by treatment with trimethylsilyl diazomethane in methanol.  From this two step 


























Scheme 67 Preparation of ester 197 from alcohol 195 via carboxylic acid 196.   
 
Whilst it was assumed that 197 had the same cis relative stereochemistry as the alcohol 195 
from which it was derived, acid induced C-11 epimerisation to the thermodynamically more 
stable trans isomer could not be completely ruled out.  Attempts were made to confirm the 
relative configuration of 197 using 1H NMR nOe techniques, but no significant 
enhancements were observed between the allylic protons and H-11 or the ester methyl group.  
Although no further direct attempts were made to determine the relative stereochemistry of 
197, an interesting fragment was observed in the mass spectrum of 197 (using the 
electrospray ionisation method) (Scheme 68).  A fragment with a m/z 233 (94%), arising 
from a loss of 100 daltons from the molecular ion m/z 333 (MH+, 100%), was observed 
without any other fragmentation occurring.  This loss of 100 daltons corresponds to a 
concurrent loss of both the allyl group and ester moiety.  One mechanism by which this could 
occur, which necessitates a cis relationship between the two groups, involves intramolecular 
attack of the carbonyl oxygen lone pair at the allyl group of the protonated species 198 to 
give 199, via a 7-endo-trig process.  Loss of the neutral carbene species 200 (100 daltons) 




























Scheme 68 Following ionisation in the mass spectrometer, a simultaneous loss of the allyl and ester groups, 
which requires a cis relationship, would lead to a fragment of m/z 233.   
 
 
4.4 Alkylation of the ester 197 
 
With ester 197 in hand, alkylation of this substrate was examined.  Deprotonation of 197 with 
the base lithium hexamethyldisilazide (LiHMDS), to generate the corresponding enolate, and 














Scheme 69. Formation of the C-11 quaternary centre by alkylation of the enolate generated from ester 197.  
HMDS = hexamethyldisilazide.   
 
Purification by chromatography followed by crystallisation to remove a small amount of an 
unidentified impurity afforded a pure sample of 203 in 59% yield as a single diastereoisomer.  
Evidence that 203 had been formed was gained from the associated 1H NMR spectrum that 
showed two sets of allyl group signals, and from the 13C NMR spectrum that showed two 
quaternary carbon signals (determined using the PENDANT pulse sequence) at 58.3 ppm and 
57.1 ppm, corresponding to the C-11 and C-10b all-carbon quaternary centres respectively.  
Finally, confirmation of the structure of 203 and unambiguous assignment of the relative 
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configuration at the two contiguous quaternary centres C-10b and C-11 was achieved by X-







Figure 19. X-ray structure of 203 showing trans relationship of allyl groups.   
 
The trans relationship of the two allyl groups indicated that, as expected, the electrophile had 
approached from the side opposite to the C-10b allyl group.  This stereochemical relationship 
of the two allyl groups (viewed as precursors of 2C units) is that present in the 
perophoramidine (17) structure.   
 
For a communesin synthesis it is necessary to have a one carbon unit trans to the C-10b allyl 
group.  This was achieved by alkylation of the enolate generated from 197, using lithium 
diisopropylamide (LDA), with formaldehyde (a one carbon electrophile) to give 204 
(Scheme 70).  Alcohol 204 was isolated in good yield after chromatographic purification and 
as before the presence of quaternary carbon signals at 58.8 ppm (C-11) and 55.8 ppm (C-10b) 
in the associated 13C NMR spectrum demonstrated the presence of the two all-carbon 










THF, -78 °C to rt, 1.5 h, 76%
197 204  
Scheme 70. Alkylation of ester 197 with formaldehyde.  LDA = lithium diisopropylamide.   
 
X-ray crystallography was again used to show that the electrophile had approached opposite 
to the C-10b allyl group to give structure 204.  Now that C-11 of 204 has two pendant C1 
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units, independent manipulation of the ester moiety into a 2C would be required to construct 
the communesin relative stereochemistry.  The difference in oxidation states of these two 
groups would seem to provide several possible methods of achieving this.  For example, after 
protection of the primary alcohol, reduction of the ester to the corresponding aldehyde would 
allow for one-carbon homologation using a Wittig reaction with the phosphorane derived 








Figure 20. X-ray structure of 204.   
 
 
4.5 Attempts at the direct formation of the C-11 quaternary centre from epoxide 191 
 
Attempts were made to form the C-11 quaternary centre directly from epoxide 191.  
Generally, epoxides can be opened with carbon nucleophiles to form various substituted 
alcohols.81  With Grignard reagents, for example, three different alcohols can be formed from 
the epoxides 205 (Scheme 71).  Nucleophilic addition at the most accessible carbon will 
afford 206 via an SN2 type process.  However, addition to the more substituted carbon to 
form 207 is generally favoured by the Lewis acidic Grignard reagents.  The formation of the 
207 type product is especially likely to occur when R1 is an electron donating group that 
favours the formation of a positive charge at C-1 thereby promoting a more SN1 like process.  
The formation of product type 208 will be competitive with the formation of 207 as prior 





















Scheme 71. Three major alcohol products are expected from the addition of Grignard reagents to 
unsymmetrical epoxides.   
 
Based on the structural features of epoxide 191, Grignard addition would be expected to give 
predominantly the 207 (or 208) type product thereby generating the C-11 quaternary centre.  
Unfortunately, no evidence for the existence of the 207 type product could be found in the 
mixture of products formed from the reaction of allylmagnesium chloride with epoxide 191 















Scheme 72. Addition of allylmagnesium chloride to epoxide 191 gave mainly the product resulting from 
formal addition to the corresponding aldehyde.   
 
The major component of this mixture was a compound that had spectrometric data consistent 
with structure 210, resulting from Grignard addition to the in situ formed aldehyde.  Of 
particular note for structural assignment was the signal corresponding to H-11 (3.15 ppm) in 
the associated 1H NMR spectrum that would not be present for the other possible addition 
products (type 206 and 207).  Although no significant 1H NMR nOe enhancements could be 
observed that would allow determination of the relative stereochemistry of 210, it seems 
reasonable to suggest, based on the model used to rationalise the stereochemistry of 178a 
(Scheme 65), that the configuration at C-11 of 210 is as depicted.  The stereochemistry at C-
12 is not as readily deduced and as such a tentative assignment will not be made.  
Additionally, purified 210 was found to contain a small amount (ca. 5% as determined by 1H 
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NMR) of a second compound that could not be separated from the major compound by 
chromatography.  This minor compound displayed 1H NMR chemical shifts that were 
coincidental with those of the major compound in all cases other than the signal associated 
with H-12 (a difference of 0.22 ppm is observed for these signals between the major and 
minor compound).  This suggests that purified 210 was predominantly a single 
diastereoisomer contaminated with a small amount of the corresponding C-12 epimer.   
 
Presumably, the reason that 210 forms in preference to the 207 type product is that once the 
tertiary carbocation centre forms (or partially forms) at C-11, the 1,2-hydride shift to form the 
aldehyde is competitive with nucleophilic attack at C-11 and the steric encumbrance around 
C-11 slows nucleophilic attack thereby favouring the 1,2-hydride shift.   
 
It has been reported in the literature that various organotitanium reagents react with 
unsymmetrical epoxides to give the more substituted product, even in the absence of highly 
electron donating substituents, and these reagents have been used to form all-carbon 
quaternary centres in a variety of substrates.90-94  For example, epoxide 211 is reported to 








THF, -78 °C, 83%211 212  
Scheme 73. Epoxide 211 is selectively opened at the more substituted carbon using allyl titanium triphenoxide.   
 
However, reaction of epoxide 191 with the both acetylinic and allylic titanium reagents, 
generated from chlorotitanium triisopropoxide in combination with trimethylsilyl acetylene 
or allylmagnesium chloride, did not form the desired C-11 quaternary centre.  With all these 
reagents no reaction was observed at room temperature, and at elevated temperatures 
decomposition to unidentified mixtures of products occurred.   
 
 
4.6 Alkylation of a C-11 nitrile and the use of TosMIC 
 
In the previous studies reported in this chapter, it was the ester functionality of 197 that 
rendered H-11 acidic and allowed the C-11 quaternary centre to be generated by alkylation of 
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the corresponding enolate.  Using this method, construction of the amidine or aminal will 
require modification of the ester into a nitrogen containing functional group.  A preferential 
route would involve the direct introduction of a nitrogen containing functional group that 
would render H-11 acidic and allow for alkylation at C-11 (Scheme 74).  The C-11 nitrile 
group of 213 would render H-11 acidic and could be alkylated with a protected nitrogen 
containing electrophile to afford a compound of the type 214.  Both the nitrogen atoms 
required to construct the amidine functionality of perophoramidine would now be in place at 
the correct oxidation state.  The amidine functionality in 215 could then presumably be 
constructed by oxidative cleavage of the alkene followed by reduction of the resulting 
aldehyde to the corresponding alcohol.  Conversion of the alcohol to a leaving group could 
potentially lead to formation of the amidine in 215 via a cascade reaction, although 

















Scheme 74. Alkylation of the C-11 nitrile 213 would allow for the rapid construction of the amidine 
functionality in 214.  P = protecting group.   
 
An example of alkylation α to a nitrile to create an all-carbon quaternary centre is illustrated 
in Scheme 75.95  As part of the total synthesis of the diterpenoids (-)-kolavenol and (-)-
agelasine B, the diastereoisomeric mixture of nitriles 216 was alkylated to give a single 











t-BuOK, t-BuOH LDA, ICH2CH2OMOM
THF, HMPA




Scheme 75. Conversion of ketone 218 to nitrile 216 and subsequent alkylation in the synthesis of diterpenoids 
(-)-kolavenol and (-)-agelasine B.95  TosMIC = tosylmethyl isocyanide, DMPU = N,'N-
dimethylpropyleneurea, LDA = lithium diisopropylamide, MOM = methoxymethyl, HMPA = 
hexamethylphosphoramide.   
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Also of interest in this total synthesis is the one step procedure that is used to generate nitrile 
216 from ketone 218 (218 undergoes a base promoted epimerisation of both of the two 
carbon centres adjacent to the carbonyl prior to reaction).  The reagent used in this case is 
tosylmethyl isocyanide (TosMIC) and is been reported to add a one carbon unit to a ketone as 
in cyanohydrin formation, without the simultaneous formation of an α-hydroxy group.96  
Such a one step reductive cyanation has clear advantages over a multi-step protocol.   
 
Mechanistically, it has been proposed that the formation of nitriles from ketones using 
TosMIC, under basic condition, involves attack of 219 at the carbonyl carbon to form anion 
220 prior to the formation of the oxazolidine ring of 221 (Scheme 76).97  Alternatively, 
formation of 221 by a one step cycloaddition has been suggested.98  Following proton 
exchange, it is proposed that 222 ring opens to give 223.  Evidence has been presented in 
support of the proposed intermediacy of 221 and 223.  For example, acidification of the 
reaction mixture before complete formation of the nitrile has, in some cases, allowed for the 
isolation of protonated 221 and 223 and when these were resubjected to the basic reaction 
conditions nitriles 224 resulted.96,97  However, whilst it is reported that tert-butoxide is 
involved, less experimental evidence is available regarding the mechanism of nitrile 224 
formation from intermediate 223 and only speculative mechanistic pathways have been 
suggested.96   
 


































Scheme 76. Proposed mechanism for the reductive cyanation using TosMIC (tosylmethyl isocyanide).   
 
In an attempt to prepare the C-11 quaternary centre using a two step protocol similar to that 
shown in Scheme 75, the reductive cyanation conditions using TosMIC were applied to 
ketone 130.96  Interestingly, but somewhat frustratingly, the expected nitrile 213 (Scheme 77) 
Chapter 4 75
could not be isolated from the mixture of products formed by the treatment of 130 with 
















Scheme 77. The attempted reductive cyanation of ketone 130 using TosMIC resulted in the formation of 25 as 
the major product.  TosMIC = tosylmethyl isocyanide, DME = 1,2-dimethoxyethane.   
 
This mixture of products was found to consist predominantly of a bright orange coloured (of 
note for structural assignment) compound that showed spectroscopic data consistent with 
structure 225.  Of particular note was the high field (33.0 ppm) methylene carbon signal in 
the associated 13C NMR spectrum suggesting that the allyl group was attached to a carbon 
atom rather than a hetero-atom.  Furthermore, the position of the allyl group was 
demonstrated through correlations in the associated 1H-13C HMBC spectrum (Figure 21).   
 
 
Figure 21. HMBC spectrum of 225 showing selected correlations used in determining the position of the allyl 
group.   
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Whilst an investigation into the mechanism and attempts to identify any intermediates 
involved in the formation of 225 would be interesting, such an investigation was not 
undertaken due to time constraints.  In addition, a full understanding of the mechanism was 
considered to be unnecessary for devising a method to avoid the formation of 225.  That is to 
say, integral involvement of the allyl group is required regardless of the precise mechanistic 
details, and manipulation of the allyl group prior to the reductive cyanation procedure would, 
presumably, prevent the formation of 225.  However, before these further synthetic studies 
are discussed two possible mechanisms will be outlined.   
 
Generally, there are two opposing mechanistic pathways that could lead to the formation of 
225 from 130.  Either the desired nitrile 213 forms and subsequently undergoes a further 
reaction to form 225 under the basic reaction conditions (Scheme 78), or 213 never forms 
and the path leading to the formation of 225 is divergent at an intermediate point in the nitrile 
forming mechanism.  Which of these two is correct could, in principle, be identified by the 
preparation of nitrile 213 using a synthetic route other than that involving TosMIC, and 























Scheme 78. A possible mechanistic pathway to 225 that requires the initial formation of the nitrile.   
 
The first of these general mechanisms can be rationalised by the more concise, once 
formation of 227 has occurred, sequence of events (Scheme 78).  Whilst it is easy to see how 
the loss of cyanide from 226 would give 225, it is harder to understand how 226 could arise.  
Formation of 226 via a direct 5-endo-trig attack of the C-11 anion of 227 at the alkene seems 
less likely than the 7-endo-trig attack through nitrogen that would form 228 before 
rearrangement to 226 via 229.  However, this attack of the nitrogen at the allyl group also 
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seems implausible as the nitrile of 227, with a planar anionic centre C-11, and allyl group of 
227 are presumably in a perpendicular conformation.  If the formation of 226 from 227 was 
to proceed by an intermolecular mechanism, the intramolecular proximity of the two groups 
would be irrelevant to attack.  However, as attack at the allyl group by the enolate derived 
from ester 197 was not observed, an intermolecular mechanism was considered unlikely in 
this case.   
 
A mechanism that does not necessitate the formation of the nitrile 227 can also be envisaged 
(Scheme 78).  In this mechanism, attack of the TosMIC anion at the less sterically 
encumbered face of ketone 130 would give 230 after proton exchange.  The carbanion of 230 
could then attack the allyl group to give 231, rather than ring opening and ultimately forming 
nitrile 213.  Breaking of the C-O bond then places the negative charge on the oxygen of 232.  
Attack of the allyl group at C-11 could in principle form isocyanate 233, however the 
cleavage of the C-C bond that would be required seems unlikely.  Isocyanate 233 then 
decomposes, with protonation, to give 225 and the formamide derivative 234.  Presumably 
nucleophilic attack by tert-butoxide converts 234 to hydrogen cyanide, tert-butyl formate and 
p-toluene sulfinate.  However, none of these by products would be diagnostic of this 
mechanism as tert-butyl formate and p-toluene sulfinate are generated during nitrile 








































Scheme 79. A mechanism for the formation of 223 that does not require the initial formation of the nitrile 211.   
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It was reasoned that if the allyl group of 130 could no longer participate in the formation of 
225, it should be possible to synthesise the desired C-11 nitrile group using the reductive 
cyanation.  Whilst it was stated in Chapter 1 that development of the allyl group would 
preferentially be a late synthetic step, allowing for a concurrent manipulation of two allyl 
groups, development of the C-10b allyl group of 130 directly after the Claisen rearrangement 
would be synthetically advantageous in light of the observed formation of 225.  Additionally, 
in the proposed synthetic route involving the α-alkylation of the nitrile it was ultimately 
intended that alkylation with a 2C nitrogen containing electrophile would be used to 
introduce the 2C unit, rather than allylation.   
 
Wishing to test the idea that the reductive cyanation could be carried out once the allyl group 
had been removed, using a short synthetic route, 130 was treated with osmium tetroxide in 
the presence of N-methylmorpholine N-oxide (NMO).  These conditions for dihydroxylation 
afforded a mixture of insoluble compounds that displayed a signal in the associated mass 
spectrum (m/z 345, MNa+) consistent with the formation of 235 (Scheme 80).  Making no 
attempt to separate the diastereoisomers or at purification other that trituration with ether, 
crude 235 was suspended in dichloromethane and converted to acetonides 236a/236b by 
pyridinium p-toluenesulfonate (PPTS) catalysed transacetalation with 2,2-dimethoxypropane.  
The acetonides 236a/236b, now sufficiently soluble to allow purification by chromatography, 
were formed as a 1:1 mixture of diastereoisomers in a combined yield of 70% (calculated 
over two steps).  Although complete separation of this diastereoisomeric mixture using 
chromatography was not achieved, small samples that were predominantly single isomers 


























1 : 1  
Scheme 80. After dihydroxylation of alkene 130, the vicinal hydroxyl groups of 235 were protected as the 
corresponding acetonide.  NMO = N-methylmorpholine N-oxide, PPTS = pyridinium p-
toluenesulfonate.   
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As oxidative cleavage of both diastereoisomers of 235 would lead to the same aldehyde, both 
diastereoisomers of 235 would be suitable synthetic intermediates and in principle could be 
transformed in one pot.  However, from a practical perspective, working simultaneously with 
the diastereoisomeric mixtures proved to be troublesome and led to greatly reduced yields, 
due to difficulties with isolation in the subsequent synthetic steps.  Therefore, the reaction 
sequence presented in Scheme 80 shows transformations conducted on a sample of 236a that 
was predominantly one diastereoisomer (the less polar of the two).   
 
After subjecting 236a to the reductive cyanation conditions used previously, the crude 
reaction mixture thus obtained was subjected to chromatography and a mixture of compounds 
that was believed to consist of predominantly nitriles 237a and 237b, epimeric at C-11, was 
separated.  The spectrometric observations that led to this conclusion were that the mass 
spectrum (using the chemical ionisation method) showed a strong peak at m/z 374 (MH+) 
consistent with the molecular formula of 237.  In addition, a diagnostic nitrile absorption at 
2243 cm-1 was observed in the IR spectrum.  The 1H NMR spectrum clearly showed the 
presence of two compounds both displaying the distinctive H-11 singlets that were well 
separated at 4.15 ppm and 4.09 ppm (integrating to in a 1:3 ratio respectively).  These 
diastereoisomers could not be separated from one another or from the minor impurities 
present in this mixture.  This mixture of diastereoisomers 237a and 237b was treated with 
lithium hexamethyldisilazide (LiHMDS) and the resulting red coloured anion was quenched 
with allyl bromide.  Whilst allyl bromide was not ultimately intended to be used in a natural 
product synthesis, it was used in this case to rapidly determine the expediency of this route.  
A compound that has spectrometric data consistent with structure 238 was separated from the 
















TosMIC, t-BuOK, t-BuOH, DME
0 °C to rt, 1 h











Scheme 81. Formation of nitrile 237 and allylation with allyl bromide.  TosMIC = tosylmethyl isocyanide, 
DME = 1,2-dimethoxyethane, HMDS = hexamethyldisilazide.  † = single unknown configuration.   
 
Of particular importance in determining that 238 was the C- and not the N-alkylated product 
was the presence of the characteristic nitrile absorption at 2243 cm-1 in the IR spectrum 
associated with this compound.  Additionally, the 13C NMR spectrum (recorded using the 
PENDANT pulse sequence) of 238 showed two high field quaternary carbon signals at 55.3 
ppm and 49.5 ppm associated with the C-10b and C-11 quaternary centres respectively.  As 
crystals of 238 could not be obtained, the assignment of the relative stereochemistry at C-10b 
and C-11 is an assumption based on the previously observed alkylation of ester 197 when X-
ray crystallography was used to demonstrate that the electrophile had approached from the 
face opposite to the C-10b allyl group.   
 
 
4.7 Summary and conclusion  
 
The aim of the model investigations described in this chapter was to develop methods for the 
formation of the second all-carbon quaternary centre at C-11 by manipulation of the C-11 
ketone of 130.  It was also necessary to determine the C-10b/C-11 relative stereochemistry 
that would be formed at these vicinal quaternary centres.  By achieving these aims, these 
investigations have been successful and have culminated in the preparation of three key 
compounds (Figure 22).  However, whilst the relative stereochemical assignment of 203 and 
















Figure 22.  Key compounds containing the vicinal quaternary centres at C-10b and C-11 contained within the 
natural products perophoramidine (17) and the communesins.   
 
Unfortunately, both of the successful synthetic routes to the C-11 quaternary centre from the 
ketone 130 are low yielding.  In the case of the ester route, it is the inelegant reductive 
opening of the epoxide that reduces the overall yield of this sequence.  To determine whether 
this reaction could be optimised, or perhaps whether a different route to the ester would be 
superior, would require further investigation.  Whilst none of the by-products from this 
reductive epoxide opening could be identified, it is possible that the allyl group is involved in 
side reactions and that prior development of the allyl group may lead to a cleaner 
transformation.   
 
The two step procedure from ketone 130 to the C-11 quaternary centre using TosMIC, whilst 
very concise, required development of the allyl group before the reductive cyanation could be 
achieved.  Furthermore, although the dihydroxylation and protection procedure provided a 
rapid method for removing the alkene functionality from the substrate so as to test a 
hypothesis, it would clearly be impractical as part of a total synthesis due to the formation of 
diastereoisomeric mixtures that are difficult to isolate.  This problem could be overcome by 
either devising a synthetic route in which the alcohol stereocentre is destroyed immediately 
after formation by, for example, cleavage of the diol with sodium periodate or lead 
tetraacetate, or by creating diol 235 as a single diastereoisomer using, for example, a matched 
asymmetric dihydroxylation.99  Cleavage of diol 235 to give the corresponding aldehyde was 
attempted using both sodium periodate, which led to complex mixtures of products, and lead 
tetraacetate, which afforded small amounts of an aldehyde product.  Attempts at asymmetric 
dihydroxylation99 of 130 resulted in complete recovery of 130.  Both these studies were 
discontinued due to time constraints.  Due to the approach of electrophiles opposite to the C-
10b allyl group in the alkylations described, it is clear that at present these synthetic 
procedures are more suited to a synthesis of perophoramidine (17) rather than to a synthesis 
of the communesins and as such a synthesis of perophoramidine (17) has been initiated using 
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the methods described in this report (see Appendix 2).  On the other hand, this alkylation 
selectivity does not preclude a communesin synthesis.  Indeed, all that would be required is 
the independent manipulation of the two C-11 C1 units present in 203 and this is easily 
envisaged due to the differences in oxidation state.   
 
The investigations described in Chapter 5 return to the rearrangements of indolo[2,3-
b]quinolines and consider the effect of a substituent at C-10 with the aim of initiating a 
synthesis of the communesin natural products.  Studies into developing of an asymmetric 




Chapter 5: Asymmetric Formation of the C-10b Quaternary Centre and 
the Effect of Bromine at C-10 
 
 
5.1 Introduction  
 
Chapter 3 outlined the structural features required for the formation of the C-10b quaternary 
centre in the indolo[2,3-b]quinoline system using a Claisen rearrangement.  Chapter 4 
described investigations that resulted in two successful methods for the formation of the 
adjacent quaternary centre at C-11.  In both these chapters investigations have been 
conducted on model compounds and no consideration has been given to the possible effect 
that substituents, which are required for the construction of the natural products, may have on 
the Claisen rearrangement.  For example, the substituent required for the construction of the 
isoprene based moiety (page 4) in the communesins, at C-10 of the indolo[2,3-b]quinoline 
ring system, may accelerate the aza-Cope rearrangement in relation to the Claisen 
rearrangement through steric interactions, as was observed in the case of 146 and 147, (pages 
49-50).   
 
It was shown in Chapter 4 that the relative stereochemistry at the C-11 quaternary centre was 
controlled by the configuration at C-10b.  Therefore, the asymmetric generation of the C-10b 
quaternary centre would allow an asymmetric synthesis of the natural products.  This is 
certainly the case for perophoramidine (17) as there are only two stereocentres present.   
 
Initially, this chapter describes the synthesis and subsequent Claisen rearrangement of the 11-
allyloxy-10-bromoindolo[2,3-b]quinoline system.  After having successfully formed the C-
10b quaternary centre in this system, the development of an asymmetric version of the 
Claisen rearrangement in this system is described.  A benzyl protecting group on N-5 was 
chosen for these investigations.  This choice was made as the benzyl group can be 
incorporated at the beginning of the synthesis and therefore makes for a shorter and higher 
yielding synthetic route.  Additionally, it must be noted that the debenzylation of a similar 
substrate has been achieved.35  Amide 61 was converted to 238 using a dissolving metal 












1) TFA, 12 h
2) Li, NH3, THF, -78 °C, THF, 10 min
3) NosCl, NEt3, THF, 8 h, 69% (3 steps)
238  
Scheme 82. Cleavage of a benzyl group under dissolving-metal conditions was used as part of a recent 
synthesis of (±)-dehaloperophoramidine.35  TFA = trifluoroacetic acid, Nos = o-
nitrobenzensulfonyl, Boc = tert-butoxycarbonyl.   
 
 
5.2 Synthesis and rearrangement of 11-alyloxy-10-bromo-5-benzyl-5H-indolo[2,3-
b]quinoline (255) 
 
The synthesis of 10-bromoindolo[2,3-b]quinolones using the previously developed 
methodology required the use of 4-bromo-1H-indole-3-carboxylic acid methyl ester (239).  
Ester 239 is not commercially available and only one method for its synthesis is described in 
the literature.100,101  This method, which has been used for the synthesis of range of 4-halo 
indoles, involves conversion of 111 to the corresponding organothallium compound with 
thallium (III) trifluoroacetate in trifluoroacetic acid followed by treatment with a solution of 
copper (II) bromide in N,N-dimethylformamide.  As 239 could be formed in one step from 
commercially available 111 in moderate yield, this thalliation method was successfully used 








 Tl(O2CCF3)3, TFA, rt, 2h
then CuBr2, DMF, 120 °C, 1h, 51%
239111  
Scheme 83. Directed bromination using thallium trifluoroacetate.  TFA = trifluoroacetic acid, DMF = 
dimethylformamide.   
 
It has been reported that, mechanistically, this electrophilic aromatic thallation is directed by 
the initial formation of the substrate-electrophile complex 240 followed by a reversible 
electrophilic aromatic substitution with loss of trifluoroacetic acid to give 241 via 242 

































Scheme 84. Bromination with CuBr2 is preceded by a directed electrophilic thalliation.   
 
There are several drawbacks associated with this thalliation procedure that make multi-gram 
preparation of 239, which would be required for a synthesis of the communesins, impractical.  
The thallium reagent, which is used in greater than stoichiometric quantities, and the waste 
that is generated are toxic and difficult to separate from the product.  Furthermore, the 
product 239 and starting substrate 111, which remained in the crude product, required careful 
chromatography to achieve separation.  The literature method for the purification of 239, 
involving elution from a silica column with dichloromethane-methanol (99:1, v/v), was found 
to be unsuitable leading to the elution of 111, 239 and metal salts in the first few fractions.100  
Better results were obtained when ethyl acetate-hexane mixtures were used for 
chromatography.   
 
As a synthesis that allowed multigram preparation of 239 was required, a three step protocol 
involving formylation, oxidation and esterification starting from 4-bromoindole (243) was 
considered.  Utilising the Vilsmeier-Haack reaction, 243 was converted to the known 






















rt, 5 days, 75%
rt, 89%
 
Scheme 85. Formylation of 4-bromoindole and subsequent oxidation.  DMF = N,N-dimethylformamide.   
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The oxidation of 244 to 245 using sodium chlorite in the presence of 2-methyl-2-butene103 is 
reported in the literature but no preparation, isolation, purification or spectroscopic data is 
reported.100  Nonetheless, it was eventually found that the transformation of 244 to 245 
required a large excess of reagents and a reaction time of five days at room temperature.  
Purification of 245 was achieved by extracting an intensely blue impurity from an aqueous 
solution of 245 at high pH with dichloromethane, followed by the addition of aqueous 
hydrochloric acid to precipitate protonated 245 of sufficient purity for the subsequent 
transformation.   
 
Whilst the esterification of the 4-iodo analogue of 245 using diazomethane is reported in the 
literature,101 the conversion of 245 to 239 is unknown.  So as to avoid the use of 
diazomethane, the conversion of 245 to 239 was attempted using methanol and a catalytic 
amount of sulfuric acid with heating at reflux (Scheme 86).  This method provided 239 in 
low yield together with the major product 243, resulting from the decarboxylation of 245.  























Scheme 86. Esterification in refluxing acidic MeOH resulted mainly in the decarboxylation of 245.   
 
A revised reaction procedure led to a much higher yielding conversion of 245 to 239.  The 
sequential treatment of 245 with oxalyl chloride followed by methanol, without isolation of 











(COCl)2, DMF, CH2Cl2, 0 °C
then MeOH, 99%
 
Scheme 87. High yielding esterification using oxalyl chloride and methanol.  DMF = N,N-dimethylformamide.   
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Now that 239 could be synthesised in high yield on a multi-gram scale without the use of 
chromatography, attention was turned to the coupling of 239 with N-benzyl aniline.  
Subjecting 239 to the same reaction conditions that had been used for the synthesis of 157 
(pages 51-52) afforded only small quantities of the expected 2-aminoindole 246 with 2-











 CH2Cl2, 2 h, 0 °C
239 247
TCA, PhNHCH2Ph












Scheme 88. Attempted coupling of 239 with N-benzylaniline.  DMP = N,'N-dimethylpiperazine, NCS = N-
chlorosucinimide, TCA = trichloroacetic acid. 
 
Presumably, 247 results from the nucleophilic attack of water rather than the aniline at C-2 of 
the intermediate chloroindolenine 248, followed by elimination of hydrogen chloride from 



































Scheme 89. Proposed mechanism of formation of oxindole 247.  DMP = N,'N-dimethylpiperazine, NCS = N-
chlorosucinimide. 
 
In an attempt to increase the yield of 246, it was considered that the attack of water on 248 
could have occurred either before the addition of N-benzylaniline to the reaction or at the 
workup stage, when significant amounts of 248 remained.  If the latter was to be the case, 
extending the reaction time after the addition of N-benzylaniline would be expected to 
increase the yield of 246.  Whilst extending the reaction time did improve the yield of 246, 
consistently high yields could only be achieved when powdered molecular sieves were also 
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added to the reaction mixture (Scheme 90).  This suggests that 248 is very sensitive to the 
presence of water under the conditions in which it is formed, although the reason for this is 




CO2MeBr DMP, NCS, CH2Cl2
4 Å sieves, 0 °C, 2h
PhNHCH2, TCA              


















Scheme 90. Coupling of 239 with N-benzylaniline.  DMP = N,'N-dimethylpiperazine, NCS = N-
chlorosucinimide, TCA = trichloroacetic acid.   
 
The 1H NMR (CDCl3) spectrum of purified 246 showed additional peaks that could not be 
attributed to structure 246 alone (Figure 23).  This complication of the 1H NMR spectrum 
was assigned to the existence of the 1H- and 3H-indole tautomers, 246 and 251, in an 8:2 
ratio.   
 
Figure 23. 1H NMR spectrum (CDCl3) showing presence of 3H-indole tautomer of 246.   
 
The presence of the 3H-indole tautomer 251, which was not observed for 157, can be 
rationalised using a steric explanation.  A steric interaction between the bromine and the ester 
moiety leads to a destabilisation of the 1H-indole tautomer 246 in relation to the 3H-indole 
tautomer 251.  This steric interaction with bromine is diminished in 251 due to the sp3 
hybridisation of C-3 that places the ester moiety out of the plane with respect to the bromine 
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atom.  Inspection of the carbonyl infrared absorption frequency associated with 111, 239, 157 
and 246/251 was instructive and suggested a close proximity of the bromine and ester 
moiety, thereby supporting this steric based rationalisation (Table 2).   
 
Carbonyl IR absorption frequency (KBr, cm-1)  












1669 (157) 1672 (246/251) 
 
Table 2. A comparison of the carbonyl IR absorption frequencies of 111, 238, 157 and 246.   
 
The carbonyl absorption frequency associated with 239 is 26 cm-1 greater than that of 111 
suggesting that the close proximity to bromine had changed the conformation of the ester 
moiety and reduced the carbonyl conjugation with the indole π-electrons.  A similar, but 
smaller magnitude, difference was seen for 246/251 and 157.  In this case, the bulky N-
benzyl and N-phenyl groups of 246/251 presumably prevent the ester moiety from twisting 
out of plane with the bromine atom leading to a smaller change in absorption frequency.  
Whilst this rationalisation is tentative, it was clear that the C-2 substituent played a role in the 
stabilisation of the 3H-tautomer 251 as the 3H-tautomer of 157 was not observed.   
 
A further complication related to the synthesis of 246 arose from the propensity of 246 to 
undergo a rapid autoxidation to 252 (Scheme 91).  In less than five days a complete and 
clean transformation of 246 to 252 was observed in either the solid state or in solution.  It 
remains challenging to rationalise why this oxidation was observed for 246 but not for 157.  
However, it appeared plausible that the difference in propensity to oxidation of 246 and 157 
was related to the presence of the 3H-indole tautomer 251.  The presence of tautomer 251 
together with traces of 252, which were always present in samples of 246, made the use of 
















O2, solution or solid state
246 252  
Scheme 91. 2-Aminoindole 246 was found to undergo a rapid autoxidation to 252.   
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Due to the oxidation of 246 to 252, 246 was used immediately after preparation and the 
cyclisation of 246 to 253 (Scheme 92) was conducted under an argon atmosphere that had 













250 °C, 2 h, 84%
253246 Ph  
Scheme 92. High temperature cyclisation of 246 to 253.   
 
As previously described, treatment of 253 with phosphorus oxycholoride afforded 254 
(Scheme 93).  However, 254 was found to be more susceptible to nucleophilic displacement 
of the chlorine than previously prepared compounds 133 and 162 (pages 40 and 52).  
Purification of 254 proved to be counterproductive leading to reduced yields of 254 due to its 
conversion back to 253.  Crude 254 was therefore used in the reaction with sodium allyloxide 
















90 °C, 1.5 h
Na
allyl alcohol
THF, 0 °C, 2 h
53 % (2 steps)
255254  
Scheme 93. Reaction of 253 with phosphorus oxychloride and subsequent reaction with sodium allyloxide 
proceeds in acceptable yield over two steps.   
 
In contrast to the non-brominated substrate 162 that required a reaction time of 18 hours at 
room temperature for conversion to 163 (page 52), the conversion of 254 to 255 required 
only two hours at 0 °C.  This increase in rate for the nucleophilic aromatic substitution was 
rationalised by considering the effect of a steric, and possibly electronic, interaction between 
Cl-11 and Br-10 in 254 (Scheme 94).  The ring system of 254 is planar, with all carbons sp2 
hybridised.  There is a repulsion between Cl-11 and Br-10 that is reduced, in the rate limiting 
step, on formation of the sp3 centre at C-11 in the intermediate species 256 (a similar release 
of steric strain does not occur on the formation of 257 from 162).  Whilst this repulsion is 
regained between O-11 and Br-10 in 255, it is important to note that changes in the rate 
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limiting (slow) step effect the overall rate.  Furthermore, there is a net reduction in steric 
repulsion on transformation of 254 to 255 as oxygen has a smaller atomic radius than 

















R = H  162
R = Br  254
R = H  257
R = Br  256
R = H  163
R = Br  255
10
 
Scheme 94. When R = Br, as opposed to R = H, there is a reduction in steric and electronic repulsion on 
formation of the sp3 centre at C-11 during the rate limiting step.   
 
With 255 in hand, the formation of 258 using the Claisen rearrangement was examined 
(Scheme 95).  Uneventfully, in refluxing toluene 255 was found to undergo rearrangement to 
258 in approximately the same time that was required for the transformation of 163 to 161 










PhMe, reflux, 5 h, 78 %
255 258  
Scheme 95. The Claisen rearrangement of the brominated substrate proceeds under the same conditions that 
were required for the non-brominated substrate.   
 
However, when 258 was heated in toluene-d8 at 100 °C for five days, conditions that had 
been shown to cause significant aza-Cope rearrangement of 130 and 161, no significant 
change in the 1H NMR spectrum of 258 was observed (Scheme 96).  Therefore the presence 
of a Br-10 substituent had not accelerated the aza-Cope rearrangement as had been 





















Scheme 96. Steric repulsion between Br-10 and O-11 in 258 increases the energy barrier associated with the 
aza-Cope rearrangement to 259.   
 
To understand how the Br-10 substituent exerts this effect a rationalisation that considers the 
interaction between bromine and oxygen, similar to that used previously (page 87), can be 
evoked (Scheme 96).  In 258 C-10b is sp3 hybridised placing the allyl group and ketone in a 
position synclinal to Br-10.  Rearrangement of 258 to 259 would move O-11 into an eclipsing 
position with Br-10 resulting in repulsion between O-11 and Br-10.  A comparison of the 
carbonyl infrared absorption frequencies of 111 and 239 (page 88) suggests a close proximity 
of the Br-10 and O-11 in 239 and presumably this is also the case for 258.  It was expected 
that a comparison of the X-ray crystal structures of 161 and 258 would further support this 
rationalisation by showing a difference in the relative position of O-11 in the two compounds 
(Figure 24).  However, the crystal structures of these two compounds showed no significant 













Figure 24. Overlaid X-ray structures of 161 (dotted lines) and 258 (solid lines) showing no significant 




5.3 Re-examination of the N-6 substituted system  
 
This observed retardation of the aza-Cope rearrangement of 258, caused by the presence of 
Br-10, led to the reconsideration of the initial, N-6 substituted, model system discussed in 
Chapter 2.  It was rationalised that the presence of a 10-Br-substituent may also slow the rate 
of the aza-Cope rearrangement in this system leading to the accumulation of the intermediate 
compound.  If this were to be the case, positioning a methyl substituent at N-6 would have 
the advantage of avoiding the use of a protecting group strategy in a synthesis of 
communesin A (9), B (10), F (14), G (15) or H (16).  This initial system was revisited and 
synthesised with a Br-10 substituent.   
 
Coupling of 239 with aniline, to give 260, followed by cyclisation in refluxing phenyl ether 
afforded 261 in high yield (Scheme 97).  It was found that the conversion of 261 to 262 by 
treatment with phosphorus oxychloride required longer reaction times than had previously 
been used for the conversion of 110 to 109 (page 28) and only impure samples of 263 could 
be obtained.  Crude 263, which could not be purified due to its insolubility in most solvents, 
was methylated with sodium hexamethyldisilazide (NaHMDS) and methyl iodide in 
tetrahydrofuran to give 264 that was isolated in 32% yield (calculated for two steps from 
261) after purification by chromatography.  The use of NaHMDS for the methylation of 263 
was found to give better results than sodium hydride that had been used previously for the 
methylation of 109 (page 29).  It was found that the displacement of the chlorine from 264 
proceeded more readily than had been observed for 115 (page 29) and could be achieved at 
room temperature.  After four days at room temperature 264 was found to have undergone a 
complete reaction with sodium allyloxide in tetrahydrofuran.  Unfortunately, 265 could not 
be separated from a second product of as yet undetermined structure (ca. 30%, determined by 
1H NMR) and as such 265 was characterised by 1H NMR only.  Nevertheless, as the signals 
associated with the allyl moiety of 265 were clearly visible and not coincidental with any of 
the peaks associated with the contaminant, the contaminated sample of 265 was considered 


























DMP, NCS, 4 Å sieves
 CH2Cl2, 0 °C, 2 h
PhNH2, TCA        
rt, 20 h, 82%
Ph2O















Scheme 97.  Synthesis of 11-allyloxy-10-bromo-6-methyl-6H-indolo[2,3-b]quinoline (5.25).  DMP = N,'N-
dimethylpiperazine, NCS = N-chlorosuccinimide, TCA = trichloroacetic acid, HMDS = hexamethyldisilazide.   
 
The contaminated sample of 265 was heated in toluene-d8 at 100 °C and analysed by 1H 
NMR (Scheme 98).  After 18 hours and later at 40 hours, only trace amounts of the 
diastereotopic allylic protons that are characteristic of 266 were observed.  The observation 
that there were only small changes in the chemical shift of the allylic proton signals and that 
the multiplicity of the β-allylic proton signal was similar to that observed for 116 (see 
Appendix 3) indicated that the formation of 267 was the major outcome (Figure 25).  
Unfortunately, this result was not significantly different from the thermal rearrangement of 
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Figure 25.  Section of the 1H NMR spectrum showing signals corresponding to the allyl group protons of 265 
266 and 267.  This spectrum was recorded after heating 265 for 40 hours at 100 °C in toluene-d8.  X = signal 
associated with contaminant of undetermined structure.   
 
It is hard to say why a retardation of the aza-Cope rearrangement is observed for 258 and not 
for 266.  One possible explanation is that in the N-5 substituted systems there is only a small 
difference between the magnitudes of the Claisen and aza-Cope rearrangement's rates with 
the Claisen rearrangement being faster.  The presence of the Br-10 substituent reinforces this 
difference by slowing the aza-Cope rearrangement.  For the N-6 substituted system, if the 
rate of the aza-Cope rearrangement is already much greater than that of the Claisen 
rearrangement, the effect the Br-10 substituent has on the aza-Cope rearrangement may not 
be sufficient to reverse the magnitudes of the rates for the two steps.  That is to say, even 
with a Br-10 substituent in 265, the rate of the aza-Cope rearrangement is still significantly 
greater than that of the Claisen rearrangement.   
 
 
5.4 Asymmetric formation of the C-10b quaternary centre  
 
The asymmetric generation of chiral centres using the Claisen rearrangement can be achieved 
by using an achiral substrate with an external chiral activator, such as a chiral Lewis acid, or 
by intramolecular chirality transfer using a chiral substrate.104,105  Asymmetric induction 
using sub-stoichiometric quantities of chiral Lewis acids in combination with achiral allyl 
vinyl ethers has not been achieved on a diverse range of substrates and often requires specific 
functionality on the allyl vinyl ethers.106-108  The frequent failure to use sub-stoichiometric 
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quantities of chiral Lewis acids to catalyse the Claisen rearrangement arises from the fact that 
coordination of the Lewis acid to the carbonyl oxygen of the product is stronger than 
coordination to the ether oxygen of the substrate.105  That is to say, the product is a stronger 
Lewis base than the starting substrate and therefore leads to product inhibition of the catalyst.  
However, regardless of this problem, chiral Lewis acids have been used in greater than 
stoichiometric quantities to good effect on a range of substrates.  For example, the chiral 
aluminum complex (R)-268 has been used to promote the Claisen rearrangement of aliphatic 
substrates of the type 269 to give γ,δ-unsaturated aldehydes 270 in high yield and good 













Scheme 99.  The aluminium complex (R)-268 has been used to catalyse the Claisen rearrangement of a range of 
allyl vinyl ethers.  R = benzyl, cyclohexyl, t-butyl or trimethylsilyl.   
 
Alternatively, if the allyl vinyl ether substrate is chiral due to substituents at the α-allylic 
position, chirality can be efficiently transferred to the newly formed chiral centres through 
the highly ordered transition state of the Claisen rearrangement.  To illustrate the use of this 
chirality transfer method in natural product synthesis, the first three steps used in a recent 

































Scheme 100.  A key step in the recent synthesis of (-)-terpestacin involves chirality transfer using a Claisen 
rearrangement.  dba = dibenzylideneacetone, TIPS = triisopropylsilyl, MW = microwave irradiation.   
 
In this synthesis of (-)-terpestacin, an asymmetric allylic alkylation111 of 3-methyl-1,2-cyclo-
pentanedione (271) with racemic isoprene monoepoxide in the presence (R,R)-272 is used to 
generate 273 with high enantioselectivity.  The chirality at the α-allylic position of 273 is 
then transferred completely (it is not reported how this was assessed) to the newly formed 
quaternary centre in 274 using a Claisen rearrangement under microwave (MW) conditions.  
After Saegusa oxidation112 of 274, 275 is isolated in 78% yield over two steps.   
 
Of the two methods discussed above, the chirality transfer method was considered to be the 
most suitable for the asymmetric construction of the indolo[2,3-b]quinoline C-10b quaternary 
centre in this current investigation.  In Chapter 3 it was shown that the Claisen rearrangement 
of 148 proceeded smoothly to give E-alkene 154 as the only observed product (page 50).  
This suggested that, if the Claisen rearrangement had proceeded exclusively via a chair 
transition state, the methyl group always adopts the equatorial position and complete chirality 
transfer had taken place in the rearrangement of racemic 148.  However, for this chirality 
transfer to be of synthetic value an enantiomerically enriched substrate must be used.  
Additionally, due to the planned oxidative cleavage of the resulting alkene (see page 20), the 
methyl group is redundant in its final position.  To test this chirality transfer in the 10-
brominated system and to potentially provide an asymmetric approach towards the 
commumesins, a synthesis of enantiomerically enriched (S)-(+)-3-butene-2-ol ((S)-153) was 
required.   
 
Chapter 5 98
Enantiomerically enriched (S)-153 was synthesised using literature procedures starting from 
trans-2-butene-1-ol (276) (Scheme 101).113,114  Sharpless asymmetric epoxidation of 276 
with tert-butyl hydroperoxide (TBHP), in the presence of L-(+)-diisopropyl tartrate (DIPT), 
followed by the in situ tosylation of the resulting epoxide 277 afforded (2S,3S)-(-)-
epoxytosylate 278 in high chemical and optical purity after repeated crystallisation in 
accordance with the literature precedent.113  The optical purity of 278 synthesised by this 
method was assessed by comparison of the optical rotation with a literature value.  It is 
reported that the (2R,3R)-(-)-enantiomer of 278 with an enantiomeric purity of >99:1 e.r., 
determined by 1H NMR analysis in combination with a chiral shift reagent, has an optical 
rotation of [α]25D = +34.2.113  The optical rotation of (2S,3S)-278 was recorded to be [α]20D = 
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Scheme 101.  Synthesis of enantiomerically enriched (S)-(+)-3-butene-2-ol.  DIPT = diisopropyl tartrate, TBHP 
= tert-butyl hydroperoxide, DMAP = 4-dimethylaminopyridine, Ts = p-toluenesulfonyl.   
 
Treatment of 278 with sodium iodide and zinc-copper couple in ethylene glycol led to the 
formation of (S)-153 in good yield.114  It is proposed that, mechanistically, this reaction 
involves the reaction of 278 with sodium iodide to form the corresponding epoxy iodide that 
subsequently undergoes reductive elimination to give (S)-153 via a radical mechanism.115  
Due to the volatility of (S)-153, ethylene glycol was used as the solvent in this reaction and 
the product was separated by distillation at atmospheric pressure.  By stirring a 
tetrahydrofuran solution of (S)-153 with 3 Å molecular sieves, the water that had co-distilled 
with (S)-153 was removed.  However, the tetrahydrofuran could not be separated from the 
volatile (S)-153 and in subsequent reactions (S)-153 was used as a solution in 
tetrahydrofuran.  The concentration of (S)-153 in tetrahydrofuran was determined by analysis 
of the 1H NMR spectrum associated with this tetrahydrofuran solution and was found to be 
ca. 2.7 M.  The enantiomeric purity of (S)-153 was determined by formation of an ester of 
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(S)-153 with the chiral derivatising reagent (R)-(-)-α-methoxy-α-
















Scheme 102.  Determination of enatiomeric purity of (S)-153 by the formation of an ester with (R)-(-)-α-
methoxy-α-(trifluoromethyl)phenylacetyl chloride.   
 
Using 1H NMR, the diastereoisomeric composition of 279, which is related to the 
enantiomeric composition of (S)-153, was determined by integration of the methyl doublet in 
279 that showed a large chemical shift non-equivalence (Figure 26).  Using this method it 
was found that (S)-153 had been formed with an enantiomeric purity of 96:4 e.r.  For 
comparison, this derivatisation and 1H NMR analysis was also conducted on commercially 
available racemic-153, using identical reaction conditions.  This showed the expected 1:1 
ratio of diastereoisomers, suggesting that under these conditions a kinetic resolution had not 
taken place.   
 
  
Figure 26.  Analysis of the MTPA esters formed from a) racemic-153 and b) (S)-153 by 1H NMR demonstrated 
that (S)-153 had been formed in 96:4 e.r. 
 
The formation of 279 not only allowed the enantiomeric purity of (S)-153 to be determined, 
but it also allowed the relative stereochemistry of 279, and therefore the absolute 
stereochemistry of (S)-153, to be confirmed by using the model developed by Mosher 
(Figure 27).117  In this model, the differences in 1H NMR chemical shifts of the methyl and 
vinyl protons for the two possible diastereoisomeric esters 279 and 280, formed from (R)-154 
with racemic-153, results from the time weighted average preferential shielding of these 
groups by the π cloud of the α-phenyl substituent of the acid moiety.  It is assumed that the 
Chapter 5 100
trifuoromethyl group eclipses the carbonyl and that the allylic proton is located in the same 
relative position in each of the two diastereoisomers.  In the (S,S)-diastereoisomer 279 the 
methyl group will be more shielded than the methyl group of the (S,R)-diastereoisomer 280, 
and will therefore resonate at lower chemical shift.  For the esters 279 derived from (S)-153, 
the major diastereoisomer did indeed show a lower chemical shift for the methyl group 
protons of the alcohol derived moiety (Figure 26b).  This supported the view that (S)-153 

























Figure 27.  Comparison of the relative 1H NMR chemical shifts for the two esters 280 and 279 formed from 
(R)-(-)-α-methoxy-α-(trifluoromethyl)phenylacetyl chloride and racemic-153 allows the relative stereochemistry 
to be determined.   
 
With (S)-153 in hand, the enantiomerically enriched allyl vinyl ether (S)-281 could be 
synthesised (Scheme 103).  Treatment of crude 254 with the sodium alkoxide generated from 
(S)-153 afforded (S)-281 that was not purified due to its observed slow rearrangement at 
room temperature (cf. page 48).  After heating crude (S)-281 in tetrahydrofuran at reflux for 
six hours, (S)-282 was isolated in 74% yield (calculated over three steps).  For comparison, 
racemic-282 was also prepared using identical conditions using commercially available 
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Scheme 103.  Synthesis of enatiomerically enriched (S)-282.   
The enantiomeric purity of (S)-282 was determined using the chiral lanthanide shift reagent 
Eu(hfc)3 (hfc = heptafluorohydroxymethylene-(+)-camphorato) (Figure 28).118  The addition 
of Eu(hfc)3 in small portions to (S)-282 in CDCl3 led to a good separation of the signal in the 
1H NMR spectrum associated with H-1 of (S)-282.  The enantiomeric purity of (S)-282 was 
measured by integration of these separated signals and was determined to be 93:7 e.r.  It must 
be noted, however, that enantiomeric ratios determined using lanthanide chiral shift reagents 
have been reported to be most accurate in the region of 70:30 e.r. to 80:20 e.r. with 
significant errors reported above these values.119  Attempts were made to determine the 
enatiomeric purity of (S)-282 with greater accuracy using chiral HPLC.  Unfortunately, using 
a variety of solvent systems in combination with both normal and reversed phase columns, 
the two enantiomers could not be satisfactorily separated.   
 
 
Figure 28.  Analysis of a) racemic-282 and b) enantiomerically enriched (S)-282 using the chiral lanthanide 
shift reagent Eu(hfc)3 in combination with 1H NMR demonstrated that the enatiomeric purity of (S)-282 was 
93:7 e.r.   
 
The enantiomeric ratio of 93:7 measured for (S)-282 is consistent with a small loss of 
enantiomeric purity in relation to (S)-153 (96:4 e.r.).  This could be due to the Claisen 
rearrangement proceeding, to a minor extent, via a mechanistic pathway other than the 
expected chair transition state (Figure 29).  A boat transition state with the methyl group 
occupying the equatorial position would give a reversal of the absolute configuration at C-
10b whilst maintaining the E-geometry of the resulting alkene.  Alternatively, a mechanism 
that involves bond breaking preceding bond formation (see page 35) could also account for 




Figure 29.  Claisen rearrangement of (S)-281 via a chair transition state with the methyl group occupying a 
equatorial position will give the S-configuration at C-10b and the E-alkene of (S)-282.   
 
Based on the proposed transition state shown in Figure 29, it was expected that using (S)-153 
would afford the (S)-absolute configuration at C-10b of the indolo[2,3-b]quinoline system.  
Crystals of (S)-282 grown from ethyl acetate/hexane were analysed by X-ray crystallography 
and the absolute configuration was established by anomalous dispersion effects in diffraction 
measurements (Figure 30).  By this method the (S)-configuration of the molecules in the 
crystal analysed was demonstrated.  This crystallographic analysis suggests, but does not 












Figure 30.  X-ray structure of (S)-281.  The absolute configuration was demonstrated by anomalous dispersion 
effects in diffraction measurements.   
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5.5 Summary and Conclusions  
 
The investigations described in this chapter were aimed at extending the methodology 
described in Chapter 2.  First, the effect of a substituent at position C-10 of the indolo[2,3-
b]quinoline system was explored with the aim of extending the methodology so as to be 
applicable to a communesin synthesis.  A high yielding route to 4-bromo-1H-indole-3-
carboxylic acid methyl ester (239), which was required for the synthesis of the 10-
bromoindolo[2,3-b]quinoline system, was established.  It was found that the chemistry that 
had been used previously for the synthesis of the indolo[2,3-b]quinoline ring system and for 
the generation of the C-10b quaternary centre was also applicable to the synthesis of 
compounds with a Br-10 substituent.   
 
Various differences in the chemical reactivity between the system discussed in this chapter 
and the model system discussed in Chapter 2 were observed.  The most important of these 
was that the presence of the Br-10 substituent did not accelerate the aza-Cope rearrangement 
of 258 as expected, but actually retarded this process.  Based on this observation, a modified 
N-6 substituted system was investigated.  Unfortunately, rearrangement of 265 did not lead to 
the accumulation of significant quantities of 266.   
 
Finally, the asymmetric construction of the C-10b quaternary centre was explored.  It was 
shown that by using an enantiomerically enriched chiral secondary alcohol for the synthesis 
of the allyl ether (S)-280, the chirality could be transferred to the newly formed stereocentre 
at C-10b through the ordered transition state of the Claisen rearrangement.  By using this 
technique (S)-281 was prepared in good yield.  In regard to a communesin synthesis, (S)-281 
has functionality a positions C-10, C-10b and C-11 that would allow asymmetric construction 
of the communesin natural products.   
 
Whist the investigations presented in this chapter are far from a complete communesin 
synthesis, it is clear that this route is applicable to a synthesis of these compounds.  
Furthermore, this is the first asymmetric strategy directed at a synthesis of the communesins 
that incorporates functionality at all the positions necessary for the construction of the rest of 
the natural products.   
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Chapter 6: Experimental 
 
 
6.1 General procedures  
 
Chemical reagents were obtained from either Alfa Aesar-Avocardo/Lancaster or Aldrich and 
were used as received unless otherwise stated.  All reactions were performed in oven-dried 
glassware, under a positive pressure of argon.  THF was dried by refluxing with sodium-
benzophenone under an argon atmosphere and was collected by distillation. CH2Cl2 was 
dried by refluxing with CaH2 under an argon atmosphere and was collected by distillation.  
Alcohols used for the formation of alkoxides were dried either by standing over 4 Å 
molecular sieves or by distillation from sodium under an argon atmosphere.  Aniline, N-
methylaniline and N,'N-dimethylpiperazine were all dried by distillation from KOH.  
NaHCO3(aq) and NH4Cl(aq) refers to saturated solutions.  The following were used for cooling 
reaction mixtures: 
-ice/water (0 °C) 
-ice/acetone (-10 °C) 
-dry ice/acetone (-78 °C) 
-A cryocool machine was used for all other temperature below 0 °C 
 
Thin-layer chromatography was performed using glass plates coated with silica gel (with 
fluorescent indicator UV254).  Developed plates were air-dried and analysed under a UV lamp 
(254/365 nm).  Flash chromatography was performed using silica gel (40-63 µm, 
Fluorochem).   
 
Melting points were recorded in open capillaries using an Electrothermal 9100 melting point 
apparatus.  Values are quoted to the nearest 1 °C and are uncorrected.   
 
Optical rotations were measured on a Perkin Elmer Model 341 Polarimeter using a 2 ml 
solution cell with a 10 cm path length.  The concentration (c) is expressed in g/dm3.   
 
Elemental microanalysis for carbon, hydrogen and nitrogen were performed within the 
School of Chemistry at the University of St Andrews.   
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Infrared spectra were recorded on a Perkin Elmer Paragon 1000 FT spectrometer.  
Absorption maxima are reported in wavenumbers (cm-1) and intensities are quoted as strong 
(s), medium (m), weak (w), and broad (br).  Assignment of absorptions is only given if was 
used for structural determination.   
 
Low and high-resolution mass spectra were recorded using either electron impact (EI), 
chemical ionisation (CI), or electrospray (ESI) ionisation methods and using time-of-flight 
mass analysis operating in positive mode.  Only the molecular ion(s) and major fragment 
peaks (>20%) are reported.  The intensities (%) are given in parentheses.   
 
Nuclear magnetic resonance (NMR) spectra were recorded either on a Bruker Advance 300 
(1H, 300; 13C, 75 MHz), Bruker Advance 400 (1H, 400; 13C, 101 MHz), or Bruker Advance 
500 (1H, 500; 13C, 125 MHz).  13C NMR spectra were recorded using the PENDANT pulse 
sequence and peaks are assigned and either C, CH, CH2 or CH3.  Assignment of peaks in the 
13C NMR spectrum to specific carbon atoms is only given if the peak was of particular 
importance for structural determination.  All NMR spectra ware acquired using the 
deuterated solvent as the lock and the residual solvent or TMS (tetramethylsilane) as the 
internal reference.  Coupling constants (J) are quoted in Hz and are recorded to the nearest 
0.1 Hz.  The multiplicity used in the assignment of 1H NMR spectra is indicated by the 
following abbreviations: s (singlet), d (doublet), dd (doublet of doublets), ddd (doublet of 
doublets of doublets), t (triplet), dt (doublet of triplets), q (quartet), m (multiplet), and br 
(broad).  Peaks were assigned with the aid of the two-dimensional NMR spectroscopic 
techniques COSY, HSQC, and HMBC.   
 
 
General method A: General procedure for the synthesis of 2-Phenylamino-1H-indole-3-
carboxylic acid methyl esters 
 
N-Chlorosuccinimide (1.1 equiv.) and N,'N-dimethylpiperazine (0.55 equiv.) were added to a 
stirred solution of indole-3-carboxylic acid methyl ester (111) (1 equiv.) in CH2Cl2 (1 vol.), 
cooled to 0 °C and maintained under an argon atmosphere.  The reaction mixture was stirred 
at 0 °C for 2 hours.  A mixture of the trichloroacetic acid (0.25 equiv.) and the appropriate 
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aniline (2 equiv) in CH2Cl2 (1 vol.) was added before allowing the reaction mixture to warm 
to room temperature.  After 2 hours, the reaction mixture was sequentially washed with 10% 
NaHCO3(aq) (0.5 vol.), 1.0 M hydrochloric acid (0.5 vol.), and water (0.5 vol.).  The CH2Cl2 
solution was dried (MgSO4), filtered through a pad of silica and the solvent was removed by 
evaporation at reduced pressure.  The crude products were purified either by crystallisation 
from CH2Cl2/hexane or by flash chromatography.   
 
 
General method B: General procedure for the synthesis of 5,6-dihydroindolo[2,3-
b]quinolin-11-ones from 2-phenylamino-1H-indole-3-carboxylic acid methyl esters 
 
The appropriate phenylamino-1H-indole-3-carboxylic acid methyl ester was heated in Ph2O 
under reflux.  After allowing the reaction mixture to return to room temperature, the solid 
insoluble product was collected by filtration and washed with ether until a fine powder 
resulted that was free of Ph2O.   
 
 
General method C: General procedure for the synthesis of 11-chloro-5H-indolo[2,3-
b]quinolines from 5,6-dihydroindolo[2,3-b]quinolin-11-ones  
 
A mixture of the appropriate 5,6-dihydroindolo[2,3-b]quinolin-11-one and POCl3 (1 vol.) 
were heated at reflux, under an argon atmosphere, and then cooled to room temperature.  The 
excess POCl3 was removed by evaporation at reduced pressure and the residue was added to 
crushed ice/water (ca. 1 vol.).  The mixture was basified with a saturated NaHCO3(aq) until all 
the yellow solids had turned orange.  The aqueous suspension was then extracted with 
CH2Cl2 (3 x 2 vol.).  The CH2Cl2 extracts were combined, dried (MgSO4) and the CH2Cl2 
was removed by evaporation at reduced pressure.  Alternatively, for large scale preparation, 







General method D: General procedure for the synthesis of 11-alkyloxy-5H-indolo[2,3-
b]quinolines from 11-chloro-5H-indolo[2,3-b]quinolines  
 
Alkoxides were formed by slowly adding the appropriate alcohol, at a rate that maintained a 
steady reaction, to sodium in THF with stirring and under an argon atmosphere.  When all the 
sodium had dissolved, the alkoxide was added via cannula to a stirred mixture of the 
appropriate 11-chloro-5H-indolo[2,3-b]quinoline in THF (1 vol.).  The reaction mixture was 
then stirred at room temperature, under an argon atmosphere, for 18 hours.  After adding a 
saturated solution of NH4Cl(aq) (0.1 vol.), the solvent was removed by evaporation at reduced 
pressure and the residue was partitioned between water (1 vol.) and CH2Cl2 (1 vol.).  The 
CH2Cl2 was separated and the aqueous phase was further extracted with CH2Cl2 (3 x 1 vol.).  
The combined CH2Cl2 extracts were dried (MgSO4) and the CH2Cl2 was removed by 
evaporation at reduced pressure.  Purification by chromatography afforded the pure product.   
 
 
6.2 Preparation of individual compounds and characterisation data 
 
Preparation of 11-allyloxy-6-methyl-6H-indolo[2,3-b]quinoline (90) 
N N
O
CH3 90  
A solution of the alkoxide generated from allyl alcohol (25.5 ml, 375 mmol) and sodium (2.6 
g, 196 mmol) in THF (70 ml) was added to 11-chloro-6-methyl-6H-indolo[2,3-b]quinoline 
(115) (3.50 g, 13.1 mmol) in THF (25 ml), maintained under an argon atmosphere, and the 
reaction mixture heated at 70 °C (bath temperature).  After 48 hours the reaction was cooled 
to room temperature and NH4Cl(aq) (10 ml) was added.  The excess allyl alcohol and THF 
were evaporated at reduced pressure and the residue was partitioned between water (25 ml) 
and CH2Cl2 (25 ml).  The CH2Cl2 was separated and the aqueous phase was further extracted 
with CH2Cl2 (2 x 25 ml).  All the CH2Cl2 extracts were combined, dried (MgSO4) and the 
solvent was evaporated at reduced pressure.  The residue was purified by flash 
chromatography (10% to 20% EtOAc/hexane) followed by crystallised from EtOAc/hexane 
to afford the title compound 90 as pale yellow crystals (1.47g, 5.10 mmol, 68%).  Mp 75-76 
oC; Anal. calcd for C19H16N2O: C, 79.14; H, 5.59; N, 9.72. Found: C, 78.86; H, 5.66; N, 9.72; 
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IR (KBr) νmax: 3057 (w), 2928 (w), 1638 (s), 1608 (s), 1570 (m), 1492 (s), 1474 (m), 1428 
(m), 1395 (s), 1292 (s), 1245 (m), 1099 (m), 993 (w), 922 (w), 765 (s), 742 (s) cm-1; MS 
(ESI) m/z 288 (MH+, 100); HRMS (ESI) m/z calcd for C19H16N2O 288.1262, found 
288.1263; 1H NMR (300 MHz, CDCl3) δ 8.31 (dd, J = 8.5, 1.1 Hz, 1H, H-1), 8.24 (d, J = 7.5 
Hz, 1H, H-10), 8.12 (d, J = 8.5 Hz, 1H, H-4), 7.72 (ddd, J = 8.5, 7.0, 1.1 Hz, 1H, H-3), 7.56 
(ddd, J = 8.0, 7.5, 1.0 Hz, 1H, H-8), 7.45 (ddd, J = 8.5, 7.0, 1.0 Hz, 1H, H-2), 7.39 (d, J = 8.0 
Hz, 1H, H-7), 7.31 (td, J = 7.5, 1.0 Hz, 1H, H-9), 6.29 (ddt, J = 17.0 Hz, 10.5 Hz, 5.5 Hz, 1H, 
CH=CH2), 5.56 (dq, J = 17.0, 1.5 Hz, 1H, CH=CH2), 5.37 (dq, J = 10.5, 1.5 Hz, 1H, 
CH=CH2), 4.89 (td J = 5.5, 1.5 Hz, 2H, OCH2), 3.97 (s, 3H, CH3); 13C NMR (75 MHz, 
CDCl3) δ 157.5 (C), 154.8 (C), 148.6 (C), 142.2 (C), 133.4 (CH), 129.4 (CH), 127.8 (CH), 
127.7 (CH), 123.8 (CH), 122.71 (CH), 122.68 (CH), 120.7 (CH), 120.1 (C), 119.3 (C), 118.6 
(CH2), 109.4 (C), 108.6 (CH), 75.2 (CH2), 28.0 (CH3). 
 
 





5,6-Dihydroindolo[2,3-b]quinolin-11-one (110) (13.7 g, 58.5 mmol) was refluxed in POCl3 
(300 ml) for 3 hours and then cooled to room temperature.  The excess POCl3 was evaporated 
at reduced pressure and the residue was added to chipped ice/water (ca 150 ml).  The mixture 
was made basic (ca pH 9) by the addition of saturated NaHCO3 solution and the yellow 
solids were collected by filtration.  After washing with water, the product was thoroughly 
dried to afford the title compound 109 in sufficient purity for the next step (13.9 g, 55.1 
mmol, 94%).  Spectroscopic data was in accordance with that published in the literature.45 
Mp 307-315 °C (dec.) (lit.45 314-316 °C (dec.)); 1H NMR (300 MHz, DMSO-d6) δ 12.11 (br 
s, 1H, NH), 8.59 (d, J = 7.8 Hz, 1H, H-10), 8.54 (dd, J = 8.4, 1.1 Hz, 1H, H-1), 8.37 (dd, J = 
8.4, 1.0 Hz, 1H, H-4), 7.91-7.80 (m, 1H, H-3), 7.71-7.50 (m, 3H, H-7, H-2, H-8), 7.41-7.31 











Prepared from 2-phenylamino-1H-indole-3-carboxylic acid methyl ester (112) (17.5 g, 65.7 
mmol) in Ph2O (90 ml) with a reaction time of 3.5 hours using general method B.  The title 
compound 110 was obtained as a light brown solid (14.6 g, 62.3 mmol, 95%).  Spectroscopic 
data was in accordance with that published in the literature.45  Mp > 400 °C (lit.45 > 360 °C); 
1H NMR (300 MHz, DMSO-d6) δ 11.95 (br s, 2H, 2 x NH), 8.29 (d, J = 7.7 Hz, 1H, H-10), 
8.19 (d, J = 7.9 Hz, 1H, H-1), 7.63-7.58 (m, 1H, H-3), 7.48-7.42 (m, 1H, H-9), 7.15-7.31 (m, 
3H, H-2, H-4, H-8); 13C NMR (75 MHz, DMSO-d6) δ 172.7 (C, C-11), 145.7 (C), 138.7 (C), 
135.4 (C), 131.1 (CH), 125.7 (CH), 124.2 (C), 123.9 (C), 123.0 (CH), 121.8 (CH), 121.2 
(CH), 120.4 (CH), 117.8 (CH), 111.3 (CH), 102.2 (C).   
 
 





Prepared from indole-3-carboxilic acid methyl ester (111) (25.9 g, 148 mmol) in CH2Cl2 (600 
ml) and aniline (26.9 ml, 295 mmol) using general method A.  The crude product was 
crystallised twice from CH2Cl2/hexane to afford the title compound 112 as a pale yellow 
crystals (19.8 g, 74.4 mmol, 50%).  Spectroscopic data was in accordance with that published 
in the literature.45  Mp 121-122 °C (lit.45 121-122 °C); 1H NMR (300 MHz, CDCl3) δ 9.01 (s, 
1H, NH), 8.22 (s, 1H, NH), 7.46-7.38 (m, 2H, 2 x ArH), 7.80 (d, J = 7.7, 1H, ArH), 7.30-7.24 








Preparation of 11-chloro-6-methyl-6H-indolo[2,3-b]quinoline (115) 
N N
Cl
Me 115  
Sodium hydride (1.58 g of a 60% dispersion in oil, 39.5 mmol) was added to a stirred 
suspension of 11-chloro-6H-indolo[2,3-b]quinoline (109) (2.00 g, 7.93 mmol) in THF (70 
ml), maintained under an argon atmosphere.  When effervescence ceased, methyl iodide 
(2.50 ml, 40.1 mmol) was added and the reaction mixture was heated at 50 °C (bath 
temperature) for 1 hour.  After cooling the reaction mixture to room temperature, NH4Cl(aq) 
(20 ml) was added and the solvent was evaporated at reduced pressure.  The residue was 
partitioned between CH2Cl2 (30 ml) and water (30 ml).  The CH2Cl2 was separated and the 
aqueous phase was further extracted with CH2Cl2 (2 x 30 ml).  All the CH2Cl2 extracts were 
combined, then dried (MgSO4) and the solvent was evaporated at reduced pressure.  The 
residue was purified by flash chromatography (10% to 20% EtOAc/Hexane) to afford the 
title compound 115 as a pale yellow crystalline solid (1.89 g, 7.09 mmol, 90%).  Mp 141-142 
oC; IR (KBr) νmax: 1603 (s), 1560 (m), 1489 (m), 1470 (m), 1422 (m), 1393 (s), 1322 (m), 
1260 (m), 1121 (w), 1073 (w), 944 (w), 863 (w), 763 (m), 749 (s), 629 (m) cm-1; MS (ESI) 
m/z 267 (MH+, 100); HRMS (ESI) m/z calcd for C16H12N235Cl 267.0689, found 267.0681; 1H 
NMR (300 MHz, CDCl3) δ 8.59 (d, J = 7.5 Hz, 1H, H-10), 8.39 (dd, J = 8.3, 1.2 Hz, 1H, H-
1), 8.11 (d, J = 8.3 Hz, 1H, H-4), 7.74 (ddd, J = 8.3, 6.8, 1.2 Hz, 1H, H-3), 7.60 (ddd, J = 8.3, 
7.5, 1.2 Hz, 1H, H-8), 7.53 (ddd, J = 8.3, 6.8, 1.0 Hz, 1H, H-2), 7.38 (d, J = 8.3 Hz, 1H, H-7), 
7.33 (td, J = 7.5, 0.8 Hz, 1H, H-9), 3.95 (s, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 152.5 
(C), 147.0 (C), 142.8 (C), 135.7 (C), 129.5 (CH), 128.6 (CH), 127.9 (CH), 124.3 (CH), 124.2 

















A mixture of 11-allyloxy-5-methyl-5H-indolo[2,3-b]quinoline (90) (200 mg, 0.694 mmol) 
and PhMe (10 ml) were heated at reflux under an argon atmosphere for 4 days.  After cooling 
the reaction mixture to room temperature, the PhMe was evaporated at reduced pressure and 
the crude product was purified by flash chromatography (50% to 80% EtOAc/Hexane) to 
afford the title compound 116 as a colourless crystalline solid (186 mg, 0.645 mmol, 93%).  
Mp 196-197 oC; IR (KBr) νmax: 1613 (m, C=O), 1591 (s), 1535 (s), 1510 (s), 1467 (m), 1396 
(w), 1242 (m), 1126 (w), 929 (w), 751 (s) cm-1; MS (EI) m/z 288 (M+, 13), 247 (44), 219 
(26), 86 (65), 84 (100); HRMS (EI) m/z calcd for C19H16N2O 288.1263, found 288.1255; 1H 
NMR (300 MHz, CDCl3) δ 8.49 (dd, J = 7.5, 0.7 Hz, 1H, H-10), 8.40 (dd, J = 7.9, 1.6 Hz, 
1H, H-1), 7.44 (td, J = 8.7, 1.6 Hz, 1H, H-3), 7.30 (td, J = 7.5, 1.0 Hz, 1H, H-9), 7.16-7.26 
(m, 3H, H-4, H-2, H-8), 6.97 (d, J = 8.0 Hz, 1H, H-7), 6.28 (m, 1H, CH=CH2), 5.43 (m, 1H, 
CH=CH2), 5.15 (m, 1H, CH=CH2), 4.92 (m, 2H, NCH2), 3.74 (s, 3H, CH3); 13C NMR (75 
MHz, CDCl3) δ 173.3 (C, C-11), 147.4 (C, C-5a), 140.5 (C), 137.4 (C), 133.6 (CH), 131.2 
(CH), 126.0 (CH), 125.1 (C), 123.5 (C), 123.2 (CH), 122.4 (CH), 122.2 (CH), 121.2 (CH), 
118.2 (CH2), 115.6 (CH), 108.9 (CH), 104.4 (C), 51.7 (CH2), 32.8 (CH3). 
 
 
Preparation of 11-allyloxy-6-ethyl-6H-indolo[2,3-b]quinoline (120) 
N N
O
Et 120  
A solution of the alkoxide generated from allyl alcohol (31.5 ml, 463 mmol) and sodium 
(1.60 g, 69.5 mmol) in THF (10 ml) was added to 11-chloro-5-ethyl-5H-indolo[2,3-
b]quinoline (122) (1.30 g, 4.63 mmol) in THF (15 ml), maintained under an argon 
atmosphere, and the reaction mixture heated at 70 °C (bath temperature).  After 48 hours the 
reaction was cooled to room temperature and NH4Cl(aq) (10 ml) was added.  The excess allyl 
alcohol and THF were evaporated at reduced pressure and the residue was partitioned 
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between water (25 ml) and CH2Cl2 (25 ml). The CH2Cl2 was separated and the aqueous phase 
was further extracted with CH2Cl2 (2 x 25 ml).  All the CH2Cl2 extracts were combined, dried 
(MgSO4) and the solvent was evaporated at reduced pressure.  The resided was purified by 
flash chromatography (5% to 15% EtOAc/hexane) and then crystallized from EtOH to give 
the title compound 120 as pale yellow crystals (686 mg, 2.27 mmol, 49%).  M.p.77-78 °C; 
Anal. calcd for C20H18N2O: C, 79.44; H, 6.00; N, 9.26. Found: C, 79.16; H, 6.15; N, 9.20; IR 
(KBr) νmax: 1636 (m), 1607 (m), 1570 (w), 1489 (m), 1471 (m), 1407 (s), 1375 (m), 1277 
(m), 1232 (m), 1177 (w), 1104 (m), 971 (w), 932 (w), 751 (s), 650 (w), 583 (w), 465 (w) cm-
1; MS (EI) m/z 302 (M+, 18), 261 (100), 205 (25); HRMS (EI) m/z calcd for C20H18N2O 
302.1419 found 302.1419; 1H NMR (300 MHz, CDCl3) δ 8.31 (dd, J = 8.5, 1.5 Hz, 1H, H-1), 
8.26 (d, J = 7.8 Hz, 1H, H-10), 8.12 (d, J = 8.7 Hz, 1H, H-4), 7.71 (ddd, J = 8.7, 6.8, 1.5 Hz, 
1H, H-3), 7.56 (ddd, J = 8.3, 7.4, 1.2 Hz, 1H, H-8), 7.41-7.48 (m, 2H, H-2, H-7), 7.31 (ddd, J 
= 7.8, 7.4, 0.8 Hz, 1H, H-9), 6.30 (ddt, J = 17.3, 10.5, 5.5 Hz, 1H, CH=CH2), 5.58 (dq, J = 
17.3, 1.5 Hz, 1H, CH=CH2), 5.38 (dq, J = 10.5, 1.5 Hz, 1H, CH=CH2), 4.90 (dt, J = 5.5, 1.2 
Hz, 2H, OCH2), 4.58 (q, J = 7.2 Hz, 2H, NCH2), 1.51 (t, J = 7.2 Hz, 3H, CH3); 13C NMR (75 
MHz, CDCl3) δ 157.3 (C), 154.1 (C), 148.5 (C), 141.1 (C), 133.3 (CH), 129.2 (CH), 127.7 
(CH), 127.4 (CH), 123.9 (CH), 122.52 (CH), 122.46 (CH), 120.1 (CH), 119.9 (C), 119.3 (C), 
118.4 (CH2), 109.3 (C), 108.6 (CH), 75.1 (CH2), 36.3 (CH2), 13.8 (CH3).   
 
 




A solution of the alkoxide generated from E-2-butene-1-ol (31.8 ml, 375 mmol) and sodium 
(1.29 g, 56.2 mmol) in THF (10 ml) was added to 11-chloro-6-methyl-5H-indolo[2,3-
b]quinoline (115) (1.00 g, 3.75 mmol) in THF (15 ml), maintained under an argon 
atmosphere, and the reaction mixture was heated at 55 °C (bath temperature).  After 65 hours 
the reaction was cooled to room temperature and NH4Cl(aq) (10 ml) was added.  The excess 
alcohol and THF were evaporated at reduced pressure and the residue was partitioned 
between water (20 ml) and CH2Cl2 (20 ml). The CH2Cl2 was separated and the aqueous phase 
was further extracted with CH2Cl2.  All the CH2Cl2 extracts were combined, dried (MgSO4), 
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and the solvent was evaporated at reduced pressure to leave an oily residue.  The residue was 
purified by flash chromatography (3% to 6% EtOAc/hexane) followed by crystallization 
from MeOH/water to afford the title compound 121 as a colourless crystalline solid (188 mg, 
0.622 mmol, 17%); Mp 60-61 °C; Anal. calcd for C20H18N2O: C, 79.44; H, 6.00; N, 9.26. 
Found: C, 79.19; H, 6.11; N, 8.91; IR (KBr) νmax: 1637 (s), 1610 (s), 1571 (m), 1491 (s), 
1475 (m), 1397 (s), 1337 (m), 1322 (m), 1289 (s), 1243 (m), 1186 (w), 1124 (w), 1097 (m), 
976 (s), 953 (m), 752 (s), 741 (s), 645 (w), 462 (w) cm-1; MS (ESI) m/z 303 (MH+, 38), 249 
(100); HRMS (ESI) m/z calcd for C20H19N2O 303.1497 found 303.1493; 1H NMR (300 MHz, 
CDCl3) δ 8.31 (dd, J = 8.4, 1.2 Hz, 1H, H-1), 8.27 (d, J = 7.5 Hz, 1H, H-10), 8.12 (d, J = 8.4 
Hz, 1H, H-4), 7.72 (ddd, J = 8.4, 6.8, 1.2 Hz, 1H, H-3), 7.58 (ddd, J = 8.2, 7.4, 1.0 Hz, 1H, 
H-8), 7.46 (ddd, J = 8.4, 6.8, 1.2 Hz, 1H, H-2), 7.43 (d, J = 8.2 Hz, 1H, H-7), 7.33 (ddd, J = 
7.5, 7.4, 1.0 Hz, 1H, H-9), 5.97 (m, 2H, CH2CH=CH), 4.84 (d, J = 5.0 Hz, 2H, OCH2), 4.00 
(s, 3H, NCH3), 1.78 (d, J = 1.5 Hz, 3H, CHCH3); 13C NMR (75 MHz, CDCl3) δ 157.9 (C), 
155.1 (C), 148.9 (C), 142.4 (C), 131.9 (CH), 129.6 (CH), 127.9 (CH), 127.8 (CH), 126.7 
(CH), 124.1 (CH), 123.1 (CH), 122.8 (CH), 120.6 (CH), 120.5 (C), 119.6 (C), 118.8 (CH2), 
109.7 (C), 108.8 (CH), 75.7 (CH2), 28.3 (CH3), 18.3 (CH3). 
 
 
Preparation of 11-chloro-6-ethyl-6H-indolo[2,3-b]quinoline (122) 
N N
Cl
Et 122  
Sodium hydride (1.58 g of a 60% dispersion in oil, 39.6 mmol) was added to a stirred 
suspension of 11-chloro-6H-indolo[2,3-b]quinoline (109) (2.00 g, 7.93 mmol) in THF (70 
ml), maintained under an argon atmosphere.  When effervescence ceased, ethyl iodide (3.18 
ml, 39.6 mmol) was added and the reaction mixture was heated at 50 °C (bath temperature) 
for 3 hours.  After cooling the reaction mixture to room temperature, NH4Cl(aq) (20 ml) was 
added and the THF was evaporated at reduced pressure.  The residue was partitioned between 
CH2Cl2 (30 ml) and water (30 ml), then filtered to remove unreacted starting material (260 
mg, 1.03 mmol, 13%).  The CH2Cl2 was separated and the aqueous phase was further 
extracted with CH2Cl2 (2 x 30 ml).  All the CH2Cl2 extracts were combined, dried (MgSO4) 
and the CH2Cl2 was evaporated at reduced pressure.  The residue was purified by flash 
chromatograph (5% to 10% EtOAc/hexane) to afford title compound 122 as a yellow 
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crystalline solid (1.50 g, 5.34 mmol, 68%).  Mp 133-134 °C; IR (KBr) νmax: 1632 (w), 1603 
(s), 1561 (w), 1485 (m), 1470 (m), 1400 (s), 1380 (w), 1321 (w), 1260 (w), 1233 (m), 1153 
(w), 1132 (w), 760 (m), 743 (s), 628 (w), 464 (m) cm-1; MS (ESI) m/z 281 (MH+, 100); 
HRMS (ESI) m/z calcd for C17H14N2Cl 281.0847 found 281.0846; 1H NMR (300 MHz, 
CDCl3) δ 8.59 (m, 1H, H-10), 8.41 (m, 1H, H-1), 8.12 (m, 1H, H-4), 7.74 (ddd, J = 8.5, 6.8, 
1.5 Hz, 1H, H-3), 7.60 (ddd, J = 7.9, 7.5, 1.3 Hz, 1H, H-8), 7.53 (ddd, J = 8.3, 6.8, 1.0 Hz, 
1H, H-2), 7.43 (d, J = 7.9 Hz, 1H, H-7), 7.33 (ddd, J = 8.0, 7.5, 1.0 Hz, 1H, H-9), 4.57 (q, J = 
7.2 Hz, 2H, CH2), 1.49 (t, J = 7.2 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 152.2 (C), 
147.3 (C), 142.2 (C), 135.9 (CH), 129.7 (CH), 128.9 (CH), 128.2 (CH), 124.7 (CH), 124.4 
(CH), 124.0 (CH), 122.7 (C), 120.5 (CH), 120.4, (C), 116.0 (C), 109.1 (CH), 36.7 (CH2), 
14.1 (CH3).   
 
 







11-(E-but-2-enyloxy)-6-methyl-6H-indolo[2,3-b]quinoline (121) (12 mg, 0.0397 mmol) and 
PhMe (0.8 ml) were heated at 100 °C for 3 hours.  The PhMe was evaporated at reduced 
pressure and the residue was purified by flash chromatography (30% to 50% EtOAc/hexane) 
to give the title compound 123 as a colourless crystalline solid (8 mg, 0.0265 mmol, 67%). 
Mp 164-165 °C; IR (KBr) νmax: 1618 (s, C=O), 1593 (s), 1577 (m), 1534 (s), 1509 (s), 1466 
(m), 1391 (w), 1350 (w), 1316 (w), 1238 (m), 1126 (w), 1041 (w), 976 (w), 879 (w), 748 (s), 
672 (w) cm-1; MS (EI) m/z 302 (M+, 20), 247 (100), 219 (46); HRMS (EI) m/z calcd for 
C20H18N2O 302.1419 found 302.1418 1H NMR (300 MHz, CDCl3) δ 8.48 (dd, J = 7.7, 0.8 
Hz, 1H, H-10), 8.39 (dd, J, = 7.9, 1.2 Hz, 1H, H-1), 7.41 (ddd, J = 8.5, 6.9, 1.2, 1H, H-3), 
7.14-7.30 (m, 4H, H-9, H-8, H-4, H-2), 6.92 (d, J = 8.2 Hz, 1H, H-7), 5.83 (m, 1H, CHCH3), 
5.52 (m, 1H, CH2CH), 4.80 (m, 2H, CH2), 3.70 (s, 3H, NCH3), 1.72 (dd, J = 1.6, 6.7 Hz, 3H, 
CHCH3); 13C NMR (75 MHz, CDCl3) δ 173.6 (C), 147.6 (C), 140.8 (C), 137.7 (C), 131.4 
(CH), 129.4 (CH), 126.5 (CH), 126.3 (CH), 125.4 (C), 123.8 (C), 123.5 (CH), 122.6 (CH), 
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122.5 (CH), 121.5 (CH), 115.9 (CH), 109.1 (CH), 104.7 (C), 52.1 (CH2), 33.2 (CH3), 18.2 
(CH3).   
 
 




Prepared from 11-chloro-5-methyl-5H-indolo[2,3-b]quinoline (133) (1.50 g, 5.62mmol) in 
THF (30 ml), with the alkoxide generated from allyl alcohol (7.50 ml, 110 mmol) and sodium 
(650 mg, 28.3 mmol) in THF (10 ml), using general method D.  The crude product was 
purified by flash chromatograph (80% EtOAc/hexane) to afford the title compound 129 as a 
dark yellow solid (1.46 g, 5.06 mmol, 90%).  Mp 93-94 oC; IR (KBr) νmax: 1643 (s), 1571 (s), 
1522 (m), 1492 (s), 1460 (m), 1352 (m), 1283 (s), 1240 (s), 1177 (m) 1149 (m), 1118 (m), 
1098 (m), 1059 (m), 965 (w), 909 (w), 750 (s), 661 (w), 595 (w), 468 (w) cm-1; MS (CI) m/z 
289 (MH+, 100), 249 (27); HRMS (CI) m/z calcd for C19H17N2O 289.1341 found 289.1339; 
1H NMR (300 MHz, CDCl3) δ 8.28 (dd, J = 8.0, 1.5 Hz, 1H, H-1), 8.08 (d, J = 8.0 Hz, 1H, 
H-10), 7.63-7.77 (m, 3H, H-7, H-3, H-4), 7.52 (td, J = 8.0, 1.0 Hz, 1H, H-8), 7.40 (ddd, J = 
8.0, 7.0, 1.0 Hz, 1H, H-2), 7.24 (td, J = 8.0, 1.0 Hz, 1H, H-9), 6.23 (ddt, J = 17.0, 10.5, 1.5, 
1H, CH=CH2), 5.54 (dq, J = 17.0, 1.5 Hz, 1H, CH=CH2), 5.35 (dq, J = 10.5, 1.5 Hz, 1H, 
CH=CH2), 4.92 (dt, J = 5.5, 1.5 Hz, 2H, OCH2), 4.28 (s, 3H, CH3); 13C NMR  (75 MHz, 
CDCl3) δ 158.4 (C), 156.6 (C), 153.9 (C), 138.1 (C), 132.8 (CH), 130.9 (CH), 128.3 (CH), 
124.3 (CH), 123.2 (CH), 122.5 (C), 121.6 (CH), 120.0 (CH), 118.8 (CH2), 117.9 (C), 117.5 














A solution of 11-allyloxy-5-methyl-6H-indolo[2,3-b]quinoline (129) (1.46 g, 5.06 mmol) and 
PhMe (50 ml) was refluxed under an argon atmosphere for 5 hours.  After cooling to room 
temperature, the PhMe was evaporated at reduced pressure and the residue was purified by 
flash chromatography (10% to 20% EtOAc/hexane) to afford the title compound 130 as a 
bright yellow crystalline solid (1.30 g, 4.51 mmol, 89%).  Crystals suitable for X-ray analysis 
were obtained from EtOAc/hexane.  Mp 94-95 oC; Anal. calcd for C19H16N2O: C, 79.14; H, 
5.59; N, 9.72. Found: C, 79.09; H, 5.33; N, 9.56; IR (KBr) νmax: 3070 (w), 2901 (w), 1692 (s, 
C=O), 1560 (s), 1471 (s), 1386 (s), 1344 (m), 1296 (m), 1207 (m), 1167 (m), 1068 (w), 1038 
(w), 985 (w), 922 (m), 844 (m), 777 (s), 762 (s), 670 (m), 676 (m), 629 (w), 504 (w), 468 (w) 
cm-1; MS (ESI) m/z 289 (MH+, 100); HRMS (ESI) m/z calcd for C19H17N2O 289.1341 found 
289.1346; 1H NMR (300 MHz, CDCl3) δ 7.97 (dd, J = 7.8, 1.4 Hz, H-1), 7.70 (d, J = 7.3 Hz, 
1H, H-10), 7.63 (ddd, J = 8.8, 7.3, 1.4 Hz, 1H, H-3), 7.42 (d, J = 7.3 Hz, 1H, H-7), 7.35 (td, J 
= 7.3, 1.3 Hz, 1H, H-8), 7.12-7.19 (m, 3H, H-4, H-9, H-2), 5.28-5.42 (m, 1H, CH=CH2), 4.99 
(m, 1H, CH=CH2), 4.83 (m, 1H, CH=CH2), 3.72 (s, 3H, CH3), 2.80 (dd, J = 13.2, 6.8 Hz, 1H, 
CCH2), 2.46 (dd, J = 13.2, 7.8 Hz, 1H, CCH2); 13C NMR (75 MHz, CDCl3) δ 192.9 (C, C-
11), 172.4 (C, C-5a), 153.6 (C), 145.4 (C), 140.0 (CH), 133.1 (C), 130.4 (CH), 128.9 (CH), 
128.6 (CH), 124.7 (CH), 123.3 (CH), 122.5 (CH), 120.3 (CH2), 119.0 (C), 118.7 (CH), 114.6 
(CH), 66.2 (C, C-10b), 45.1 (CH2), 33.2 (CH3).   
 
 





Prepared from 2-(methylphenylamino)-1H-indole-3-carboxylic acid methyl ester (132) (17.0 
g, 60.6 mmol) in Ph2O (80 ml), with a reaction time of 2.5 hours, using general method B.  
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The title compound 131 was obtained as a light brown micro crystalline solid (13.8 g, 55.6 
mmol, 91%).  Spectroscopic data was in accordance with that published in the literature.45  
Mp >400 °C (lit.45 >360 °C); 1H NMR (300 MHz, CDCl3) δ 12.07 (br s, 1H, NH), 8.39 (dd, J 
= 8.3, 1.4 Hz, 1H, H-10), 8.22-8.18 (m, 1H, H-1), 7.82-7.71 (m, 2H, H-3, H-9), 7.50-7.46 (m, 
1H, H-8), 7.39 (ddd, J = 7.9, 6.3, 1.7 Hz, 1H, H-2), 7.31-7.18 (m, 2H, H-4, H-7), 3.98 (s, 3H, 
CH3).   
 
 






Prepared from indole-3-carboxilic acid methyl ester (111) (18.8 g, 107 mmol) in CH2Cl2 (440 
ml) and N-methylaniline (23.4 ml, 216 mmol) using general method A.  The crude product 
was crystallised from CH2Cl2/hexane to afford the title compound 132 as colourless crystals 
(22.6 g, 80.6 mmol, 75%).  Spectroscopic data was in accordance with that published in the 
literature.45  Mp 144-146 °C (lit.45 146-147 °C); 1H NMR (300 MHz, CDCl3) δ 8.19 (broad s, 
1H, NH), 8.17-8.10 (m, 1H, ArH), 7.31-7.19 (m, 5H, 5 x ArH), 6.94-6.83 (m, 3H, 3 x ArH), 
3.84 (s, 3H, OCH3), 3.47 (s, 3H, NCH3).   
 
 




Prepared from 5,6-dihydro-6-methylindolo[2,3-b]quinolin-11-one (131) (7.80 g, 31.4 mmol) 
and POCl3 (70 ml), with a reaction time of 1 hour, using general method C.  Following 
isolation by extracting into CH2Cl2, the crude product was purified by flash chromatography 
(80% to 100% EtOAc/hexane) to afford the title compound 133 as a bright orange solid (7.80 
g, 29.2 mmol, 93%).  Mp 182-183 oC; IR (KBr) νmax: 1632 (m), 1610 (m), 1572 (s), 1523 (s), 
1491 (s) , 1438 (s), 1272 (s), 1235 (s), 1193 (w), 1139 (w), 1076 (m), 950 (w), 887 (w), 850 
(w), 751 (s), 598 (w), 465 (w) cm-1; MS (ESI) m/z 267 (MH+, 100); HRMS (ESI) m/z calcd 
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for C16H12N2Cl 267.0689 found 267.0688; 1H NMR (300 MHz, CDCl3) δ 8.42-8.47 (m, 2H, 
H-10, H-1), 7.72-7.84 (m, 3H, H-7, H-3, H-4), 7.49-7.62 (m, 2H, H-8, H-2), 7.26-7.31 (m, 
1H, H-9), 4.35 (s, 3H, CH3); 13C NMR  (75 MHz, CDCl3) δ 155.6 (C), 155.2 (C), 137.1 (C), 
136.0 (C), 131.2 (CH), 129.9 (CH), 126.2 (CH), 125.0 (C), 124.1 (CH), 124.0 (C), 122.4 
(CH), 120.4 (CH), 119.3 (C), 117.8 (CH), 114.4 (CH), 33.3 (CH3).   
 
 





















11-Allyloxy-5-methyl-5H-indolo[2,3-b]quinoline (129) (80.0 mg, 0.277 mmol) and MeOH 
(4.0 ml) were heated at reflux for 19 hours.  The reaction mixture was cooled to room 
temperature and the MeOH was evaporated at reduced pressure.  The residue was purified by 
flash chromatograph and two compounds were isolated.  The first, bright yellow crystalline 
solid, compound to be eluted (25% EtOAc/hexane) was 6-allyl-5-methyl-5H-indolo[2,1-
b]quinazolin-12-one (138) (30 mg, 0.104 mmol, 38%).  Crystals suitable for X-ray analysis 
were obtained from MeOH.  Mp 160-161 °C; Anal. calcd for C19H16N2O: C, 79.14; H, 5.59; 
N, 9.72. Found: C, 79.04; H, 5.54; N, 9.75; IR (KBr) νmax: 1673 (s, C=O), 1618 (s), 1585 (s), 
1491 (s), 1463 (m), 1397 (m), 1371 (m), 1253 (w), 1170 (w), 1073 (w), 1020 (w), 912 (m), 
879 (m), 775 (w), 738 (s), 684 (w) cm-1; MS (CI) m/z 289 (MH+, 100); HRMS (CI) m/z calcd 
for C19H17N2O 289.1341 found 289.1341; 1H NMR (300 MHz, CDCl3) δ 8.67-8.72 (m, 1H, 
H-10), 8.29 (dd, J = 7.8, 1.5 Hz, 1H, H-1), 7.57 (ddd, J = 8.5, 7.3, 1.5 Hz, 1H, H-3), 7.34-
7.38 (m, 1H, H-7), 7.28 (td, J = 7.3, 1.3 Hz, 1H, H-8), 7.18-7.24 (m, 1H, H-9), 7.02-7.12 (m, 
2H, H-2, H-4), 6.01-6.14 (ddt, J = 16.9, 10.1, 5.1 Hz, 1H, CH=CH2), 5.13 (dq, J = 10.1, 1.7 
Hz, 1H, CH=CH2), 5.04 (dq, J = 16.9, 1.7 Hz, 1H, CH=CH2), 3.73 (s, 1H, CH3), 3.69 (dt, J = 
5.1, 1.7 Hz, 1H, OCH2); 13C NMR (75 MHz, CDCl3) δ 159.4 (C, C-12), 142.6 (C), 136.8 
(CH), 135.6 (C), 134.6 (CH), 131.1 (C), 129.8 (C), 128.7 (CH), 124.2 (CH), 121.5 (CH), 
120.4 (CH), 116.3 (CH), 116.14 (CH), 116.09 (CH2), 114.0 (C), 112.5 (CH), 92.5 (C, C-6), 
36.2 (CH3), 28.8 (CH2). 
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The second, orange solid, compound to be eluted (EtOAc) was 11-methoxy-5-methyl-5H-
indolo[2,3-b]quinoline (137) (40 mg, 0.152 mmol, 55%).  Spectroscopic data was in 
accordance with that published in the literature.53  Mp 183-186 °C (lit.53 184-186°C); MS 
(ESI) m/z 263 (MH+, 100); HRMS (ESI) m/z calcd for C17H15N2O 263.1184 found 263.1180; 
1H NMR (300 MHz, CDCl3) δ 8.32 (dd, J = 8.0, 0.9 Hz, 1H, H-1), 8.14 (d, J = 7.7, 1H, H-
10), 7.82-7.71 (m, 3H, H-7, H-3, H-4), 7.54 (ddd, J = 8.3, 8.0, 1.0, 1H, H-8), 7.46 (ddd, J = 
8.0, 6.5, 1.3 Hz, 1H, H-2), 7.27 (ddd, J = 8.0, 7.7, 1.0 Hz, 1H, H-9), 4.33 (s, 3H, 
OCH3/NCH3), 4.31 (s, 3H, OCH3/NCH3).   
 
 







5,10b-Dihydro-10b-allyl-5-methylindolo[2,3-b]quinolin-11-one (130) (25mg, 0.0867 mmol) 
and MeOH (2.5 ml) were heated at reflux for 12 hours.  The reaction mixture was cooled to 
room temperature and the MeOH was evaporated at reduced pressure to afford the title 
compound 138 as a bright yellow crystalline solid (25 mg, 0.0867 mmol, 100%).  
Spectroscopic data was identical to that of 138 prepared by the above procedure.   
 
 










5,10b-Dihydro-10b-allyl-5-methylindolo[2,3-b]quinolin-11-one (130) (200 mg, 0.694 mmol) 
and PhMe (10 ml) were heated at reflux, under an argon atmosphere, for 4 days.  After 
cooling the reaction mixture to room temperature, the PhMe was evaporated at reduced 
pressure and the residue was purified by flash chromatography.  The first, colourless 
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crystaline solid, compound to be eluted (1% MeOH/CHCl3) was 5,6-dihydro-6-allyl-5-
methylindolo[2,3-b]quinolin-11-one (140) (143 mg, 0.496 mmol, 72%).  Mp 187-188 oC; IR 
(KBr) νmax: 1619 (s, C=O), 1594 (s), 1509 (s) , 1467 (s), 1384 (m), 1311 (m), 1242 (s), 1158 
(m), 1125 (m), 1039 (m), 1014 (w), 983 (w), 925 (m), 878 (m), 740 (s), 675 (m), 654 (w), 
584 (w), 545 (m), 452 (w) cm-1; MS (EI) m/z 288 (M+, 12), 247 (42), 86 (66), 84 (100); 
HRMS (EI) m/z calcd for C19H16N2O 288.1263 found 288.1268; 1H NMR (300 MHz, CDCl3) 
δ 8.50 (dd, J = 8.0, 1.5 Hz, 1H, H-10), 8.43 (dd, J = 8.0, 1.5 Hz, 1H, H-1), 7.49 (ddd, J = 8.5, 
7.0, 1.5 Hz, 1H, H-3), 7.12-7.30 (m, 4H, H-9 H-8, H-4, H-2), 7.00 (d, J = 8.0 Hz, 1H, H-7), 
6.05-6.18 (m, 1H, CH=CH2), 5.30-5.37 (m, 1H, CH=CH2), 5.08-5.17 (m, 1H, CH=CH2), 
4.72-4.76 (m, 2H, NCH2), 3.84 (s, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 173.3 (C, C-11), 
148.5 (C, C-5a), 141.3 (C), 137.5 (C), 132.9 (CH), 131.2 (CH), 126.3 (CH), 125.5 (C), 124.0 
(C), 123.5 (CH), 122.6 (CH), 122.4 (CH), 121.3 (CH), 117.9 (CH2), 115.4 (CH), 109.4 (CH), 
105.0 (C), 49.2 (CH2), 37.1 (CH3).   
The second, colourless crystaline solid, compound to be eluted (2% MeOH/CHCl3) was 
5,10b-dihydro-10-allyl-5-methylindolo[2,3-b]quinolin-11-one (141) (24 mg, 0.0832 mmol, 
12%).  Mp 270-280 °C (dec.); IR (KBr) νmax: 3052 (br s, N-H), 1617 (s, C=O), 1576 (s), 
1546 (s), 1510 (s), 1433 (m), 1380 (m), 1303 (m), 1273 (m), 1217 (w), 1165 (w), 1133 (w), 
1057 (w), 997 (w), 911 (w), 875 (m), 787 (w), 753 (s), 708 (w), 625 (w), 490 (w) cm-1; MS 
(ESI) m/z 311 (MNa+, 100); HRMS (ESI) m/z calcd for C19H16N2ONa 311.1160 found 
311.1154; 1H NMR (400 MHz, (CD3)2SO) δ 12.08 (s, 1H, NH), 8.42 (d, J = 8.0 Hz, 1H, H-
1), 7.70-7.78 (m, 2H, H-4, H-3), 7.36 (ddd, J = 8.0, 6.5, 1.0 Hz, 1H, H-2), 7.32 (dd, J = 7.5, 
1.0 Hz, 1H, H-9), 7.20 (t, J = 7.5 Hz, 1H, H-8), 7.00 (d, J = 7.5 Hz, 1H, H-7), 6.02-6.12 (m, 
1H, CH=CH2), 4.96-5.02 (m, 1H, CH=CH2), 4.87-4.91 (m, 1H, CH=CH2), 4.52 (d, J = 6.5 
Hz, 2H, CH2CH=CH2), 3.96 (s, 3H, CH3); 13C NMR (101 MHz, (CD3)2SO) δ170.7 (C, C-11), 
147.3 (C), 140.3 (CH), 138.7 (C), 135.5 (C, C-10), 133.8 (C), 131.2 (CH), 126.5 (CH), 124.9 
(C), 123.3 (CH), 123.1 (C), 122.7 (CH), 121.6 (CH), 114.8 (CH), 113.8 (CH2), 108.7 (CH), 
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Crude 11-(E-but-2-enyloxy)-5-methyl-5H-indolo[2,3-b]quinoline (146) was prepared from 
11-chloro-5-methyl-5H-indolo[2,3-b]quinoline (133) (200 mg, 0.750mmol) in THF (10 ml), 
with the alkoxide generated from trans-2-butene-1-ol (0.51 ml, 6.01 mmol) and sodium (35 
mg, 1.52 mmol) in THF (0.5 ml), using general method D.  1H NMR (300 MHz, CDCl3) δ 
8.34 (dd, J = 8.2, 1.3 Hz, 1H, H-1), 8.11 (d, J = 7.5 Hz, 1H, H-10), 7.72-7.83 (m, 3H, H-7, H-
3, H-4), 7.46-7.56 (m, 2H, H-8, H-2), 7.24-7.29 (m, 1H, H-9), 5.91-5.96 (m, 1H, CH2CH), 
5.66-5.70 (m, 1H, CHCH3), 4.89-4.92 (m, 2H, CH2), 4.35 (s, 3H, NCH3), 1.76-1.78 (m, 3H 
CHCH3).  Crude 145 was dissolved in THF (10 ml) and the mixture was heated at reflux for 
2.5 hours.  The reaction was cooled to room temperature and the solvent was evaporated at 
reduced pressure.  The residue was purified by flash chromatography.  The first, bright 
yellow crystalline solid, compound to be eluted (CHCl3) was rac-(1'R,10bS)-5,10b-dihydro-
10b-(1-methylallyl)-5-methylindolo[2,3-b]quinolin-11-one (149) (91 mg, 0.301 mmol, 40%).  
Mp 123-124 oC (dec.); IR (KBr) νmax: 3080 (w), 2977 (w), 2932 (w), 1698 (s, C=O), 1559 
(s), 1470 (s), 1469 (s), 1388 (s), 1342 (w), 1304 (m), 1206 (m), 1194 (m), 1156 (m), 1122 
(w), 1066 (m), 1036 (m), 970 (w), 920 (m), 872 (m), 857 (m), 801 (w), 763 (s), 748 (s), 700 
(m), 644 (w), 524 (w), 456 (w) cm-1; MS (CI) m/z 303 (MH+, 68), 249 (100); HRMS (CI) 
m/z calcd for C20H19N2O 303.1497 found 303.1488; 1H NMR (300 MHz, CDCl3) δ 7.90 (dd, 
J = 7.5 1.5 Hz, H-10), 7.58-7.64 (m, 2H, H-1, H-3), 7.33-7.43 (m, 2H, H-7, H-8), 7.10-7.17 
(m, 3H, H-9, H-4, H-2), 5.79 (ddd, J = 17.0, 10.5, 8.5 Hz, 1H, CH=CH2), 5.11 (ddd, J=10.5, 
1.5, 1.0 Hz, 1H, CH2), 4.78 (dt, J = 17.0, 1.5 Hz, 1H, CH2), 3.73 (s, 3H, NCH3), 2.83-2.92 
(m, 1H, CHCH3), 0.56 (d, J = 7.0 Hz, 3H, CHCH3); 13C NMR (75 MHz, CDCl3) δ 193.3 (C, 
C-11), 172.1 (C), 154.6 (C), 145.2 (C), 136.7 (CH), 135.7 (CH), 130.8 (C), 129.0 (CH), 
128.5 (CH), 125.6 (CH), 123.0 (CH), 122.6 (CH), 119.8 (C), 118.5 (CH), 117.7 (CH2), 114.5 
(CH), 70.5 (C, C-10b), 46.3 (CH), 33.2 (CH3), 14.1 (CH3).   
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The second, colourless crystalline solid, compound to be eluted (1% MeOH/CHCl3) was 5,6-
dihydro-6-(E-but-2-enyl)-5-methylindolo[2,3-b]quinolin-11-one (150).  Mp 165-166 oC; 
Anal. calcd for C20H18N2O: C, 79.44; H, 6.00; N, 9.26. Found: C, 79.11; H, 5.80; N, 9.15; IR 
(KBr) νmax: 3053 (w), 2915 (w), 1617 (s, C=O), 1590 (s), 1538 (s), 1506 (s), 1461 (s), 1394 
(m), 1362 (m), 1323 (m), 1285 (m), 1262 (m), 1189 (m), 1168 (w), 1125 (m), 1069 (w), 1036 
(m), 981 (m), 927 (w), 879 (m), 753 (s), 675 (w), 606 (w), 542 (w), 487 (w), 456 (w) cm-1; 
MS (CI) m/z 303 (MH+, 100); HRMS (CI) m/z calcd for C20H19N2O 303.1497 found 
303.1488; 1H NMR (300 MHz, CDCl3) δ 8.52 (dd, J = 8.5, 2.0 Hz, 1H, H-1), 8.50 (d, J = 7.5, 
1H, H-10), 7.52 (ddd, J = 8.5, 7.5, 2.0 Hz, 1H, H-3), 7.16-7.32 (m, 4H, H-8, H-4, H-2, H-9), 
7.08 (d, J = 8.0 Hz, 1H, H-7), 5.69-5.79 (m, 1H, CH2CH), 5.54-5.67 (m, 1H, CHCH3), 4.68-
4.73 (m, 2H, CH2), 3.90 (s, 3H, NCH3), 1.72 (dd, J = 6.5, 1.5 Hz, 3H, CHCH3); 13C NMR (75 
MHz, CDCl3) δ 173.4 (C, C-11), 148.5 (C, C-5a), 141.4 (C), 137.6 (C), 131.2 (CH), 129.0 
(CH), 126.4 (CH), 125.7 (CH), 125.6 (C), 124.1 (C), 123.4 (CH), 122.6 (CH), 122.4 (CH), 
121.4 (CH), 115.4 (CH), 109.5 (CH), 105.1 (C), 48.5 (CH2), 37.3 (CH3, NCH3), 17.9 (CH3, 









Crude 5-methyl-11-(3-methyl-2-butenyloxy)-5H-indolo[2,3-b]quinoline (147) was Prepared 
from 11-chloro-5-methyl-5H-indolo[2,3-b]quinoline (133) (200 mg, 0.750mmol) in THF (10 
ml), with the alkoxide generated from 3-methyl-2-butene-1-ol (0.61 ml, 6.09 mmol) and 
sodium (35 mg, 1.52 mmol) in THF (0.5 ml), using general method D.  1H NMR (300 MHz, 
CDCl3) δ 8.32 (dd, J = 8.2, 1.0 Hz, 1H, H-1), 8.15 (d, J = 7.3 Hz, 1H, H-10), 7.68-7.77 (m, 
3H, H-7, H-3, H-4), 7.40-7.55 (m, 2H, H-8, H-2), 7.20-7.28 (m, 1H, H-9), 5.71-5.77 (m, 1H, 
CH2CH), 4.97 (d, J = 7.1, 2H, CH2), 4.31 (s, 3H, NCH3), 1.81 (s, 3H, CCH3), 1.68 (s, 3H, 
CCH3).  Crude 147 was dissolved in THF (10 ml) and the mixture was heated at reflux for 
2.5 hours.  The reaction was cooled to room temperature and the solvent was evaporated at 
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reduced pressure.  The residue was purified by flash chromatography (1% MeOH/CHCl3) to 
afford the title compound 152 as a colourless crystalline solid (208 mg, 0.657, 88%).  Mp 
220-221 oC; Anal. calcd for C21H20N2O: C, 79.72; H, 6.37; N, 8.85. Found: C, 79.50; H, 6.28; 
N, 8.78; IR (KBr) νmax: 3057 (w), 2980 (w), 2912 (w), 1621 (s, C=O), 1594 (s), 1539 (s), 
1509 (s), 1460 (s), 1389 (w), 1372 (m), 1327 (m), 1264 (m), 1211 (w), 1182 (m), 1155 (w), 
1039 (m), 984 (w), 926 (w), 880 (m), 745 (s), 673 (w), 610 (w), 488 (w), 463 (w) cm-1; MS 
(ESI) m/z 339 (MNa+, 100); HRMS (ESI) m/z calcd for C21H20N2ONa 339.1473 found 
339.1470; 1H NMR (300 MHz, CDCl3) δ 8.45-8.50 (m, 2H, H-1, H-10), 7.50 (ddd, J = 8.5, 
7.0, 2.0 Hz, 1H, H-3), 7.17-7.30 (m, 4H, H-8, H-4, H-2, H-9), 7.05 (d, J = 8.0 Hz, 1H, H-7), 
5.30-5.34 (m, 1H, CHC(CH3)2), 4.66 (d, J = 5.0 Hz, 2H, NCH2), 3.83 (s, 3H, NCH3), 1.81 (s, 
3H, C(CH3)2), 1.78 (d, J = 1.0 Hz, 3H, C(CH3)2); 13C NMR (75 MHz, CDCl3) δ173.4 (C, C-
11), 148.3 (C, C-5a), 141.4 (C), 137.5 (C), 136.2 (C), 131.1 (CH), 126.4 (CH), 125.5 (C), 
124.1 (C), 123.3 (CH), 122.5 (CH), 122.4 (CH), 121.5 (CH), 120.4 (CH), 115.3 (CH), 109.3 









Crude 5-methyl-11-(1-methylallyloxy)-5H-indolo[2,3-b]quinoline (148) was prepared from 
11-chloro-5-methyl-5H-indolo[2,3-b]quinoline (133) (100 mg, 0.375 mmol) in THF (5 ml), 
with the alkoxide generated from 3-buten-2-ol (0.25 ml, 2.91 mmol) and sodium (20 mg, 
0.870 mmol) in THF (0.5 ml), using general method D.  1H NMR (300 MHz, CDCl3) δ 8.34 
(dd, J = 8.4, 1.4 Hz, 1H, H-1), 8.11 (d, J = 7.7 Hz, 1H, H-10), 7.69-7.78 (m, 3H, H-7, H-3, 
H-4), 7.53 (ddd, J = 8.2, 7.7, 1.7 Hz, 1H, H-8), 7.42 (ddd, J = 8.4, 6.4, 1.6 Hz, 1H, H-2), 
7.22-7.27 (m, 1H, H-9), 6.10 (ddd, J = 17.2, 10.5, 6.4 Hz, 1H, CH=CH2), 5.32-5.41 (m, 1H, 
CHCH3), 5.18 (dt, J = 17.2, 1.1 Hz, 1H, CH=CH2), 5.08 (dt, J = 10.5, 1.1 Hz, 1H, CH=CH2), 
4.33 (s, 3H, NCH3), 1.60 (d, J = 10.4 Hz, 3H, CHCH3).  Crude 148 was dissolved in THF and 
heated at reflux for 2.5 hours under an argon atmosphere.  The reaction mixture was cooled 
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to room temperature and the solvent was evaporated at reduced pressure.  The residue was 
purified by flash chromatography (10 to 20% EtOAc/hexane) to afford the title compound 
154 as a bright yellow crystalline solid (94 mg, 0.311 mmol, 83%).  Mp 114-116 oC; IR 
(KBr) νmax: 3027 (w), 2936 (w), 1693 (s, C=O), 1559 (s), 1472 (s), 1453 (s), 1387 (m), 1344 
(w), 1289 (m), 1204 (m), 1164 (m), 1121 (w), 1054 (w), 1016 (w), 964 (m), 845 (w), 764 (s), 
746 (s), 690 (w), 654 (w), 583 (w), 504 (w) cm-1; MS (EI) m/z 302 (M+, 28), 248 (100), 219 
(45); HRMS (EI) m/z calcd for C20H18N2O 302.1419 found 302.1426; 1H NMR (300 MHz, 
CDCl3) δ 7.96 (dd, J = 8.0, 1.5 Hz, 1H, H-1), 7.67 (d, J = 7.5 Hz, 1H, H-10), 7.62 (ddd, J = 
8.5, 7.5, 1.5 Hz, 1H, H-8), 7.14 (d, J = 7.5 Hz, 1H, H-4), 7.34 (ddd, J = 7.5, 7.5, 1.5 Hz, 1H, 
H-3), 7.11-7.17 (m, 3H, H-2, H-7, H-9), 5.17-5.29 (m, 1H, CHCH3), 4.96-5.07 (m, 1H, 
CH2CH), 3.72 (s, 3H, NCH3), 2.72 (dd, J = 13.0, 6.5 Hz, 1H, CH2), 2.36 (dd, J = 13.0, 8.0 
Hz, 1H, CH2), 1.52 (d, J = 6.5 Hz, 3H, CHCH3); 13C NMR (75 MHz, CDCl3) δ 193.0 (C, 
C=O), 172.6 (C), 153.5 (C), 145.4 (C), 135.9 (CH), 133.4 (C), 131.4 (CH), 128.8 (CH), 128.5 
(CH), 124.7 (CH), 123.1 (CH), 122.7 (CH), 122.4 (CH), 119.2 (C), 118.6 (C), 114.5 (CH), 
66.6 (C, C-10b), 44.4 (CH2), 33.1 (CH3), 18.0 (CH3).   
 
 










NaBH4 (3.78 g, 100 mmol) was added to a stirred solution of (E)-N-[(4-
methoxyphenyl)methylene]benzenamine (156) and MeOH (80 ml).  After 12 hours, water 
(20 ml) was added and the MeOH was evaporated at reduced pressure.  The aqueous residue 
was extracted with CH2Cl2 (3 x 20 ml).  The CH2Cl2 extracts were combined, dried (MgSO4), 
and the CH2Cl2 was evaporated at reduced pressure.  The residue was crystallised from 
hexane to afford the title compound 155 as colourless crystals (5.00 g, 23.5 mmol, 93%).  
Spectroscopic data was in accordance with that published in the literature.67  Mp 58-60 oC 
(lit.67 61-62 oC); 1H NMR (300 MHz, CDCl3) δ 7.27-7.32 (m, 2H, 2 x H-4), 7.14-7.21 (m, 
2H, 2 x H-2), 6.86-6.91 (m, 2H, 2 x H-3), 6.72 (tt, J = 7.2, 1.0 Hz, 1H, H-1), 6.62 (m, 2H, 2 x 










Prepared from indole-3-carboxilic acid methyl ester (111) (24.8 g, 142 mmol) in CH2Cl2 (440 
ml) and N-benzylaniline (51.9 g, 283 mmol) using general method A.  The crude product was 
crystallised from CH2Cl2/hexane to afford the title compound 157 as colourless crystals (33.6 
g, 94.3 mmol, 67%).  Mp 165-166 oC; IR (KBr) νmax: 3270 (br s, N-H), 1669 (s, C=O), 1599 
(m), 1543 (s), 1498 (s), 1443 (s), 1421 (m), 1338 (m), 1273 (m), 1212 (s), 1115 (m), 1085 
(m), 1061 (m), 1016 (w), 790 (w), 747 (s), 728 (m), 696 (m), 636 (w), 503 (w) cm-1; MS 
(ESI) m/z 379 (MNa+, 100); HRMS (ESI) m/z calcd for C23H20N2O2Na 379.1422 found 
379.1427; 1H NMR (300 MHz, CDCl3) δ 8.26 (br s, 1H, NH), 8.11-8.15 (m, 1H, ArH), 7.16-
7.37 (m, 10H, 10 x ArH), 6.83-6.91 (m, 3H, 3 x ArH), 5.13 (s, 2H, NCH2), 3.80 (s, 3H, CH3); 
13C NMR (101 MHz, CDCl3) δ 164.8 (C), 147.3 (C), 147.2 (C), 138.9 (C), 132.1 (C), 129.4 
(2 x CH), 128.9 (2 x CH), 127.3 (CH), 126.99 (2 x CH), 126.81 (C), 123.0 (CH), 122.1 (CH), 
121.8 (CH), 120.9 (CH), 116.9 (2 x CH), 110.8 (CH), 98.8 (C), 56.7 (CH2), 51.0 (CH3).   
 
 









Prepared from indole-3-carboxilic acid methyl ester (111) (1.88 g, 10.8 mmol) in CH2Cl2 (50 
ml) and N-(p-methoxybenzyl)aniline (155) (4.59 g, 21.5 mmol) using general method A.  The 
crude product was purified by flash chromatography (5% to 10% EtOAc/hexane) to afford 
the title compound 158 as colourless crystalline solid (3.54 g, 9.16 mmol, 85%).  Mp 158-159 
oC; IR (KBr) νmax: 3284 (br s, N-H), 2949 (m), 1668 (s, C=O), 1560 (m), 1542 (s), 1499 (s), 
1443 (s), 1246 (s), 1124 (s), 944 (m), 878 (m), 870 (m), 748 (s), 693 (s), 633 (m), 504 (w), 
436 (w) cm-1; MS (CI) m/z 387 (MH+, 52), 386 (73), 266 (24), 235 (47), 121 (100); HRMS 
(CI) m/z calcd for C24H23N2O3 387.1709 found 387.1705; 1H NMR (300 MHz, CDCl3) δ 
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8.33 (s, 1H, NH), 8.11-8.15 (m, 1H, ArH), 7.15-7.25 (m, 7H, 8 x ArH), 6.77-6.90 (m, 5H, 5 x 
ArH), 5.04 (s, 2H, CH2), 3.78 (s, 3H, NCH3), 3.73 (s, 3H, OCH3); 13C NMR (101 MHz, 
CDCl3) δ 164.8 (C), 158.8 (C), 147.3 (C), 132.1 (C), 130.8 (C), 129.4 (2 x CH), 128.3 (2 x 
CH), 126.8 (C), 122.9 (CH), 122.1 (CH), 121.7 (CH), 120.9 (CH), 117.1 (2 x CH), 114.2 (2 x 
CH), 110.7 (CH), 98.7 (C), 56.0 (CH2), 55.4 (CH3), 51.1 (CH3).   
 
 





Prepared from 2-(benzylphenylamino)-1H-indole-3-carboxylic acid methyl ester (157) (17.0 
g, 94.0 mmol) in Ph2O (150 ml), with a reaction time of 2 hours, using general method B.  
The title compound 159 was obtained as a light brown micro crystalline solid (25.3 g, 78.0 
mmol, 83%).  Mp ca. 300 oC (dec.); IR (KBr) νmax: 3061 (br m N-H), 1609 (s, C=O), 1576 
(s), 1514 (s), 1460 (s), 1392 (m), 1242 (m), 1138 (w), 1053 (w), 1021 (w), 871 (w), 751 (m), 
730 (m), 682 (m), 623 (m), 533 (m) 447 (w) cm-1; MS (CI) m/z 325 (MH+, 100), 235 (51); 
HRMS (CI) m/z calcd for C22H17N2O 325.1341, found 325.1348; 1H NMR (400 
MHz,(CD3)2SO) δ 12.25 (s, 1H, NH), 8.41 (dd, J = 8.4, 1.3 Hz, 1H, ArH), 8.23-8.26 (m, 1H, 
ArH), 7.57-7.64 (m, 2H, 2 x ArH), 7.43-7.46 (m, 1H, ArH), 7.16-7.46 (m, 8H, 8 x ArH), 5.81 
(s, 2H, CH2); 13C NMR (101 MHz,(CD3)2SO) δ 171.7 (C), 147.0 (C), 138.4 (C), 135.8 (C), 
134.8 (C), 131.3 (CH), 128.9 (2 x CH), 127.5 (CH), 126.0 (2 x CH), 126.0 (CH), 124.9 (C), 
124.1 (C), 122.9 (CH), 121.9 (CH), 121.3 (CH), 120.2 (CH), 115.6 (CH), 110.9 (CH), 102.3 
















A solution of 11-allyloxy-5-benzyl-6H-indolo[2,3-b]quinoline (163) (5.50 g, 15.1 mmol) and 
PhMe (200 ml) was refluxed under an argon atmosphere for 5.5 hours.  After cooling to room 
temperature, the PhMe was evaporated at reduced pressure and the residue was purified by 
flash chromatography (10% to 20% EtOAc/hexane) to afford the title compound 161 as a 
bright yellow crystalline solid (4.82 g, 13.2 mmol, 88%).  Crystals suitable for X-ray analysis 
were obtained from EtOAc/hexane.  Mp 137-138 oC; IR (KBr) νmax: 1692 (m, C=O), 1601 
(w), 1558 (s), 1484 (w), 1467 (s), 1452 (m), 1390 (w), 1339 (w), 1293 (w), 1202 (w), 1023 
(w), 926 (w) 844 (w), 757 (m), 734 (w), 705 (m) cm-1; MS (EI) m/z 364 (M+, 23), 323 (100), 
273 (20), 178 (22); HRMS (EI) m/z calcd for C25H20N2O 364.1576, found 364.1570; 1H 
NMR (300 MHz, CDCl3) δ 7.96 (dd, J = 7.7, 1.7 Hz, 1H, H-1), 7.72 (dd, J = 7.4, 1.2 Hz, 1H, 
H-10), 7.24-7.49 (m, 8H, 8 x ArH), 7.01-7.50 (m, 3H, 3 x ArH), 5.91 (d, J = 16.8 Hz, 1H, 
HCH2), 5.34-5.48 (m, 1H, CH=CH2), 5.12 (d, J = 16.8 Hz, 1H, HCH2), 4.99-5.03 (m, 1H, 
CH=CH2), 4.82-4.89 (m, 1H, CH=CH2), 2.92 (dd, J = 13.6, 7.0 Hz, 1H, CH2CH=CH2), 2.55 
(dd, J = 13.6, 7.7 Hz, 1H, CH2CH=CH2); 13C NMR (75 MHz, CDCl3) δ 192.9 (C, C-11), 
172.2 (C), 153.6 (C), 144.8 (C), 136.4 (C), 135.9 (CH), 133.4 (C), 130.3 (CH), 129.1 (2 x 
CH), 129.0 (CH), 128.5 (CH), 127.7 (CH), 126.8 (2 x CH), 124.8 (CH), 123.4 (CH), 122.7 
(CH), 120.5 (CH2), 119.3 (C), 118.9 (CH), 115.6 (CH), 66.2 (C, C-10b), 49.7 (CH2), 45.1 
(CH2).   
 
 






Prepared from 5,6-dihydro-6-benzylindolo[2,3-b]quinolin-11-one (159) (6.84 g, 21.1 mmol) 
and POCl3 (100 ml), with a reaction time of 1 hour, using general method C.  Following 
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isolation by extracting into CH2Cl2, the crude product was purified by flash chromatography 
(50% to 100% EtOAc/hexane) to afford the title compound 162 as a bright orange solid (6.58 
g, 19.2 mmol, 91%).  Mp 220-222 oC; IR (KBr) νmax: 2920 (w), 1632 (m), 1611 (m), 1560 
(s), 1523 (s), 1492 (s), 1438 (s), 1397 (m), 1267 (m), 1233 (m), 1141 (w), 1088 (w), 964 (w), 
944 (w), 851 (w), 751 (s), 699 (m) cm-1; MS (CI) m/z 343 (MH+, 100), HRMS (CI) m/z calcd 
for C22H16N235Cl 343.1002, found 343.0998; 1H NMR (400 MHz, CDCl3) δ 8.48 (d, J = 7.7 
Hz, 1H, ArH), 8.41 (d, J = 8.3 Hz, 1H, ArH), 7.73 (d, J = 8.0 Hz, 1H, ArH), 7.56-7.64 (m, 
3H, 3 x ArH), 7.41-7.46 (m, 1H, ArH), 7.17-7.32 (m, 6H, 6 x ArH), 6.15 (s, 2H, CH2); 13C 
NMR (101 MHz, CDCl3) δ 156.0 (C), 155.5 (C), 136.53 (C), 136.45 (C), 135.6 (C), 131.2 
(CH), 130.0 (CH), 129.1 (2 x CH), 127.8 (CH), 126.7 (2 x CH), 126.3 (CH), 125.3 (C), 124.4 
(C), 124.1 (CH), 122.5 (CH), 120.6 (CH), 119.6 (C), 118.1 (CH), 115.4 (CH), 49.7 (CH2).   
 
 






Prepared from 11-chloro-5-benzyl-5H-indolo[2,3-b]quinoline (162) (6.50 g, 19.0 mmol) in 
THF (100 ml), with the alkoxide generated from allyl alcohol (45.0 ml, 662 mmol) and 
sodium (2.18 mg, 94.8 mmol) in THF (20 ml), using general method D.  The crude product 
was purified by flash chromatograph (80% to 100% EtOAc/hexane) to afford the title 
compound 163 as a dark yellow solid.  Mp 147-148 oC; IR (KBr) νmax: 1641 (m), 1563 (m), 
1516 (s), 1494 (s), 1441 (s), 1407 (w), 1319 (m), 1284 (s), 1239 (s), 1168 (m), 1146 (s), 1100 
(m), 970 (w), 931 (m), 751 (s), 695 (w) cm-1; MS (CI) m/z 365 (MH+, 100), 325 (83); HRMS 
(CI) m/z calcd for C25H21N2O 365.1654, found 365.1650; 1H NMR (400 MHz, CDCl3) δ 8.34 
(ddd, J = 7.9, 1.0, 1.0 Hz, 1H, H-1), 8.16 (d, J = 7.7 Hz, 1H, H-10), 7.77 (d, J = 8.0 Hz, 1H, 
ArH), 7.61-7.63 (m, 2H, ArH), 7.54 (dd, J = 7.4, 8.7 Hz, 1H, ArH), 7.37-7.42 (m, 1H, ArH), 
7.20-7.30 (m, 6H, 6 x ArH), 6.29 (ddt, J = 17.2, 10.5, 5.6 Hz, 1H, OCH2CH), 6.19 (s, 2H, 
NCH2), 5.59 (dq, J = 17.2, 1.5 Hz, 1H, CH=CH2), 5.41 (dq, J = 10.5, 1.5 Hz, 1H, CH=CH2), 
5.02 (dt, J = 5.6, 1.5 Hz, 1H, OCH2); 13C NMR (101 MHz, CDCl3) δ 159.0 (C), 157.0 (C), 
154.4 (C), 137.7 (C), 136.0 (C), 133.0 (CH), 131.0 (CH), 129.0 (2 x CH), 128.5 (CH), 127.7 
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(CH), 126.8 (2 x CH), 124.6 (CH), 123.4 (CH), 123.0 (C), 121.8 (CH), 120.2 (CH), 119.0 
(CH2), 118.5 (C), 118.0 (CH), 116.7 (C), 115.3 (CH), 75.3 (CH2), 49.5 (CH).   
 
 







A solution of PBr3 (6.29 ml, 66.6 mmol) and Et2O (20 ml) was slowly added to a stirred 
solution of 3,4-dimethoxybenzyl alcohol (169) (5.63 g, 33.5 mmol) in Et2O (50 ml) at 0 °C, 
maintained under an argon atmosphere.  The reaction mixture was allowed to warm to room 
temperature and, after 12 hours, water (100 ml) was cautiously added.  When the vigorous 
reaction had subsided, the Et2O was separated and the aqueous phase was further extracted 
with Et2O (3 x 50 ml).  The Et2O extracts were combined, dried (MgSO4) and the Et2O was 
evaporated at reduced pressure.  The residue was crystallised from EtOAc/hexane to afford 
the title compound 168 as colourless crystals (4.72 g, 20.4 mmol, 61%)  Spectroscopic data 
was in accordance with that published in the literature.73  Mp: 47-49 °C (lit.73 50-51 °C); 1H 
NMR (300 MHz, CDCl3) δ 6.96 (dd, J = 8.2, 2.0 Hz, 1H, H-6), 6.91 (d, J = 2.0 Hz, 1H, H-2), 
6.81 (d, J = 8.2 Hz, 1H, H-5), 4.51 (s, 2H, CH2), 3.90 (s, 3H, OCH3), 3.88 (s, 3H, OCH3).   
 
 







Sodium hydride (80 mg of a 60% dispersion in oil, 2.00 mmol) was added to a stirred 
suspension of 5,6-dihydroindolo[2,3-b]quinolin-11-one (110) (469 mg, 2.00 mmol) in THF 
(30 ml), maintained under an argon atmosphere.  When effervescence ceased, p-
methoxybenzyl chloride (0.4 ml, 3.00 mmol) and tetrabutyl ammonium iodide (222 mg, 
0.601 mmol) were added and the reaction mixture was stirred at room temperature for 4 days.  
NH4Cl(aq) (20 ml) was added and the THF was evaporated at reduced pressure.  The residue 
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was collected by filtration and washed with water (50 ml) and CH2Cl2 (100 ml) to afford 
crude 5,6-dihydro-5-(p-methoxybenzyl)indolo[2,3-b]quinolin-11-one (170) as a colourless 
solid (420 mg).  A portion of crude 170 (150 mg) and POCl3 (4 ml) were heated at reflux for 
1.5 hours, under an argon atmosphere.  After cooling the reaction mixture to room 
temperature, the excess POCl3 was evaporated at reduced pressure and NaHCO3(aq) (150 ml) 
was added to the residue.  The aqueous suspension was then extracted with CH2Cl2 (3 x 70 
ml). The CH2Cl2 extracts were combined, dried (MgSO4) and the CH2Cl2 was evaporated at 
reduced pressure.  The residue was purified by flash chromatography (60% to 100% 
EtOAc/hexane) to afford the title compound 172 as a bright orange solid (120 mg, 0.322 
mmol, 76%).  Mp 207-208 oC; IR (KBr) νmax: 2925 (w), 1631 (W), 1610 (m), 1561 (m), 1515 
(s), 1491 (s), 1439 (m), 1397 (w), 1249 (s), 1232 (m), 1178 (w), 1140 (w), 1079 (w) 1031 
(w), 816 (w), 748 (s) cm-1; MS (ESI) m/z 395 (MNa+, 100), 373 (MH+, 43); HRMS (ESI) m/z 
calcd for C23H18N2O35Cl 373.1108, found 373.1108; 1H NMR (300 MHz, CDCl3) δ 8.48 (d, J 
= 7.6 Hz, 1H, H-10), 8.41 (d, J = 8.3 Hz, 1H, H-1), 7.47 (d, J = 8.1 Hz, 1H, H-7), 7.56-7.66 
(m, 3H, H-3, H-4, H-8), 7.41-7.47 (m, 1H, H-2), 7.30 (t, J = 7.5 Hz, H-9), 7.14-7.19 (m, 2H, 
2 x H-2'), 6.75-6.81 (m, 2H, 2 x H-3'), 6.09 (s, 2H, CH2), 3.72 (s, 3H, CH3); 13C NMR (75 
MHz, CDCl3) δ 159.2 (C), 155.9 (C), 155.5 (C), 136.5 (C), 131.2 (CH), 129.9 (CH), 128.2 (2 
x CH), 127.7 (C), 126.3 (CH), 125.3 (C), 124.3 (C), 124.1 (CH), 122.4 (CH), 120.5 (CH), 
119.6 (C), 118.1 (CH), 115.4 (CH), 114.5 (2 x CH), 55.4 (CH3), 49.2 (CH2).   
 
 









Sodium hydride (205 mg of a 60% dispersion in oil, 5.12 mmol) was added to a stirred 
suspension of 5,6-dihydroindolo[2,3-b]quinolin-11-one (110) (1.00 g, 4.27 mmol) in THF 
(30 ml), maintained under an argon atmosphere.  When effervescence ceased, a solution of 
3,4-dimethoxybenzyl bromide (168) (1.48 g, 6.40 mmol) and THF (5 ml) was added and the 
reaction mixture was stirred at room temperature for 24 hours.  NH4Cl(aq) (5 ml) was added 
and the THF was evaporated at reduced pressure.  The residue was washed with water and 
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was then, after decanting the water, pulverised under Et2O until a fine powder resulted.  The 
product was collected by filtration and washed with Et2O to afford crude 5,6-dihydro-5-(3,4-
dimethoxybenzyl)indolo[2,3-b]quinolin-11-one (171) as a light brown solid (1.50 g).  A 
portion of crude 161 (500 mg) and POCl3 (5 ml) were heated at reflux for 1.5 hours, under an 
argon atmosphere.  After allowing the reaction mixture to cool to room temperature, the 
excess POCl3 was evaporated at reduced pressure and NaHCO3(aq) (30 ml) was added to the 
residue.  The aqueous suspension was extracted with CH2Cl2 (3 x 30 ml). The CH2Cl2 
extracts were combined, dried (MgSO4) and the CH2Cl2 was evaporated at reduced pressure.  
The residue was purified by flash chromatography (80% to 100% EtOAc) to afford the title 
compound 173 as a bright orange solid (340 mg, 0.844 mmol, 59%).  Mp 217-218 oC; IR 
(KBr) νmax: 1637 (w), 1608 (w), 1561 (m), 1519 (s), 1491 (m), 1438 (m), 1283 (m), 1262 
(m), 1231 (m), 1141 (m), 1077 (w), 1026 (w), 754 (m) cm-1; MS (ESI) m/z 403 (MH+, 100), 
151 (26) HRMS (ESI) m/z calcd for C25H20N2O235Cl 403.1213, found 403.1201; 1H NMR 
(300 MHz, CDCl3) δ 8.49 (d, J = 7.6 Hz, 1H, H-10), 8.43 (d, J = 8.0 Hz, 1H, H-1), 7.75 (d, J 
= 7.6 Hz, 1H, H-7), 7.65-7.70 (m, 2H, H-3, H-4), 7.59 (td, J = 7.6, 1.2 Hz, 1H, H-8), 7.46 
(ddd, J = 8.0, 6.0, 2.3 Hz, 1H, H-2), 7.30 (td, J = 7.6, 1.2 Hz, 1H, H-9), 6.90 (d, J = 1.3 Hz, 
1H, H-2'), 6.68-6.75 (m, 2H, H-5', H-6'), 6.10 (s, 2H, CH2), 3.80 (s, 3H, CH3), 3.74 (s, 3H, 
CH3); 13C NMR (75 MHz, CDCl3) δ 155.9 (C), 155.5 (C), 149.6 (C), 148.7 (C), 136.6 (C), 
136.5 (C), 131.2 (CH), 129.9 (CH), 128.2 (C), 126.3 (CH), 125.3 (C), 124.3 (C), 124.1 (CH), 
122.5 (CH), 120.6 (CH), 119.6 (C), 119.1 (CH), 118.1 (CH), 115.4 (CH), 111.5 (CH), 110.3 
(CH), 56.1 (CH3), 56.0 (CH3), 49.6 (CH2).   
 
 








Prepared from 11-chloro-5-(p-methoxybenzyl)-5H-indolo[2,3-b]quinoline (172) (110 mg, 
0.300 mmol) in THF (5 ml), with the alkoxide generated from allyl alcohol (0.70 ml, 10.5 
mmol) and sodium (35 mg, 1.50 mmol) in THF (5 ml), using general method D.  The crude 
product was purified by flash chromatograph (60% to 80% EtOAc/hexane) to afford the title 
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compound 174 as a dark yellow solid (110 g, 0.279 mmol, 93%).  Mp 133-134 oC; IR (KBr) 
νmax: 1643 (s), 1561 (s), 1513 (s), 1251 (s), 1033 (m), 875 (w), 751 (s), 466 (m) cm-1; MS 
(CI) m/z 395 (MH+, 100), 275 (100), 235 (94), 121 (99); HRMS (CI) m/z calcd for 
C26H23N2O2 395.1760, found 395.1761; 1H NMR (300 MHz, CDCl3) δ 8.30 (d, J = 8.4, Hz, 
1H, H-1), 8.14 (d, J = 7.9 Hz, 1H, H-10), 7.78 (d, J = 8.4 Hz, 1H, H-7), 7.50-7.62 (m, 3H, H-
3, H-4, H-8), 7.13-7.39 (m, 4H, H-2, H-9, 2 x H-2'), 6.74-6.78 (m, 2H, 2 x H-3'), 6.26 (ddt, J 
= 17.0, 10.5, 1.5, 1H, CH=CH2), 6.09 (s, 2H, NCH2), 5.56 (dq, J = 17.0, 1.3 Hz, 1H, 
CH=CH2), 5.38 (dq, J = 10.5, 1.3 Hz, 1H, CH=CH2), 4.98 (dt, J = 5.7, 1.3 Hz, 2H, OCH2), 
3.69 (s, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 159.1 (C), 158.9 (C), 156.9 (C), 154.3 (C), 
137.7 (C), 133.0 (CH), 130.9 (CH), 128.5 (CH), 128.2 (2 x CH), 128.1 (C), 124.5 (CH), 
123.3 (CH), 122.9 (C), 121.7 (CH), 120.2 (CH), 118.9 (CH2), 118.4 (C), 117.9 (CH), 116.7 
(C), 115.3 (CH), 114.3 (2 x CH), 75.3 (CH2), 55.3 (CH3), 48.9 (CH2).   
 
 









Prepared from 11-chloro-5-(3,4-dimethoxybenzyl)-5H-indolo[2,3-b]quinoline (173) (320 mg, 
0.794 mmol) in THF (15 ml), with the alkoxide generated from allyl alcohol (1.90 ml, 27.9 
mmol) and sodium (91 mg, 3.79 mmol) in THF (5 ml), using general method D.  The crude 
product was purified by flash chromatograph (60% to 80% EtOAc/hexane) to afford the title 
compound 175 as a dark yellow solid (316 g, 0.744 mmol, 94%).  Mp 146-148 oC; IR (KBr) 
νmax: 2935 (w), 1639 (m), 1613 (m), 1565 (s), 1516 (s), 1493 (s), 1439 (s), 1346 (m), 1314 
(m), 1285 (s), 1238 (s), 1201 (m), 1140 (s), 1099 (m), 1028 (s), 936 (w), 757 (s), 467 (w) cm-
1; MS (ESI) m/z 425 (MH+, 100); HRMS (ESI) m/z calcd for C27H25N2O3 425.1865, found 
425.1876; 1H NMR (300 MHz, CDCl3) δ 8.33 (d, J = 8.2 Hz, 1H, H-1), 8.15 (d, J = 7.5 Hz, 
1H, H-10), 7.78 (d, J = 7.5 Hz, 1H, H-7), 7.61-7.71 (m, 2H, H-3, H-4), 7.56 (td, J = 7.5, 1.2 
Hz, 1H, H-8), 7.40 (ddd, J = 8.2, 6.5, 1.6 Hz, 1H, H-2), 7.30 (td, J = 7.5, 1.0, 1H, H-9), 6.90 
(s, 1H, H-2'), 6.72-6.74 (m, 2H, H-5', H-6'), 6.28 (ddt, J = 17.2, 10.5, 5.6 Hz, 1H, CH=CH2), 
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6.11 (s, 2H, NCH2), 5.57 (dq, J = 17.2, 1.3, 1.3 Hz, 1H, CH=CH2), 5.40 (dq, J = 10.5, 1.3, 1.3 
Hz, 1H, CH=CH2), 5.01 (dt, J = 5.6, 1.3 Hz, 1H, OCH2), 3.80 (s, 3H, CH3), 3.74 (s, 3H, 
CH3); 13C NMR (75 MHz, CDCl3) δ 158.9 (C), 157.0 (C), 154.4 (C), 149.5 (C), 148.6 (C), 
137.8 (C), 133.0 (CH), 131.0 (CH), 128.6 (C), 128.5 (CH), 124.6 (CH), 123.3 (CH), 123.0 
(C), 121.8 (CH), 120.2 (CH), 119.1 (CH), 119.0 (CH2), 118.4 (C), 118.0 (CH), 116.8 (C), 











A mixture of 11-allyloxy-5-(p-methoxybenzyl)-5H-indolo[2,3-b]quinoline (174) (110 mg, 
0.279 mmol) and THF (10 ml) was heated at reflux for 4 days, under an argon atmosphere, 
and was then cooled to room temperature.  The THF was evaporated at reduced pressure and 
the residue was purified by flash chromatography (10% EtOAc/hexane) to afford the title 
compound 176 as a bright yellow crystalline solid (66 mg, 0.167 mmol, 60%)  Mp 121-122 
oC; IR (KBr) νmax: 2959 (w), 1691 (s), 1455 (s), 1470 (s), 1249 (s), 1024 (m), 928 (m), 846 
(m), 760 (s), 506 (m) cm-1; MS (CI) m/z 395 (MH+, 48), 275 (75), 235 (55), 121 (100); 
HRMS (CI) m/z calcd for C26H23N2O2 395.1760, found 395.1752; 1H NMR (300 MHz, 
CDCl3) δ 7.95 (dd, J = 8.0, 1.6 Hz, H-1), 7.70-7.73 (m, 1H, H-10), 7.28-7.51 (m, 5H, H-3, H-
7, H-8, 2 x H-3'), 7.06-7.19 (m, 3H, H-4, H-9, H-2), 6.84-6.89 (m, 2H, 2 x H-3'), 5.80 (d, J = 
16.2 Hz, 2H, NCH2), 5.33-5.47 (m, 1H, CH=CH2), 5.10 (d, J = 16.2 Hz, 2H, NCH2), 4.99-
5.03 (m, 1H, CH=CH2), 4.81-4.88 (m, 1H, CH=CH2), 3.78 (s, 3H, CH3), 2.90 (dd, J = 13.1, 
6.7 Hz, 1H, CH2CH=CH2), 2.53 (dd, J = 13.1, 7.8 Hz, 1H, CH2CH=CH2); 13C NMR (75 
MHz, CDCl3) δ 193.0 (C, C-11), 172.3 (C), 159.2 (C), 153.7 (C), 144.8 (C), 135.8 (CH), 
133.4 (C), 130.3 (CH), 129.0 (CH), 128.5 (CH), 128.3 (C), 128.2 (2 x CH), 124.8 (CH), 
123.3 (CH), 122.6 (CH), 120.5 (CH2), 119.3 (C), 118.9 (CH), 115.6 (CH), 114.5 (2 x CH), 















A solution of 11-allyloxy-5-(3,4-dimethoxybenzyl)-6H-indolo[2,3-b]quinoline (175) (290 
mg, 0.683 mmol) and PhMe (20 ml) was refluxed under an argon atmosphere for 5 hours.  
After cooling to room temperature, the PhMe was evaporated at reduced pressure and the 
residue was purified by flash chromatography (10% to 20% EtOAc/hexane) to afford the title 
compound 177 as a bright yellow crystalline solid (211 mg, 0.497 mmol, 73%).  Mp 132-135 
oC; IR (KBr) νmax: 2936, (w), 1693 (s, C=O), 1594 (m), 1557 (s), 1516 (s), 1470 (s), 1390 
(m), 1257 (s), 1140 (m), 1140 (m), 1026 (m), 927 (w), 851 (w), 761 (s), 702 (w) cm-1; MS 
(ESI) m/z 447 (MNa+, 100), 425 (MH+, 12); HRMS (ESI) m/z calcd for C27H25N2O3 
425.1865, found 425.1862; 1H NMR (300 MHz, CDCl3) δ 7.95 (dd, J = 8.0, 1.8 Hz, 1H, H-
1), 7.72 (d, J = 7.4 Hz, 1H, H-10), 7.49 (ddd, J = 8.4, 7.4, 1.8 Hz, 1H, H-3), 7.42 (d, J = 7.5 
Hz, 1H, H-7), 7.35 (td, J = 7.5, 1.3 Hz, 1H, H-8), 7.07-7.20 (m, 3H, H-4, H-9, H-2), 6.89-
6.96 (m, 2H, H-2', H-6'), 6.82 (d, J = 8.2, 1H, H-5'), 5.83 (d, J = 16.5, 1H, NCH2), 5.36-5.51 
(m, 1H, CH=CH2), 5.07 (d, J = 16.5 Hz, 1H, NCH2), 4.98-5.03 (m, 1H, CH=CH2), 4.80-4.88 
(m, 1H, CH=CH2), 3.85 (s, 3H, CH3), 3.81 (s, 3H, CH3), 2.91 (dd, J = 13.0, 7.1 Hz, 1H, 
CH2CH=CH2), 2.53 (dd, J = 13.0, 7.4, 1H, CH2CH=CH2); 13C NMR (101 MHz, CDCl3) δ 
192.9 (C, C-11), 172.2 (C), 153.6 (C), 149.6 (C), 148.6 (C), 144.8 (C), 135.9 (CH), 133.3 
(C), 130.2 (CH), 129.0 (CH), 128.8 (C), 128.5 (CH), 124.9 (CH), 123.4 (CH), 122.7 (CH), 
120.5 (CH2), 119.2 (C), 119.0 (CH), 118.9 (CH), 115.6 (CH), 111.5 (CH), 110.2 (CH), 66.2 












MeLi (0.20 ml of a 1.6 M solution in Et2O, 0.320 mmol) was added to a solution of 5,10b-
dihydro-10b-allyl-5-methyl-10bH-indolo[2,3-b]quinolin-11-one (130) (46 mg, 0.160 mmol) 
and Et2O (1 ml) cooled to 0 ºC, maintained under an argon atmosphere.  After 0.5 hours, the 
reaction mixture was allowed to warm to room temperature and NH4Cl(aq) (0.5 ml) was 
added.  The Et2O was separated and the aqueous phase was further extracted with Et2O (3 x 5 
ml). The Et2O extracts were combined, dried (MgSO4), and the Et2O was evaporated at 
reduced pressure to afford the title compound 185 as colourless crystalline solid (49 mg, 
0.160 mmol, 100%).  Mp 94-95 oC; IR (KBr) νmax: 3241 (br m, O-H), 2974 (m), 1554 (s), 
1470 (m), 1402 (m), 1293 (w), 1201 (m), 1154 (m), 1123 (m), 1075 (w), 927 (m), 814 (w), 
759 (s), 679 (w), 658 (w), 505 (w) cm-1; MS (CI) m/z 305 (MH+, 96), 304 (M+, 100), 263 
(33); HRMS (CI) m/z calcd for C20H21N2O 305.1654 found 305.1641; 1H NMR (400 MHz, 
CDCl3) δ 7.59 (dd, J = 7.5, 1.3 Hz, 1H, H-1), 7.40 (d, J = 7.3 Hz, 1H, H-10), 7.24-7.34 (m, 
3H, H-3, H-7, H-8), 7.11 (ddd, J = 8.5, 7.5, 1.3 Hz, 1H, H-2), 6.98-7.05 (m, 2H, H-4, H-9), 
5.19-7.05 (m, 1H, CH=CH2), 4.73-4.82 (m, 2H, CH=CH2), 3.59 (s, 3H, NCH3), 7.27 (dd, J = 
13.5, 7.1 Hz, 1H, CH2CH=CH2), 2.45 (dd, J = 13.5, 7.4 Hz, 1H, CH2CH=CH2), 2.34 (s, 1H, 
OH), 1.18 (s, 3H, CCH3); 13C NMR (75 MHz, CDCl3) δ 173.9 (C), 156.2 (C), 139.3 (C), 
135.8 (C), 133.2 (CH), 131.9 (C), 128.9 (CH), 128.8 (CH), 124.8 (CH), 123.4 (CH), 122.9 
(CH), 122.7 (CH), 118.5 (CH2), 117.5 (CH), 114.2 (CH), 76.1 (C, C-11), 61.0 (C, C-10b), 
















NaBH4 (164 mg, 4.34 mmol) was added to a solution of 5,10b-dihydro-10b-allyl-5-methyl-
10bH-indolo[2,3-b]quinolin-11-one (130) (250 mg, 0.867 mmol) and MeOH (10 ml).  After 2 
hours, water (2 ml) was added and the MeOH was evaporated at reduced pressure.  The 
aqueous residue was extracted with CH2Cl2 (3 x 5 ml).  The combined extracts were dried 
(MgSO4) and the CH2Cl2 was evaporated at reduced pressure.  The residue was purified by 
flash chromatography (10% to 20% EtOAc/hexane) the afford the title compound 186 as a 
colourless crystalline solid (224 mg, 0.771 mmol, 89%).  Crystals suitable for X-ray analysis 
were obtained from EtOH.  Mp 181-182 oC; IR (KBr) νmax: 3416 (m, br, O-H), 3076 (m), 
1557 (s), 1491 (s), 1468 (m), 1455 (s), 1399 (s), 1339 (m), 1305 (m), 1214 (m), 1189 (m), 
1125 (m), 1056 (m), 1015 (m), 912 (m), 841 (w), 754 (s) 694 (m), 659 (w), 501 (w), 488 (w), 
434 (w) cm-1; MS (CI) m/z 291 (MH+, 100), 273 (27), 249 (31), 233 (22); HRMS (CI) m/z 
calcd for C19H19N2O 291.1497, found 291.1496; 1H NMR (300 MHz, CDCl3) δ 7.60 (ddd, J 
= 7.6, 1.3, 1.0 Hz, 1H, H-1), 7.47 (d, J = 7.3 Hz, 1H, H-10), 7.24-7.38 (m, 3H, H-3, H-7, H-
8), 7.13 (td, J = 7.6, 1.0 Hz, 1H, H-2), 6.99-7.05 (m, 2H, H-4, H-9), 5.12-5.26 (m, 1H, 
CH=CH2), 4.98 (d, J = 7.3 Hz, 1H, CHOH), 4.71-4.78 (m, 2H, CH=CH2), 3.57 (s, 3H, CH3), 
2.94 (d, J = 7.3 Hz, 1H, OH), 2.63 (dd, J = 13.7, 7.1 Hz, 1H, CCH2), 2.32 (dd, J = 13.7, 7.7 
Hz, 1H, CCH2); 13C NMR (75 MHz, CDCl3) δ 173.1 (C), 155.8 (C), 140.1 (C), 137.2 (C), 
132.7 (CH), 128.94 (CH), 128.87 (CH), 126.7 (C), 125.8 (CH), 123.1 (CH), 123.0 (CH), 
122.6 (CH), 118.5 (CH2), 117.5 (CH), 114.3 (CH), 72.1 (CH, C-11), 57.0 (C, C-10b), 33.6 














MeLi-LiBr (15.0 ml of a 1.5 M solution, 22.5 mmol) was slowly added, over a period of 20 
minutes, to a mixture of 5,10b-dihydro-10b-allyl-5-methyl-10bH-indolo[2,3-b]quinolin-11-
one (130) (5.40 g, 18.7 mmol), chloroiodomethane (1.70 ml, 23.9 mmol) and THF (75 ml) at 
-78 °C, maintained under an argon atmosphere.  After 0.5 hours, the reaction mixture was 
allowed to warm the room temperature and stirring was continued for 12 hours.  NH4Cl(aq) 
was added and the solvent was evaporated at reduced pressure.  Water (40 ml) and Et2O (40 
ml) were added to the residue.  The Et2O was separated and the aqueous phase was further 
extracted with Et2O (3 x 40 ml).  The combined Et2O extracts were dried (MgSO4) and 
filtered through a plug of silica.  The Et2O solution of the crude product was then placed in 
an open flask and allowed to slowly evaporate at ambient temperature and pressure until 
nearly dry (ca. 10 ml Et2O remaining).  There was thus obtained the title compound 191 as 
large colourless crystals (4.98 g, 16.5 mmol, 88%).  Crystals form Et2O were suitable for X-
ray analysis.  Mp 119-120 oC; IR (KBr) νmax: 3062 (w), 2988 (w), 1558 (s), 1493 (s), 1470 
(s), 1451 (s), 1398 (s), 1298 (m), 1212 (s), 1124 (m), 1040 (m), 1016 (m), 961 (w), 918 (m), 
899 (m), 845 (w), 755 (s), 663 (m), 634 (w), 501 (w) cm-1; MS (ESI) m/z 303 (MH+, 100); 
HRMS (ESI) m/z calcd for C20H19N2O 303.1497, found 303.1492; 1H NMR (300 MHz, 
CDCl3) δ 7.18-7.40 (m, 5H, 5 x ArH), 6.97-7.11 (m, 3H, 3 x ArH), 5.18-5.32 (m, 1H, 
CH=CH2), 4.73-4.85 (m, 2H, CH=CH2), 3.64 (s, 3H, CH3), 3.06 (d, J = 5.5 Hz, 1H, OCH2), 
2.75 (dd, J = 13.0, 6.5 Hz, 1H, CH2CH=CH2), 2.57 (dd, J = 13.5, 8.0 Hz, 1H, CH2CH=CH2), 
2.51 (d, J = 5.5 Hz, 1H, OCH2); 13C NMR (75 MHz, CDCl3) δ 172.4 (C), 155.6 (C), 141.7 
(C), 134.2 (C), 132.0 (CH), 129.6 (CH), 129.0 (CH), 124.0 (CH), 123.3 (C), 123.2 (CH), 
122.9 (2 x CH), 118.8 (CH2), 118.0 (CH), 114.2 (CH), 60.3 (C, C-11), 55.0 (C, C-10b), 53.8 












F3BOEt2 (0.84 ml, 6.69 mmol) was slowly added, over a period of 0.5 hours, to a solution of 
rac-(10bS,11S)-10b-allyl-5-methyl-5,11-dihydro-10bH-indolo[2,5-b]quinolin-11-spiro-2'-
oxirane (191) (400 mg, 1.32 mmol) in THF (10 ml) at -25 °C under an argon atmosphere.  
After 3 hours, NH3(g) was bubbled into the reaction mixture for 5 minutes and then water (5 
ml) was added.  The THF was evaporated at reduced pressure and the aqueous residue was 
extracted with CH2Cl2 (3 x 5 ml).  The combined CH2Cl2 extracts were dried (MgSO4) and 
the CH2Cl2 was evaporated at reduced pressure.  The residue was purified by flash 
chromatograph (10% to 25% EtOAc/hexane) to afford an impure sample of the title 
compound 178a as a colourless oil that rapidly turned black (82 mg).  IR (film) νmax: 3075 
(w), 298 (w), 1723 (s, C=O), 1617 (w), 1558 (s), 1493 (m), 1471 (s), 1454 (s), 1400 (m), 
1297 (w), 1214 (m), 1133 (w), 925 (w), 954 (s) cm-1; 1H NMR (300 MHz, CDCl3) δ 8.98 (d, 
J = 4.2 Hz, 1H, CHO), 7.19-7.42 (m, 5H, 5 x ArH), 7.00-7.15 (m, 3H, 3 x ArH), 5.41-5.56 
(m, 1H, CH=CH2), 5.02-5.07 (m, 1H, CH=CH2), 4.79-4.86 (m, 1H, CH=CH2), 3.98 (d, J = 
4.2 Hz, 1H, CHCHO), 3.66 (s, 3H, CH3), 2.47 (dd, J = 13.5, 8.2 Hz, 1H, CH2CH=CH2), 2.34 










A sample of impure rac-(10bR,11R)-10b-allyl-5-methyl-5,11-dihydro-10bH-indolo[2,5-
b]quinoline-11-carbaldehyde (178a) (7 mg) was dissolved in MeOH (0.5 ml) and NaBH4 (5 
mg, 0.132 mmol) was added.  After 2 hours, water (0.5 ml) was added and the mixture was 
extracted with CH2Cl2 (3 x 1 ml).  The combined extracts were dried (MgSO4) and the 
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solvent was evaporated at reduced pressure to give the title compound 192 as a colourless 
solid (7 mg).  A crystal suitable for X-ray analysis was obtained from CDCl3/hexane.  IR 
(film) νmax: 3192 (br s, O-H), 1556 (s), 1493 (s), 1469 (s), 1455 (s), 1403 (m), 1219 (m), 
1132 (w), 1063 (m), 922 (w), 753 (s), 737 (s), cm-1; MS (CI) m/z 304 (M+, 100), 233 (68); 
HRMS (CI) m/z calcd for C20H20N2O 304.1576, found 304.1577; 1H NMR (300 MHz, 
CDCl3) δ 7.21-7.36 (m, 5H, 5 x ArH), 6.99-7.08 (m, 3H, 3 x ArH), 5.38-5.52 (m, 1H, 
CH=CH2), 4.94-4.98 (m, 1H, CH=CH2), 4.74-4.81 (m, 1H, CH=CH2), 3.61 (s, 3H, CH3), 
3.51 (dd, J = 14.2, 8.4 Hz, 1H, CH2OH), 3.31-3.39 (m, 2H, CHCH2OH), 2.47 (dd, J = 13.4, 










A stirred mixture of rac-(10bS,11S)-10b-allyl-5-methyl-5,11-dihydro-10bH-indolo[2,5-
b]quinolin-11-spiro-2'-oxirane (191) (560 mg, 1.84 mmol) and NaBH3CN (291 mg, 4.63 
mmol) in THF (20 ml), maintained under an argon atmosphere, was cooled to -10 °C.  A 
solution of F3BOEt2 (0.51 ml, 4.06 mmol) in THF (5 ml) was added over a period of 20 min.  
After 2 hours, an additional portion of F3BOEt2 (0.12 ml, 0.955 mmol) in THF (1 ml) was 
added and stirring was continued for 1 hour at -10 °C.  NaHCO3(aq) (50 ml) was added and 
the reaction mixture was allowed to warm to room temperature.  The aqueous solution was 
extracted with CH2Cl2 (4 x 30 ml), the combined extracts were washed with brine (50 ml), 
dried (MgSO4), and the CH2Cl2 was evaporated at reduced pressure.  The residue was 
crystallised from MeOH/water to afford the title compound 195 as a colourless crystalline 
solid (196 mg, 0.644 mmol, 35%).  Crystals from MeOH were suitable for X-ray analysis.  
Mp 190-191 oC; Anal. calcd for C20H20N2O: C, 78.92; H, 6.62; N, 9.20. Found: C, 78.99; H, 
6.66; N, 9.53; IR (KBr) νmax: 3201 (br s, O-H), 2928 (m), 2876 (m), 1616 (m), 1557 (s), 1495 
(s), 1472 (s), 1456 (s), 1401 (s), 1316 (m), 1222 (s), 1139 (w), 1105 (m), 1051 (s), 986 (m), 
931 (m), 809 (w), 758 (m) 652 (w), 499 (w) cm-1; MS (CI) m/z 305 (MH+, 83), 304 (M+, 
100), 233 (54); HRMS (CI) m/z calcd for C20H20N2O 304.1576, found 304.1569; 1H NMR 
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(300 MHz, CDCl3) δ 7.68 (ddd, J = 8.0, 1.5, 1.0 Hz, 1H, H-1), 7.23-7.26 (m, 4H, 4 x ArH), 
6.98-7.14 (m, 3H, 3 x ArH), 4.96-5.10 (m, 1H, CH=CH2), 4.62-4.73 (m, 3H, CH=CH2 and 
CH2OH), 4.39-4.48 (m, 1H, CH2OH), 3.58 (s, 3H, CH3), 3.07-3.12 (m, 1H, CHCH2OH), 
2.35-2.38 (m, 2H, CH2CH=CH2), 2.01 (dd, J = 7.5, 3.5, 1H, OH); 13C NMR (75 MHz, 
CDCl3) δ 173.9 (C), 156.0 (C), 141.4 (C), 136.7 (C), 132.6 (CH), 128.8 (CH), 128.2 (CH), 
127.4 (CH), 125.4 (C), 123.7 (CH), 123.2 (CH), 122.3 (CH), 118.2 (CH2), 117.4 (CH), 114.6 









A solution of rac-(10bR,11S)-10b-allyl-11-hydroxymethyl-5-methyl-5,11-dihydro-10bH-
indolo[2,5-b]quinoline (195) (470 mg, 1.54 mmol) in acetone (20 ml) was added to a stirred 
mixture of CrO3 (772 mg, 7.72 mmol) and celite (2.00 g) in 1.5 M H2SO4 (10 ml).  After 5 
hours, i-PrOH (2.0 ml, 26 mmol) was added and stirring was continued for 0.5 hours.  The 
reaction mixture was filtered through celite and the celite was washed with EtOAc (50 ml).  
Brine (50 ml) was added to the filtrate followed by sufficient NaHCO3(aq) to neutralise (pH 7) 
the aqueous phase.  The EtOAc was separated and the aqueous phase was further extracted 
with EtOAc (4 x 50 ml).  The combined extracts were dried (MgSO4) and the solvent was 
evaporated at reduced pressure to afford crude 196.  Crude 196 was dissolved in MeOH (20 
ml) and Me3SiCHN2 (1.54 ml of a 2.0 M solution in Et2O, 3.08 mmol) was added.  After 
stirring for 0.5 hours, AcOH (0.5 ml) was added and stirring was continued for an additional 
0.5 hours.  The solvent was evaporated at reduced pressure and the residue was partitioned 
between NaHCO3(aq) (10 ml) and CH2Cl2 (10 ml).  The CH2Cl2 was separated and the 
aqueous phase was further extracted with CH2Cl2 (3 x 10 ml).  The combined extracts were 
dried (MgSO4) and the solvent was evaporated at reduced pressure.  The residue was purified 
by flash chromatography (5% EtOAc/hexane) to afford the title compound 197 as a 
colourless crystalline solid (267 mg, 0.803 mmol, 52%).  Mp 137-138 oC; IR (KBr) νmax: 
2951 (w), 1740 (s, C=O), 1618 (m), 1560 (s), 1495 (m), 1470 (s), 1400 (m), 1215 (m), 1161 
Chapter 6 141
(m), 921 (w), 751 (m) cm-1; MS (ESI) m/z 333 (MH+, 100), 233 (94); HRMS (ESI) m/z calcd 
for C21H21N2O2 333.1603, found 333.1599; 1H NMR (300 MHz, CDCl3) δ 7.24-7.38 (m, 3H, 
3 x ArH), 6.99-7.12 (m, 4H, 4 x ArH), 4.97-5.11 (m, 1H, CH=CH2), 4.66-4.76 (m, 2H, 
CH=CH2), 4.09 (s, 1H, CHCO2CH3), 3.94 (s, 3H, OCH3), 3.61 (s, 3H, NCH3), 2.87 (dd, J = 
14.0, 6.5 Hz, 1H, CH2CH=CH2), 2.55 (dd, J = 14.0, 8.0 Hz, 1H, CH2CH=CH2); 13C NMR (75 
MHz, CDCl3) δ 172.6 (C, C=O), 172.0 (C), 156.0 (C), 141.0 (C), 136.4 (C), 132.4 (CH), 
129.2 (CH), 129.0 (CH), 127.5 (CH), 123.0 (CH), 122.7 (CH), 122.4 (CH), 121.2 (C), 118.4 










LiHMDS (0.36 ml of a 1.0 M solution in THF, 0.36 mmol) was added to a solution of rac-
(10bR,11S)-10b-allyl-5-methyl-5,11-dihydro-10bH-indolo[2,5-b]quinoline-11-carboxylic 
acid methyl ester (197) (60 mg, 0.181 mmol) in THF (2 ml) at -78 °C, maintained under an 
argon atmosphere.  The reaction mixture was warmed to 0 °C and then, after 1 hour, cooled 
to -78 °C.  Allyl bromide (0.047 ml, 0.543 mmol) was added and the reaction mixture was 
slowly warmed to room temperature.  After 16 hours, NH4Cl(aq) (0.3 ml) was added and the 
THF was evaporated at reduced pressure.  The residue was partitioned between water (1 ml) 
and CH2Cl2 (2 ml), the CH2Cl2 was separated and the aqueous phase was further extracted 
with CH2Cl2 (3 x 2 ml).  The combined CH2Cl2 extracts were dried (MgSO4) and the CH2Cl2 
was evaporated at reduced pressure.  The crude product was purified by flash 
chromatography (5% to 15% EtOAc/hexane) followed by crystallisation from EtOAc/hexane 
to afford the title compound 203 as a colourless crystalline solid (39 mg, 0.105 mmol, 59%).  
Crystals form EtOAc/hexane were suitable for X-ray analysis.  Mp 171-173 oC; IR (KBr) 
νmax: 2984 (w), 2955 (w), 1728 (s, C=O), 1617 (m), 1562 (s), 1495 (w), 1468 (m), 1455 (m), 
1400 (m), 1316 (w), 1292 (w), 1233 (s), 1220 (s), 935 (w), 759 (s) cm-1; MS (ESI) m/z 373 
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(MH+, 100); HRMS (ESI) m/z calcd for C24H25N2O2 373.1916, found 373.1907; 1H NMR 
(300 MHz, CDCl3) δ 7.23-7.24 (m, 3H, 3 x ArH), 6.97-7.06 (m, 5H, 5 x ArH), 5.32-5.47 (m, 
1H, C(10b)CH2CH), 4.93-5.07 (m, 1H, C(11)CH2CH), 4.57-4.84 (m, 4H, 
C(10b)CH2CH=CH2 and C(11)CH2CH=CH2), 3.96 (s, 3H, OCH3), 3.61 (s, 3H, NCH3), 2.76 
(dd, J = 13.6, 8.2 Hz, 1H, C(10b)CH2), 2.63 (dd, J = 13.9, 7.0 Hz, 1H, C(11)CH2), 2.39 (dd, J 
= 13.6, 6.2 Hz, 1H, C(10b)CH2), 2.03 (dd, J = 13.9, 7.0 Hz, 1H, C(11)CH2); 13C NMR (75 
MHz, CDCl3) δ 172.7 (C, C=O), 171.7 (C), 156.3 (C), 140.0 (C), 134.7 (C), 133.3 (CH), 
132.3 (CH), 131.3 (CH), 129.0 (CH), 128.7 (CH), 123.7 (C), 122.9 (CH), 122.6 (CH), 121.9 
(CH), 119.0 (CH2), 118.5, (CH2), 117.5 (CH), 114.5 (CH), 58.3(C, C-11), 57.1 (C, C-10b), 










n-BuLi (0.27 ml of a 1.46 M solution, 0.394 mmol) was added to a mixture of i-Pr2NH (0.058 
ml, 0.412 mmol) and THF (1 ml) at -78 °C, maintained under an argon atmosphere.  The 
reaction mixture was allowed to warm to room temperature and then, after 0.5 hours, was 
cooled to -78 °C before a solution of rac-(10bR,11S)-10b-allyl-5-methyl-5,11-dihydro-10bH-
indolo[2,5-b]quinoline-11-carboxylic acid methyl ester (197) (65 mg, 0.196 mmol) in THF (2 
ml) was added.  The reaction mixture was warmed to -10 °C and after 1 hour formaldehyde, 
generated by heating paraformaldehyde (59 mg) to 150 °C, was bubbled through the 
vigorously stirred reaction mixture.  The reaction mixture was then allowed to warm to room 
temperature and was stirred for 1 hour.  NH4Cl(aq) (0.5 ml) was added and the THF was 
evaporated at reduced pressure.  The aqueous residue was extracted with CH2Cl2 (3 x 4 ml) 
and the combined CH2Cl2 extracts were dried (MgSO4).  The CH2Cl2 was evaporated at 
reduced pressure and the residue was purified by flash chromatography (20% to 40% 
EtOAc/hexane) to afford the title compound 204 as colourless crystals (55 mg, 0.152 mmol, 
76%).  Crystals suitable for X-ray analysis were obtained from EtOAc/hexane.  Mp 202-203 
oC; Anal. calcd for C22H22N2O3: C, 72.91; H, 6.12; N, 7.73. Found: C, 72.92; H, 6.11; N, 
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7.89; IR (KBr) νmax: 3240 (br m, O-H), 2954 (w), 1733 (s, C=O), 1618 (m), 1561 (s), 1497 
(m), 1470 (m), 1455 (m), 1406 (m), 1311 (m), 1235 (s), 1162 (w), 1116 (m), 1066 (m), 923 
(w),  805 (w), 760 (s), 731 (m), 643 (w) cm-1; MS (ESI) m/z 385 (MNa+, 100); HRMS (ESI) 
m/z calcd for C22H22N2O3Na 385.1528, found 385.1527; 1H NMR (300 MHz, CDCl3) δ 7.36 
(ddd, J = 8.3, 7.2, 1.7 Hz, 1H, ArH), 7.25-7.28 (m, 2H, 2 x ArH), 6.97-7.15 (m, 5H, 5 x 
ArH), 4.92-5.07 (m, 1H, CH=CH2), 4.67-4.79 (m, 2H, CH=CH2), 4.01 (s, 3H, OCH3), 3.91 
(dd, J = 11.6, 6.6 Hz, 1H, CH2OH), 3.59 (s, 3H, NCH3), 3.38 (dd, J = 11.6, 8.0 Hz, 1H, 
CH2OH), 2.77 (dd, J = 13.6, 7.9 Hz, 1H, CH2CH=CH2), 2.51 (dd, J = 13.6, 6.6 Hz, 1H, 
CH2CH=CH2), 1.75 (dd, J = 6.6, 8.0 Hz, OH); 13C NMR (75 MHz, CDCl3) δ 172.8 (C, 
C=O), 171.5 (C) 155.9 (C), 140.4 (C), 134.3 (C), 131.7 (CH), 131.0 (CH), 129.2 (CH), 129.2 
(CH), 122.8 (CH), 122.7 (CH), 122.53 (C), 122.50 (CH), 118.9 (CH2), 117.7 (CH), 114.8 










Allylmagnesium chloride (0.25 ml of a 2.0 M solution in THF, 0.500 mmol) was added to a 
solution of rac-(10bS,11S)-10b-allyl-5-methyl-5,11-dihydro-10bH-indolo[2,5-b]quinolin-11-
spiro-2'-oxirane (191) (101 mg, 0.334 mmol) in THF (1.5 ml) cooled to -78 °C and 
maintained under an argon atmosphere.  The reaction mixture was allowed to warm to room 
temperature and, after 3 hours, NH4Cl(aq) (0.5 ml) was added.  The THF was evaporated at 
reduced pressure and the residue was partitioned between CH2Cl2 (5 ml) and water (5ml).  
The CH2Cl2 was separated and the aqueous phase was further extracted with CH2Cl2 (3 x 5 
ml).  The combined CH2Cl2 extracts were dried (MgSO4), and the CH2Cl2 was evaporated at 
reduced pressure.  The residue was purified by flash chromatograph (10% EtOAc/hexane) to 
afford the title compound 210 as a colourless crystalline solid (88 mg, 0.255 mmol, 76%).  
Mp 182-183 oC; IR (KBr) νmax: 3233 (br m), 3076 (w), 2927 (w), 1615 (m), 1557 (s), 1470 
(s), 1455 (s), 1400 (s), 1317 (w), 1273 (w), 1215 (s), 1182 (w), 1049 (w), 922 (m), 758 (s), 
714 (w) cm-1; MS (ESI) m/z 345 (MH+, 100); HRMS (ESI) m/z calcd for C23H25N2O 
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345.1967, found 345.1975; 1H NMR (300 MHz, CDCl3) δ 7.77 (d, J = 7.7 Hz, 1H, H-1), 
7.24-7.35 (m, 4H, 4 x ArH), 7.00-7.10 (m, 3H, 3 x ArH), 5.77-5.91 (m, 1H, HOCHCH2CH), 
5.18-5.27 (m, 2H, HOCHCH2CH=CH2), 4.97-5.11 (m, 1H, CCH2CH), 4.73-4.80 (m, 1H, 
CHOH), 4.61-4.71 (m, 2H, CCH2CH=CH2), 3.60 (s, 3H, CH3), 3.15 (s, 1H, CHCHOH), 
2.85-2.96 (m, 1H, HOCHCH2), 2.71 (dd, J = 13.9, 6.5 Hz, 1H, 1H, CCH2), 2.44-2.55 (m, 2H, 
HOCHCH2 and CCH2), 2.07 (d, J = 3.6 Hz, 1H, OH); 13C NMR (75 MHz, CDCl3) δ 174.9 
(C), 156.8 (C), 142.2 (C), 136.6 (C), 134.8 (CH), 133.2 (CH), 128.8 (CH), 128.7 (CH), 127.9 
(CH), 124.2 (CH), 123.5 (C), 122.4 (CH), 122.2 (CH), 119.4 (CH2), 117.9 (CH2), 117.4 
(CH), 115.3 (CH), 70.6 (CH), 55.9 (C, C-10b), 45.5 (CH, C-11), 42.0 (CH2), 35.6 (CH2), 
33.2 (CH3).   
 
 
Preparation of 11-allyl-5-methyl-5H-indolo[2,3-b]quinoline (225) 
N N
CH3225  
t-BuOK (0.83 ml of a 1.0 M solution in t-BuOH, 0.830 mmol) was added to a stirred mixture 
of 5,10b-dihydro-10b-allyl-5-methyl-10bH-indolo[2,3-b]quinolin-11-one (130) (100 mg, 
0.347 mmol), TosMIC (88 mg, 0.451 mmol) and DME (2.5 ml) that was cooled to 0 °C and 
maintained under an argon atmosphere.  After 0.5 hours, the reaction mixture was allowed to 
warm to room temperature and the stirring was continued for 1 hour.  Water (2 ml) was 
added and the mixture was extracted with CH2Cl2 (3 x 5 ml).  The combined extracts were 
washed with brine (10 ml) and then dried (MgSO4).  The solvent was evaporated at reduced 
pressure and the residue was purified by flash chromatography (50% to 80% EtOAc/hexane) 
to afford the title compound 225 as an orange solid (57 mg, 0.209 mmol, 61%).  Mp 125-127 
oC; IR (KBr) νmax: 3049 (w), 1627 (s), 1608 (m), 1565 (s), 1525 (s), 1492 (s), 1455 (s), 1418 
(s), 1286 (s), 1237 (s), 1173 (m), 1135 (m), 1080 (m), 996 (w), 939 (m), 834 (m), 751 (s), 
662 (w), 595 (m), 466 (m) cm-1; MS (EI) m/z 272 (M+, 100), 255 (20), 84 (46); HRMS (EI) 
m/z calcd for C19H16N2O 272.1313, found 272.1317; 1H NMR (500 MHz, CDCl3) δ 8.17 (d, 
J = 8.2 Hz, 1H, H-1), 8.08 (d, J = 7.5 Hz, 1H, H-10), 7.73-7.78 (m, 3H, H-7, H-3, H-4), 7.54 
(t, J = 7.5 Hz, 1H, H-8), 7.45-7.49 (m, 1H, H-2), 7.24 (t, J = 7.5 Hz, 1H, H-9), 6.19 (ddt, J = 
16.4, 10.4, 5.6 Hz, 1H, CH=CH2), 5.13-5.18 (m, 2H, CH=CH2), 4.31-4.35 (m, 5H, CH3, 
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CH2CH=CH2); 13C NMR (101 MHz, CDCl3) δ 155.8 (C, C-6a), 155.3 (C, C-5a), 141.0 (C, C-
11), 137.1 (C, C-4a), 133.3 (CH), 130.4 (CH), 128.9 (CH), 126.0 (CH), 124.3 (C), 123.3 
(CH), 122.0 (CH), 120.8 (C), 120.0 (CH), 117.82 (CH2), 117.79 (CH), 114.7 (CH), 33.3 












Osmium tetroxide (3.26 ml of a 2.5% solution in t-BuOH) was added to a vigorously stirred 
solution of 5,10b-dihydro-10b-allyl-5-methyl-10bH-indolo[2,3-b]quinolin-11-one (130) (1.50 
g, 5.20 mmol) and NMO (1.28 g, 10.9 mmol) in THF/water (9:1, 40 ml).  After 24 hours a 
saturated solution of sodium sulphite (90 ml) was added and stirring was continued for 0.5 
hours before the reaction mixture was extracted with CH2Cl2 (3 x 150 ml).  The combined 
CH2Cl2 extracts were washed with brine (200 ml), dried (MgSO4) and the solvent was 
evaporated at reduced pressure.  The residue was triturated with Et2O and the yellow solids 
were collected by filtration to afford crude 235 (1.47 g).  MS (ESI) m/z 345 (MNa+, 100).  
2,2-dimethoxypropane (9.57 ml, 78.0 mmol) and PPTS (1.31 g, 5.21 mmol) were added to a 
stirred suspension of crude 235 in CH2Cl2 (100 ml), maintained under an argon atmosphere.  
After 2 days, when all the solids had gone into solution, NaHCO3(aq) (50 ml) was added and 
the CH2Cl2 was separated.  The aqueous phase was further extracted with CH2Cl2 (3 x 25 
ml).  The combined extracts were dried (MgSO4) and the solvent was evaporated at reduced 
pressure.  The residue was purified by flash chromatography (5% to 10% EtOAc/hexane) to 
yield the title compound 236 as a 1:1 mixture of diastereomers (1.32 g, 3.64 mmol, 70%).  
Whilst complete separation of the diastereomers could not be achieved, small highly enriched 
samples of each diastereomer could be obtained (122 mg of the less polar isomer and 50 mg 
of the more polar) by careful flash chromatography.   
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Less polar isomer (236a): IR (film) νmax: 2986 (m), 2937 (w), 1694 (s, C=O), 1563 (s), 1471 
(s), 1454 (s), 1387 (m), 1296 (w), 1210 (m), 1156 (m), 1059 (m), 915 (w), 858 (w), 758 (m), 
512 (w) cm-1; MS m/z (CI) 363 (MH+, 100), 261 (20); HRMS (CI) m/z calcd for C22H23N2O3 
363.1709, found 363.1698; 1H NMR (400 MHz, CDCl3) δ 7.92 (dd, J = 7.7, 1.3 Hz, 1H, H-
1), 7.70 (d, J = 7.2 Hz 1H, H-10), 7.58 (t, J = 7.8 Hz, 1H, H-3), 7.43 (d, J = 7.6 Hz, 1H, H-7), 
7.36 (td, J = 7.6, 1.3 Hz, 1H, H-8), 7.06-7.18 (m, 3H, H-9, H-4, H-2), 3.69 (s, 3H, NCH3), 
3.51-3.58 (m, 1H, OCH), 3.27 (dd, J = 8.6, 6.0 Hz 1H, OCH2), 3.01 (dd, J = 8.6, 6.0 Hz 1H, 
OCH2), 2.45 (dd, J = 13.5, 5.5 Hz 1H, OCH2), 2.18 (dd, J = 13.5, 7.1 Hz 1H, OCH2), 1.22 (s, 
3H, CCH3), 1.17 (s, 3H, CCH3); 13C NMR (101 MHz, CDCl3) δ 193.2 (C, C-11), 172.3 (C), 
153.9 (C), 145.4 (C), 136.1 (CH), 132.4 (C), 129.3 (CH), 128.6 (CH), 124.7 (CH), 123.4 
(CH), 122.3 (CH), 118.8 (CH), 118.4 (C), 114.5 (CH), 108.4 (C, CMe2), 72.0 (CH), 69.3 
(CH2), 64.4 (C, C-10b), 44.6 (CH2), 33.3 (CH3), 26.8 (CH3), 25.6 (CH3).   
More polar isomer (236b): IR (film) νmax: 2986 (m), 2937 (w), 1696 (s), 1471 (s), 1454 (m), 
1386 (m), 1296 (w), 1209 (m), 1159 (m), 1060 (m), 917 (w), 854 (w), 758 (m), 514 (w) cm-1; 
MS (CI) m/z 363 (MH+, 100), 261 (24); HRMS (CI) m/z calcd for C22H23N2O3 363.1709, 
found 363.1700; 1H NMR (300 MHz, CDCl3) δ 7.94 (dd, J = 8.3, 1.5 Hz, 1H, H-1), 7.77 (d, J 
= 7.4 Hz, 1H, H-10), 7.61 (td, J = 8.0, 1.5 Hz, 1H, H-3), 7.34-7.44 (m, 2H, H-7, H-8), 7.11-
7.21 (m, 3H, H-9, H-4, H-2), 3.82-3.91 (m, 2H, OCH, OCH2), 3.71 (s, 3H, NCH3), 3.26-3.33 
(m, 1H, OCH2), 2.51 (dd, J = 13.5, 5.8 Hz, 1H, CCH2), 1.88 (dd, J = 13.5, 6.1 Hz, 1H, 
CCH2), 1.89 (s, 3H, CCH3), 1.15 (s, 3H, CCH3); 13C NMR (101 MHz, CDCl3) δ 193.1 (C, C-
11), 173.0 (C), 153.7 (C), 145.0 (C), 135.8 (CH), 133.0 (C), 129.2 (CH), 128.9 (CH), 125.0 
(CH), 123.5 (CH), 122.7 (CH), 119.5 (C), 118.9 (CH), 114.6 (CH), 109.0 (C, C-Me2), 72.1 



















t-BuOK (0.73 ml of a 1.0 M solution in t-BuOH, 0.730 mmol) was added to a stirred mixture 
of 236a (110 mg, 0.304 mmol), TosMIC (77 mg, 0.396 mmol) and DME (2.5 ml), cooled to 
0 °C and maintained under an argon atmosphere.  After 0.5 hours, the reaction mixture was 
allowed to warm to room temperature and the stirring was continued for 0.5 hour.  Water (2 
ml) was added and the mixture was extracted with CH2Cl2 (3 x 5 ml).  The combined extracts 
were washed with brine (10 ml) and then dried (MgSO4).  The solvent was evaporated at 
reduced pressure and the residue was purified by flash chromatography (5% to 10% 
EtOAc/hexane) to afford a sample that was predominantly 237 as a mixture of diastereomers 
(* = minor isomer) that could not be separated (59 mg).  IR (KBr) νmax: 2985 (m), 2934 (w), 
2243 (w, C≡N), 1562 (s), 1496 (s), 1471 (s), 1457 (s), 1401 (m), 1380 (m), 1370 (m), 1300 
(w), 1213 (s), 1152 (m), 1060 (m), 857 (w), 830 (w), 756 (s), 650 (w), 510 (w) cm-1; MS (CI) 
m/z 374 (MH+, 100), 316 (20); HRMS (CI) m/z calcd for C23H24N3O2 374.1869, found 
374.1858; 1H NMR (400 MHz, CDCl3) δ 7.47-7.52 (m, 2H, 2 x ArH, 2 x ArH*), 6.99-7.37 
(m, 6H, 6 x ArH, 6 x ArH*), 4.16 (s, 0.75H, CHCN), 4.09 (s, 0.25H, CHCN*), 3.60 (s, 
0.75H, NCH3*), 3.53 (s, 2.25H, NCH3), 3.32-3.44 (m, 1H, CHO, CHO*), 3.12-3.19 (m, 1H, 
CH2O, CH2O*), 2.98 (dd, J = 8.6, 6.5 Hz, 0.75H, CH2O), 2.89 (dd, J = 8.5, 6.5 Hz, 0.75H, 
CH2O*), 2.15-2.22 (m, 1H, CCH2, CCH2*), 2.02 (dd, J = 13.4, 5.6 Hz, 0.75H, CCH2), 1.69 
(dd, J = 13.4, 6.3 Hz, 0.25H, CCH2*), 1.08-1.11 (m, 6H, C(CH3)2, C(CH3)2*).  This mixture 
of diastereomers (59 mg) was dissolved in THF (1 ml) and cooled to -78 °C, under an argon 
atmosphere.  LiHMDS (0.24 ml of a 1.0 M solution in THF) was added and the reaction 
mixture was warmed to 0 °C for 0.5 hours.  The orange reaction mixture was then cooled to -
78 °C and allyl bromide (27 µl, 0.312 mmol) was added.  After stirring -78 °C for 2 hours, 
the reaction mixture slowly warmed to room temperature and stirred for a further 16 hours.  
NH4Cl(aq) (0.5 ml) was added and the solvent was evaporated at reduced pressure.  The 
residue was partitioned between CH2Cl2 (1 ml) and water (1 ml).  The CH2Cl2 was separated 
and the aqueous phase was further extracted with CH2Cl2 (3 x 1 ml).  The combined extracts 
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were dried (MgSO4) and the solvent was evaporated at reduced pressure.  The residue was 
purified by chromatography (5% to 10% EtOAc/hexane) to afford the title compound 238 as 
a colourless oil (43 mg, 0.104 mmol, 34%).  IR (film) νmax: 2985 (w), 2934 (w), 2241 (w, 
C≡N), 1564 (s), 1495 (m), 1470 (m), 1454 (m), 1401 (m), 1211 (m), 1155 (w), 1064 (m), 926 
(w), 754 (m), 951 (w) cm-1; MS (EI) m/z 413 (M+, 70), 314 (44), 257 (100); HRMS (EI) m/z 
calcd for C26H27N3O2 413.2103, found 413.1998; 1H NMR (400 MHz, CDCl3) δ 7.50 (d, J = 
7.5 Hz, 1H, H-10), 7.31-7.43 (m, 4H, 4 x ArH), 7.03-7.12 (m, 3H, 3 x ArH), 5.38-5.49 (m, 
1H, CH=CH2), 5.01-5.05 (m, 1H, CH=CH2), 4.82-4.87 (m, 1H, CH=CH2), 3.61 (s, 3H, 
NCH3), 3.43-4.39 (m, 1H, HCO), 3.26 (dd, J = 8.5, 6.1 Hz, 1H, CH2O), 3.06 (dd, J = 8.5, 6.6 
Hz, 1H, CH2O), 2.39 (dd, J= 13.8, 6.7 Hz, 1H, CH2CHO), 2.24-2.33 (m, 2H, CH2CHO, 
CH2CH=CH2), 2.18 (dd, J = 13.8, 7.0 Hz, 1H, CH2CH=CH2), 1.18 (s, 3H, CCH3), 1.15 (s, 
3H, CCH3); 13C NMR (101 MHz, CDCl3) δ 170.9 (C), 156.4 (C), 138.8 (C), 133.3 (C), 130.7 
(CH), 130.20 (CH), 130.17 (CH), 129.3 (CH), 123.4 (CH), 123.0 (CH), 122.5 (CH), 121.0 
(CH2), 120.5 (C), 119.6 (C), 118.2 (CH), 115.3 (CH), 108.5 (C), 72.2 (CH), 69.6 (CH2), 55.3 
(C, C-10b), 49.5 (C, C-11), 38.9 (CH2), 38.6 (CH2), 33.0 (CH3), 26.9 (CH3), 25.7 (CH3).   
 






A solution of indole-3-carboxylic acid methyl ester (111) (2.15 g, 12.3 mmol) and TFA (20 
ml) was added to a mixture of thallium trifluoroacetate (10.0 g, 18.4 mmol) and TFA (20 ml), 
and the reaction mixture was stirred for 2 hours at room temperature.  After evaporation of 
the TFA at reduced pressure, a solution of copper (II) bromide (11 g, 49.2 mmol) in DMF (70 
ml) was added to the residue and the reaction mixture was stirred at 120 °C for 1 hour.  The 
reaction mixture was cooled to room temperature and CH2Cl2 (100 ml) was added.  The 
insoluble precipitate was removed by filtration through celite and the filtrate was washed 
with brine (2 x 200 ml), dried (MgSO4), and the solvent was evaporated at reduced pressure.  
The crude product was purified by flash chromatograph (5% to 15% EtOAc/hexane) to afford 
the title compound 239 as tan crystalline solid (1.61 g, 6.34 mmol, 51%).  Spectroscopic data 
was in accordance with that published in the literature.100  Mp 123-124 °C (lit.100 125-126 
°C); 1H NMR (400 MHz, CDCl3) δ 8.93 (br, s, 1H, NH), 7.89 (d, J = 3.1 Hz, 1H, H-2), 7.48 
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(dd, J = 8.0, 0.8 Hz, 1H, H-5/H-7), 7.37 (dd, J = 8.0, 0.8 Hz, 1H, H-5/H-7), 7.09 (t, J = 8.0, 
8.0 Hz, 1H, H-6), 3.91 (s, 3H, CH3).   
 
Method 2: 
4-Bromo-1H-indole-3-carboxylic acid (245) (500 mg, 2.08 mmol), H2SO4 (1 drop) and 
MeOH (25 ml) were heated at reflux under an argon atmosphere for 6 hours.  NaHCO3(aq) (5 
ml) was added and the MeOH was evaporated at reduced pressure.  The residue was 
extracted with CH2Cl2 (3 x 10 ml) and the combined extracts were dried (MgSO4).  The 
CH2Cl2 was evaporated at reduced pressure and the residue was purified by flash 
chromatography.  The first compound to be eluted (10% EtOAc/hexane) was 4-bromoindole 
(243) as a colourless oil (330 mg, 1.68 mmol, 81%).  Spectroscopic data was identical to that 
of commercially available 4-bromoindole.  1H NMR (400 MHz, CDCl3) δ 8.29 (br s, 1H, 
NH), 7.25-7.36 (m, 3H, H-2, H-5, H-7), 7.05 (dd, J = 7.9, 7.9 Hz, 1H, H-6), 6.60-6.63 (m, 
1H, H-3).  The second compound to be eluted (20% EtOAc/hexane) was 4-bromo-1H-indole-
3-carboxylic acid methyl ester (239) as a tan crystalline solid (58 mg, 0.228 mmol, 11%).  
Spectroscopic data was identical to that of 239 prepared by method 1.   
 
Method 3: 
A mixture of 4-bromo-1H-indole-3-carboxylic acid (245) (1.10 g, 4.58 mmol) and oxalyl 
chloride (0.48 ml, 5.50 mmol) in CH2Cl2 (25 ml) was cooled to 0 °C, under an argon 
atmosphere.  DMF (0.35 ml, 4.52 mmol) was added over a period of 0.5 hours.  After 1.5 
hours, when effervescence had ceased, MeOH (5 ml, 123 mmol) was added and the reaction 
mixture was allowed to warm to room temperature.  Water (40 ml) was added and the 
mixture was made basic (pH 10) by the addition of 15% NaOH(aq).  The CH2Cl2 was 
separated and the aqueous phase was extracted with CH2Cl2 (2 x 20 ml).  The combined 
CH2Cl2 extracts were washed with 0.5 M NaOH (20 ml), brine (20 ml) and dried (MgSO4).  
Removal of the solvent afforded the title compound 239 as a tan solid of sufficient purity for 
subsequent reactions (1.15 g, 4.53 mmol, 99%).  Spectroscopic data was identical to that of 











A solution of 4-Bromoindole (5.00 g, 25.5 mmol) in DMF (10 ml) was added dropwise to a 
stirred mixture of POCl3 (5.9 ml, 63.3 mmol) and DMF (10 ml).  The temperature of the 
reaction mixture was maintained at 35-40 °C for 45 min and then the reaction mixture was 
added to ice (ca. 50 g) and water (100 ml).  NaOH (13 g) in water (60 ml) was added over a 
period of 0.5 hours.  The mixture was boiled for 5 min and then cooled rapidly to 50 °C.  The 
product was collected by filtration and washed with water to afford the title compound 244 as 
colourless crystals (5.07 g, 22.6 mmol, 89%).  Spectroscopic data was in accordance with 
that published in the literature.100  Mp 182-185 °C (lit.100 185-187 °C); 1H NMR (400 MHz, 
CDCl3) δ 10.93 (s, 1H, CHO), 9.32 (br, s, 1H, NH), 8.12 (d, J = 3.3 Hz, 1H, H-2), 7.51 (dd, J 
= 8.0, 0.9 Hz, 1H, H-5/H-7), 7.46 (dd, J = 8.0, 0.9 Hz, 1H, H-5/H-7), 7.16 (t, J = 8.0, 1H Hz, 
H-6).   
 
 





A solution of NaClO2 (24.2 g, 268 mmol) and NaHPO4.H2O (41.9g, 304 mmol) in water (320 
ml) was added to a mixture of 4-bromo-1H-indole-3-carbaldehyde (244) (4.00 g, 17.9 mmol), 
2-methyl-2-butene (47.0 ml, 444 mmol) and t-BuOH (200 ml).  The reaction mixture was 
vigorously stirred for 5 days.  The t-BuOH was evaporated at reduced pressure and, after the 
addition of water (200 ml), the aqueous residue was extracted with EtOAc (4 x 80 ml).  The 
combined EtOAc extracts were washed with brine (100 ml) and then the EtOAc was 
evaporated at reduced pressure.  The residue was dissolved in 0.5 M NaOH(aq) (300 ml) and 
the resulting basic solution was repeatedly extracted with CH2Cl2 (ca. 10 x 50 ml) until the 
aqueous phase was no longer blue.  After filtering the aqueous solution through celite, 
concentrated hydrochloric acid was added to the filtrate until the solution was acidic (ca. pH 
5) and the product had crystallised.  The product was collected by filtration and washed with 
water to afford the title compound 245 as a tan crystalline solid (3.20 g, 13.3 mmol, 75%).  
Chapter 6 151
Mp 189-190 °C (dec.); IR (KBr) νmax: 3371 (s, N-H), 2931 (br m, O-H), 1675 (s), 1563 (w), 
1517 (m), 1447 (m), 1425 (m), 1355 (w), 1329 (w), 1307 (m), 1256 (w), 1192 (m), 1143 (w), 
1021 (w), 910 (w), 764 (m), 730 (w), 653 (w), 612 (w), 566 (w) cm-1; MS (EI) m/z 241 
(81BrM+, 15),  239 (79BrM+, 15), 197 (90), 195 (100), 116 (49); HRMS (EI) m/z calcd for 
C9H6NO279Br 238.9582, found 238.9584; 1H NMR (400 MHz, (CD3)2CO) δ 11.49 (br, s, 1H, 
NH/OH), 11.20 (br, s, 1H, NH/OH), 8.06 (d, J = 3.0 Hz, 1H, H-2), 7.53 (dd, J = 8.0, 0.9 Hz, 
1H, H-5/H-7), 7.39 (dd, J = 8.0, 0.9 Hz, 1H, H-5/H-7), 7.09 (t, J = 8.0 Hz, 1H, H-6); 13C 
NMR (101 MHz, (CD3)2CO) δ 164.9 (C), 139.3 (C), 134.6 (CH), 127.5 (CH), 125.7 (C), 
124.4 (CH), 114.3 (C), 112.4 (CH), 109.5 (C).   
 
 









N-Chlorosuccinimide (116 mg, 0.869 mmol) and N,N'-dimethylpiperazine (0.059ml, 0.436 
mmol) were added to a mixture of 4-bromo-1H-indole-3-carboxylic acid methyl ester (239) 
(200 mg, 0.787 mmol) and powdered 4 Å molecular sieves (400 mg) in CH2Cl2 (4 ml) at 0 
°C, maintained under an argon atmosphere.  After stirring for 2 hours a solution of N-
benzylaniline (288 mg, 1.57 mmol) and trichloroacetic acid (32 mg 0.196 mmol) in CH2Cl2 
(4 ml) was added.  The reaction mixture was allowed to warm to room temperature and 
stirring was continued for 20 hours.  The molecular sieves were removed by filtration and the 
filtrate was washed sequentially with 1.0 M HCl(aq) (4 ml), NaHCO3(aq) (4 ml) and water (4 
ml).  The organic phase was dried (MgSO4) and the solvent was evaporated at reduced 
pressure.  The residue was purified by flash chromatography (5% to 10% EtOAc/hexane) to 
afford the title compound 246 as a colourless crystalline solid (310 mg, 0.712 mmol, 90%).  
Mp 156-157 °C; IR (KBr) νmax: 3267 (br s, N-H), 1672 (s, C=O), 1599 (m), 1543 (s), 1498 
(s), 1446 (s), 1325 (s), 1253 (s), 1172 (s), 1127 (s), 1083 (m), 1029 (w), 950 (w), 772 (s), 743 
(s), 690 (s), 622 (w), 506 (w), 459 (w), 437 (w) cm-1; MS (CI) m/z 434 (79BrM+,86), 435 
(79BrMH+,97), 436 (81BrM+, 100), 437 (81BrMH+, 85), 405 (25), 403 (26), 356 (40); HRMS 
(CI) m/z calcd for C23H20N2O281Br 437.0688, found 437.0678; The NMR data presented 
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shows both the 3H*- and 1H-indole tautomer.  1H NMR (300 MHz, CDCl3) δ 8.16 (s, 0.8H, 
NH), 6.85-7.39 (m, 13H, 7.5 x ArH, 7.5 ArH*), 5.22 (d, J = 14 Hz, 0.2H, CH2*), 5.12 (d, J = 
14 Hz, 0.2H, CH2*), 4.58 (s, 0.2H, H-3*), 3.65 (s, 2.4H, CH3), 3.37 (s, 0.6H, CH3*).   
 
 











The above procedure was carried out without the addition of molecular sieves and with a 
reaction time of 2 hours after the addition of N-benzylaniline using 4-bromo-1H-indole-3-
carboxylic acid methyl ester (239) (100 mg, 0.394 mmol).  After workup, the crude product 
was purified by flash chromatograph (10% to 30% EtOAc/hexane).  The first product to be 
eluted was 246 (11 mg, 0.0253 mmol, 6%).  The second product to be eluted was the title 
compound 247 as a colourless crystalline solid (68 mg, 0.252 mmol, 64%).  Mp 151-153 °C; 
IR (KBr) νmax: 3247 (br m), 1749 (s), 1715 (s), 1617 (m), 1586 (w), 1453 (m), 1298 (m), 
1251 (m), 1167 (m), 1021 (w), 942 (w), 773 (w), 722 (w) cm-1; MS (ESI) m/z 292 
(79BrMNa+,100), 294 (81BrMNa+, 80); HRMS (ESI) m/z calcd for C10H8NO381BrNa 
293.9565, found 293.9572; 1H NMR (300 MHz, CDCl3) δ 8.85 (s, 1H, NH), 7.14-7.22 (m, 
2H, 2 x ArH), 6.89 (dd, J = 6.9, 1.7 Hz, 1H, ArH), 4.46 (s, 1H, H-3), 3.83 (s, 3H, CH3); 13C 
NMR (75 MHz, CDCl3) δ 172.1 (C), 166.1 (C, C-2), 143.5 (C), 131.2 (CH), 126.6 (CH), 
125.5 (C), 120.2 (C), 109.6 (CH), 55.0 (CH, C-3), 53.7 (CH3).   
 
 
Preparation of 2-(benzylphenylamino)-4-bromo-3-hydroxy-3H-indole-3-carboxylic acid 











Samples of 2-(benzylphenylamino)-4-bromoindole-3-carboxylic acid methyl ester (246) were 
found to undergo complete autoxidation to the title compound 252 in less than 5 days.  
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Colourless crystalline solid.  Mp 156-158 °C; IR (KBr) νmax: 3478 (br m, O-H), 1747 (s, 
C=O), 1558 (s), 1496 (m), 1454 (m), 1430 (s), 1249 (s), 1167 (m), 1103 (m), 1018 (w), 946 
(w), 905 (w), 782 (m), 753 (w), 700 (m), 515 (w) cm-1; MS (CI) m/z 451 (79BrMH+,100), 453 
(81BrMH+, 85); HRMS (CI) m/z calcd for C23H20N2O379Br 451.0657, found 451.0652; 1H 
NMR (300 MHz, CDCl3) δ 7.04-7.37 (m, 12H, 12 x ArH), 6.98 (dd, J = 7.5, 1.5 Hz, 1H, 
ArH), 5.28 (d, J = 14.5 Hz, 1H, CH2), 4.97 (d, J = 14.5 Hz, 1H, CH2), 3.72 (s, 1H, OH), 3.60 
(s, 3H, CH3); 13C NMR (75 MHz, CDCl3) δ 170.5 (C, C=O), 169.7 (C, C-2), 158.4 (C), 140.3 
(C), 136.7 (C), 134.0 (C), 132.2 (CH), 130.1 (CH), 129.0 (2 x CH), 128.9 (4 x CH), 128.6 (2 
x CH), 127.8 (CH), 125.9 (CH), 116.9 (C), 116.6 (CH), 84.0 (C, C-3), 57.2 (CH2), 53.9 
(CH3).   
 
 






A solution of 2-(benzylphenylamino)-indole-3-carboxylic acid methyl ester (246) (310 mg, 
0.712 mmol) in Ph2O (2.5 ml) was heated at 250 °C, under an argon atmosphere, for 2 hours.  
After cooling to room temperature the formed solids were collected by filtration and washed 
with Et2O to yield the title compound 253 as a light brown crystalline solid (241 mg, 0.598 
mmol, 76%).  Mp ca. 320 oC (dec.); IR (KBr) νmax: 3031 (br s, N-H), 1616 (s, C=O), 1546 
(s), 1508 (s), 1454 (m), 1431 (m), 1371 (m), 1325 (m), 1115 (m), 1053 (m), 871 (m), 755 (s), 
739 (m), 692 (m), 538 (m), 505 (w), 458 (w) cm-1; MS (CI) m/z 402 (79BrM+,60), 403 
(79BrMH+,85), 404 (81BrM+, 78), 405 (81BrMH+, 60), 325 (70), 315 (87), 314 (100), 313 (90), 
312 (89), 234 (35); HRMS (CI) m/z calcd for C22H16N2O79Br 403.0446 found 403.0436; 1H 
NMR (300 MHz, (CD3)2SO) δ 12.46 (s, 1H, NH), 8.39 (d, J = 8.0 Hz, 1H, H-1), 7.12-7.64 
(m, 11H, 11 x ArH) 5.77 (s, 2H, CH2); 13C NMR (75 MHz, (CD3)2SO) δ 170.5 (C, C-11), 
147.6 (C), 138.1 (C), 136.7 (C), 135.7 (C), 131.5 (CH), 128.9 (2 x CH), 127.5 (CH), 126.7 
(CH), 126.6 (CH), 126.0 (2 x CH), 125.6 (C), 124.5 (C), 124.2 (CH), 122.0 (CH), 115.2 









5,6-Dihydro-5-benzyl-10-bromoindolo[2,3-b]quinolin-11-one (253) (110 mg, 0.273 mmol) 
and POCl3 (2 ml) were heated at 90 °C for 1.5 hours, under an argon atmosphere, and then 
cooled to room temperature.  The POCl3 was evaporated at reduced pressure, with the final 
traces being removed by the addition and evaporation of a small amount of PhMe.  THF (1 
ml) was added to the residue and the mixture was cooled to 0 °C, under an argon atmosphere.  
A solution of the alkoxide generated from sodium (31 mg, 1.35 mmol) and allyl alcohol (0.50 
ml, 7.33 mmol) in (THF 0.5 ml) was added and the reaction mixture was stirred for 2 hours.  
NH4Cl(aq) (0.5 ml) was added and the solvent was evaporated at reduced pressure.  The 
residue was partitioned between CH2Cl2 (2 ml) and water (2ml).  The CH2Cl2 was separated 
and the residue was further extracted with CH2Cl2 (3 x 2 ml).  The combined CH2Cl2 extracts 
were dried (MgSO4), and the CH2Cl2 was evaporated at reduced pressure.  The residue was 
purified by flash chromatography (20% to 50% EtOAc/hexane) to afford the title compound 
255 as an orange solid (63 mg, 0.142 mmol, 53%).  Mp 143-145 oC; IR (KBr) νmax: 1625 (s), 
1561 (s), 1518 (s), 1491 (s), 1453 (w), 1408 (w), 1276 (m), 1260 (m), 1177 (w), 1141 (w), 
952 (w), 869 (w), 754 (m) cm-1; MS (CI) m/z 445 (81BrMH+, 100), 443 (79BrMH+, 95), 403 
(30), 364 (27), 91 (23); HRMS (CI) m/z calcd for C25H20N2O79Br 443.0759 found 443.0753; 
1H NMR (300 MHz, CDCl3) δ 8.33-8.36 (m, 1H, H-1), 7.59-7.69 (m, 3H, 3 x ArH), 7.19-
7.49 (m, 8H, 8 x ArH), 6.15-6.28 (m, 3H, CH=CH2, NCH2), 5.49 (dq, J = 17.0, 1.5 Hz, 1H, 
CH=CH2), 5.32 (dq, J = 10.5, 1.5 Hz, 1H CH=CH2), 4.86 (dt, J = 5.5, 1.5 Hz, 2H, OCH2); 
13C NMR (125 MHz, CDCl3) δ 158.7 (C), 158.4 (C), 156.4 (C), 137.8 (C), 135.9 (C), 132.7 
(CH), 131.6 (CH), 129.5 (CH), 129.1 (2 x CH), 127.8 (CH), 126.8 (2 x CH), 125.7 (CH), 
125.4 (CH), 124.0 (C), 122.1 (CH), 119.1 (CH2), 118.9 (C), 117.0 (CH), 116.71 (C), 116.67 














11-Allyloxy-5-benzyl-10-bromo-5H-indolo[2,3-b]quinoline (255) (37 mg, 0.0835 mmol) and 
PhMe were heated at reflux for 5 hours, under an argon atmosphere, and then cooled to room 
temperature.  The PhMe was evaporated at reduced pressure.  The residue was purified by 
flash chromatography (5% to 10% EtOAc/hexane) to afford the title compound 258 as a 
bright yellow crystalline solid (29 mg, 0.0654 mmol, 78%).  Crystals suitable for X-ray 
analysis were obtained from EtOAc/hexane.  Mp 175-177 oC; IR (KBr) νmax: 1697 (m, C=O), 
1603 (w), 1559 (s), 1467 (s), 1417 (m), 1280 (w), 1211 (w), 1040 (w), 926 (w), 854 (w), 783 
(w), 758 (m), 702 (w) cm-1; MS (ESI) m/z 467 (81BrMNa+, 84), 465 (79BrMNa+, 100); HRMS 
(ESI) m/z calcd for C25H20N2O79Br 443.0759 found 443.0751; 1H NMR (300 MHz, CDCl3) δ 
7.89 (dd, J = 8.0, 1.5 Hz 1H, H-1), 7.02-7.50 (m, 11H, 11 x ArH), 5.84 (d, J = 17 Hz, 1H, 
NCH2), 4.95-5.17 (m, 3H, NCH2, CH=CH2), 4.82-4.87 (m, 1H, CH=CH2), 3.57 (dd, J = 13.5, 
6.5 Hz, 1H, CH2CH=CH2), 2.93 (dd, J = 13.5, 6.5 Hz, 1H, CH2CH=CH2); 13C NMR (75 
MHz, CDCl3) δ 193.0 (C, C-11), 171.2 (C), 156.6 (C), 144.3 (C), 136.2 (C), 135.6 (CH), 
131.7 (C), 130.6 (CH), 129.8 (CH), 129.1 (2 x CH), 128.7 (CH), 128.2 (CH), 127.8 (CH), 
126.9 (2 x CH), 123.1 (CH), 120.3 (CH2), 120.2 (C), 119.1 (C), 117.8 (CH), 115.5 (CH), 69.3 
(C, C-10b), 50.1 (CH2), 39.1 (CH2). 
 
 








N-Chlorosuccinimide (711 mg, 5.32 mmol) and N,N'-dimethylpiperazine (0.36ml, 2.66 
mmol) were added to a mixture of 4-bromo-1H-indole-3-carboxylic acid methyl ester (239) 
(1.23 g, 4.84 mmol) and powdered 4 Å molecular sieves (2 g) in CH2Cl2 (30 ml) at 0 °C, 
maintained under an argon atmosphere.  After stirring for 2 hours a solution of aniline (0.88 
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ml, 9.68 mmol) and trichloroacetic acid (198 mg, 1.21 mmol) in CH2Cl2 (30 ml) was added.  
The reaction mixture was allowed to warm to room temperature and stirring was continued 
for 20 hours.  The molecular sieves were removed by filtration and the filtrate was washed 
sequentially with 1.0 M HCl(aq) (15 ml), NaHCO3(aq) (15 ml) and water (15 ml).  The organic 
phase was dried (MgSO4) and the solvent was evaporated at reduced pressure.  The residue 
was crystallised from EtOAc/hexane to afford the title compound 260 as a colourless 
crystalline solid (1.37 g, 3.97 mmol, 82%).  Mp 172-173 oC; IR (KBr) νmax: 3328 (m, N-H), 
3269 (m, N-H), 1650 (s, C=O), 1590 (s), 1572 (s), 1494 (m), 1476 (m), 1446 (m), 1430 (m), 
1369 (s), 1306 (m), 1253 (s), 1189 (m), 1131 (m), 1095 (m), 964 (w), 917 (w), 810 (w), 763 
(s), 740 (m), 695 (m), 633 (w), 528 (w) cm-1; MS (EI) m/z 346 (81BrM+, 18), 344 (79BrM+, 
21), 314 (91), 312 (100), 205 (57); HRMS (EI) m/z calcd for C16H13N2O281Br 346.0140, 
found 346.0148; 1H NMR (300 MHz, CDCl3) δ 9.30 (s, 1H, NH), 8.25 (s, 1H, NH), 7.36-
7.46 (m, 3H, 3 x ArH), 7.18-7.28 (m, 3H, 3 x ArH), 7.06 (dd, J = 7.9, 0.8 Hz, 1H, ArH), 6.86 
(dd, J = 7.8, 7.8 Hz, 1H, ArH), 3.91 (s, 1H, CH3); 13C NMR (101 MHz, CDCl3) δ 167.3 (C), 
150.4 (C), 138.3 (C), 133.5 (C), 130.5 (2 x CH), 128.4 (CH), 125.5 (CH), 125.4 (C), 122.3 (2 
x CH), 121.9 (CH), 112.6 (C), 109.1 (CH), 87.1 (C), 50.5 (CH2).   
 
 








Prepared from 4-bromo-2-phenylamino-1H-indole-3-carboxylic acid methyl ester (260) (300 
mg, 0.869 mmol) in Ph2O (2 ml), with a reaction time of 1.5 hours, using general method B.  
The title compound 261 was obtained as a light brown solid (235 mg, 0.750 mmol, 86%).  
Mp ca. 360 (dec.) oC; IR (KBr) νmax: 3333 (s, N-H), 3053 (m, br, N-H), 1636 (s), 1584 (s), 
1530 (s), 1478 (m), 1455 (m), 1337 (w), 1311 (w), 1191 (w), 1112 (w), 1021 (w), 885 (w), 
758 (m), 740 (m), 584 (m) cm-1; MS (EI) m/z 314 (81BrM+, 88), 312 (79BrM+, 100), 205 (24); 
HRMS (EI) m/z calcd for C15H9N2O79Br 311.9898, found 311.9894; 1H NMR (400 
MHz,(CD3)2SO) δ 12.06 (s, 2H, 2 x NH), 8.25 (d, J = 7.5 Hz, 1H, H-1), 7.57-7.64 (m, 2H, H-
3, H-4), 7.45 (d, J = 7.8 Hz, 1H, H-9/H-7), 7.36 (d, J = 7.8 Hz, 1H, H-9/H-7), 7.27 (t, J = 7.5, 
Hz, 1H, H-2), 7.10 (t, J = 7.8 Hz, 1H, H-8); 13C NMR (101 MHz,(CD3)2SO) δ 171.1 (C, C-
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11), 146.0 (C), 137.8 (C), 136.9 (C), 131.0 (CH), 126.2 (CH), 126.0 (CH), 124.31 (C), 
124.26 (C), 123.9 (CH), 121.5 (CH), 116.9 (CH), 112.6 (C), 110.1 (CH), 100.6 (C).   
 
 





Me 264  
10-Bromo-5,6-dihydroindolo[2,3-b]quinolin-11-one (261) (500 mg, 1.45 mmol) was refluxed 
in POCl3 (5 ml) for 24 hours and then cooled to room temperature.  The excess POCl3 was 
evaporated at reduced pressure and the residue was added to chipped ice/water (ca 20 ml).  
The mixture was made basic (ca pH 9) by the addition of saturated NaHCO3 solution and the 
solids were collected by filtration.  After washing with water, the product was thoroughly 
dried to afford crude 263 as a mustard coloured solid (570 mg).  A portion of crude 263 (300 
mg) was suspended in THF (10 ml) under an argon atmosphere and cooled to 0 °C.  
NaHMDS (1.81 ml, of a 1.0 M solution in THF) was added.  After all the solids had gone 
into solution, methyl iodide (0.14 ml, 2.26 mmol) was added and the reaction mixture was 
allowed to warm to room temperature.  After stirring for 18 hours, NH4Cl(aq) (0.5 ml) was 
added and the solvent was evaporated at reduced pressure.  Water (10 ml) and CH2Cl2 (10 
ml) were added to the residue and the mixture was filtered through celite.  The CH2Cl2 was 
separated and the aqueous residue was further extracted with CH2Cl2 (3 x 15 ml).  The 
combined CH2Cl2 extract were dried (MgSO4) and the solvent was evaporated at reduced 
pressure.  The residue was purified by flash chromatography (15% EtOAc/hexane) to afford 
the title compound 264 as a pale yellow crystalline solid (110 mg, 0.318 mmol, 35%).  Mp 
202-204 oC; IR (KBr) νmax: 1590 (s), 1563 (m), 1478 (m), 1383 (m), 1303 (m), 1249 (w), 863 
(w), 811 (w), 773 (s), 757 (s), 744 (m), 630 (m) cm-1; MS (EI) m/z 346 (81BrM+, 100), 344 
(79BrM+, 69), 135 (25), 115 (27), 98 (39), 91 (57), 73 (92), 60 (76); HRMS (EI) m/z calcd for 
C16H10N235Cl79Br 343.9716, found 343.9716; 1H NMR (300 MHz, CDCl3) δ 8.54 (dd, J = 
8.6, 1.0 Hz, 1H, H-1), 8.07 (d, J = 8.5 Hz, 1H, H-4), 7.77 (ddd, J = 8.5, 6.8, 1.0 Hz, 1H, H-3), 
7.51-7.61 (m, 2H, H-8, H-2), 7.34-7.44 (m, 2H, H-7, H-9), 3.98 (s, 3H, CH3); 13C NMR (101 
MHz, CDCl3) δ 152.1 (C), 146.9 (C), 144.9 (C), 136.2 (C), 130.3 (CH), 129.4 (CH), 127.5 
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(CH), 127.3 (CH), 125.6 (CH), 124.1 (CH), 123.3 (C), 119.8 (C), 117.2 (C), 115.2 (C), 107.8 
(CH), 28.3 (CH3).   
 
 




Me 265  
A solution of the alkoxide generated from allyl alcohol (0.53 ml, 7.79 mmol) and sodium (60 
mg, 2.61 mmol) in THF (0.5 ml) was added to 10-bromo-11-chloro-6-methyl-6H-indolo[2,3-
b]quinoline (264) (90 mg, 0.260 mmol) in THF (1 ml), maintained under an argon 
atmosphere. and the reaction mixture was stirred at room temperature for 4 days.  NH4Cl(aq) 
(0.5 ml) was added and the solvent was evaporated at reduced pressure.  The residue was 
partitioned between water (1 ml) and CH2Cl2 (2 ml).  The CH2Cl2 was separated and the 
aqueous phase was further extracted with CH2Cl2 (2 x 2 ml).  All the CH2Cl2 extracts were 
combined, dried (MgSO4) and the solvent was evaporated at reduced pressure.  The residue 
was purified by flash chromatography (10% to 20% EtOAc/hexane) to afford the title 
compound as 265 as a pale yellow solid (95 mg).  This compound could not be separated 
from a contaminant of undetermined structure (ca. 30%, determined by 1H NMR).  However, 
the peaks associated with the title compound 265 were readily distinguished.  1H NMR (400 
MHz, CDCl3) δ 8.31 (dd, J = 8.4, 1.5 Hz, 1H, H-1), 8.08 (d, J = 8.9 Hz, 1H, H-4), 7.34 (td, J 
= 8.9, 1.5 Hz, 1H, H-3), 7.53 (dd, J = 7.3, 1.3 Hz, 1H, H-7), 7.32-7.50 (m, 3H, H-8, H-2, H-
9), 6.23 (ddt, J = 16.9, 10.5, 5.4 Hz, 1H, CH=CH2), 5.52 (dq, J = 16.9, 1.5 Hz, 1H, CH=CH2), 
5.31 (dq, J = 10.5, 1.5 Hz, 1H, CH=CH2), 4.79 (dt, J = 5.4, 1.5 Hz, 2H, CH2), 3.97 (s, 3H, 















CH2Cl2 (200 ml) was added to crushed activated 3 Å molecular sieves (3.0 g), maintained 
under a argon atmosphere, in a 1 L flask and the mixture was cooled to -20 °C.  L-(+)-
Diisopropyl tartrate (1.42 g, 6.00 mmol), (E)-2-buten-1-ol (7.21 g, 100 mmol), and Ti(O-i-
Pr)4 (1.42 g, 5.00 mmol) were added sequentially.  After stirring at -20 °C for 15 min, tert-
butyl hydroperoxide (36.4 ml of a 5.5 M solution in nonane, 200 mmol) was added and the 
reaction mixture was stirred at -20 °C for 2 hours.  Trimethyl phosphite (18.9 ml, 160 mmol) 
was added carefully, so as not to allow the temperature to rise above -20 °C.  Triethylamine 
(20.6 ml, 141 mmol), DMAP (1.47 g, 12.0 mmol), and p-toluenesulfonyl chloride (19.1 g 100 
mmol) as a solution in CH2Cl2 (250 ml) were then added.  After stirring at  -10 °C for 10 
hours, the reaction mixture was filtered through celite.  The filtrate was washed with 10% 
tartaric acid solution (200 ml), NaHCO3(aq) (200 ml), brine (200 ml) and then dried (MgSO4).  
After removal of the CH2Cl2 by evaporation at reduced pressure, the remaining volatile 
material was removed by Kugelrohr distillation (40-50 °C, 0.1 mmHg).  The residue was then 
crystallised three times from Et2O/hexane to afford the title compound 278 as colourless 
crystals (7.05 g, 29.1 mmol, 29%).  Spectroscopic data was in accordance with that published 
in tha literature.113  Mp 61-62 °C (lit.113 61.5-62.0 °C); [α]20D -38.6 (c 3.60, CHCl3) (lit.113 
[α]25D +34.2 (c 3.29, CHCl3) for (R,R)-enantiomer of >99:1 e.r.); 1H NMR (300 MHz, 
CDCl3) δ 7.78-7.82 (m, 2H, ArH), 7.33-7.38 (m, 2H, ArH), 4.18 (dd, J = 11.3, 3.9 Hz, 1H, 
CH2), 3.98 (dd, J = 11.3, 5.7 Hz, 1H, CH2), 2.84-2.94 (m, 2H, CHOCH), 2.46 (s, 3H, 
ArCH3), 1.30 (d, J = 5.2 Hz, 3H, CHCH3).   
 
 




A solution of (-)-(2S,3S)-3-Methyl-2-(4-methylbenzenesulfonate)-2-oxiranemethanol (278) 
(6.38 g, 26.3 mmol) in ethylene glycol (30 ml) was added to a mixture of zinc-copper couple 
(3.19 g) and sodium iodide (11.8g, 79.0 mmol) in ethylene glycol (60 ml).  The reaction 
Chapter 6 160
mixture was heated at 70 °C and stirred for 2 hours.  After allowing the reaction mixture to 
cool to room temperature, the insoluble material was removed by filtration through a silica 
plug (positive pressure) and filtrate was fractionally distilled.  The fractions between 86-94 
°C were collected as (S)-(+)-3-butene-2-ol ((S)-153) (1.60 g, 22.2 mmol, 84%).  1H NMR 
(300 MHz, CDCl3) δ 5.92 (ddd, J = 17.2, 10.4, 5.8 Hz, 1H, CH=CH2), 5.21 (dt, J = 17.2, 1.4 
Hz, 1H, CH=CH2), 5.05 (dt, J = 10.4, 1.4 Hz, 1H, CH=CH2), 4.24-4.34 (m, 1H, CHOH), 2.19 
(d, J = 10.4 Hz, 1H, OH).   
Removal of water: (S)-(+)-3-butene-2-ol was dissolved in THF and stirred with 3 Å 
molecular sieves (800 mg) for 3 days.  The molecular sieves were removed by filtration and 
washed with THF.  The filtrate and washings were combined and the concentration of (S)-
(+)-3-butene-2-ol in THF was determined by 1H NMR (ca. 2.7 M).   






The following procedure was carried out for both racemic 3-butene-2-ol and (S)-(+)-3-
butene-2-ol.  Pyridine-d5 (150 µl), (R)-(-)-MTPACl (13 µl, 0.0700 mmol), and 3-butene-2-ol 
(19 µl of a 2.7 M solution in THF) were added sequentially to a dry, argon flushed, NMR 
tube.  After 0.5 hours, CDCl3 (0.6 ml) was added.  Analysis by 1H NMR indicated that all the 
3-butene-2-ol had been consumed.  3-dimethylamino-1-propylamine (12 µl, 0.0961 mmol) 
was added and after 5 min the reaction mixture was diluted with Et2O (3 ml).  The Et2O 
solution was washed sequentially with dilute hydrochloric acid (0.5 M, 1.0 ml), NaHCO3(aq) 
(1 ml), and brine (1 ml), and then dried (MgSO4).  The solvent was evaporated at reduced 
pressure and to afford the MTPA ester of 3-butene-2-ol as a colourless oil.  The NMR data 
presented is for the racemic material showing both the (S,S)-diastereomer* and the (S,R)-
diastereomer.  1H NMR (300 MHz, CDCl3) δ 7.51-7.54 (m, 2H, ArH, ArH*), 7.38-7.42 (m, 
3H, 1.5 x ArH, 1.5 x ArH*), 5.72-5.94 (m, 1H, CH=CH2, CH=CH2*), 5.56-5.63 (m, 1H, 
OCH, OCH*), 5.15-5.37 (m, 2H, CH=CH2, CH=CH2*), 3.56-3.58 (m, 1.5H, OCH3), 3.54-
3.56 (m, 1.5H, OCH3*), 1.43 (d, J = 6.6 Hz, 1.5H, CHCH3), 1.36 (d, J = 6.6 Hz, 1.5H, 
CHCH3*); 19F NMR (376 MHz, CDCl3) -71.56 (s, 1.5F, CF3*), -71.60 (s, 1.5F, CF3).  
Analysis of the MTPA ester formed from (S)-(+)-3-butene-2-ol by 1H NMR indicated the 









A mixture of 5,6-dihydro-5-benzyl-10-bromoindolo[2,3-b]quinolin-11-one (253) (200 mg, 
0.496 mmol) and POCl3 (3 ml) were heated at reflux for 3 hours, under an argon atmosphere.  
After the excess POCl3 had been evaporated at reduced pressure (the addition and 
evaporation of a small amount of dry PhMe was used to remove the last remaining traces of 
POCl3), CH2Cl2 (10 ml) and NaHCO3(aq) (10 ml) were added and the mixture was stirred until 
completely orange with no remaining yellow solids.  The CH2Cl2 was separated and the 
aqueous phase was further extracted with CH2Cl2 (2 x 10 ml).  The extracts were combined, 
dried (MgSO4) and the solvent was evaporated at reduced pressure.  The resulting bright 
orange residue was dissolved in THF (10 ml), under an argon atmosphere, and the alkoxide 
generated from (S)-(+)-3-buten-2-ol (1.50 ml of a 2.7 M solution in THF, 0.556 mmol) and 
sodium (34 mg, 1.48 mmol) in THF (5 ml) was added.  After stirring for 1.5 hours, NH4Cl(aq) 
(0.5 ml) was added and the solvent was evaporated at reduced pressure.  The residue was 
partitioned between CH2Cl2 (5 ml) and water (5 ml), the CH2Cl2 was separated and the 
aqueous phase was further extracted with CH2Cl2 (3 x 5 ml), the extracts were combined, 
dried (MgSO4) and the CH2Cl2 was evaporated at reduced pressure.  The residue was 
dissolved in THF and heated at reflux under an argon atmosphere for 6 hours.  The THF was 
evaporated at reduced pressure and the crude product was purified by flash chromatography 
(10% EtOAc/hexane) to yield the title compound (S)-282 as a bright yellow crystalline solid 
(167 mg, 0.364 mmol, 74%, [α]20D -347.1 (c 5.80, CHCl3)).  This material was crystallised 
from Et2O/hexane to give a sample for X-ray analysis.  Mp 124-125 oC; IR (KBr) νmax: 1700 
(s, C=O), 1602 (m), 1560 (s), 1467 (s), 1415 (s), 1391 (m), 1323 (w), 1240 (m), 1212 (m), 
1163 (w), 1042 (w), 965 (m), 856 (m), 785 (m), 765 (s), 693 (m), 533 (w) cm-1; MS (CI) m/z 
456 (79BrM+, 30), 457 (79BrMH+, 42), 458 (81BrM+, 41), 459 (81BrMH+, 39), 405 (65), 403 
(100), 325 (75); HRMS (CI) m/z calcd for C26H22N2O79Br 457.0915 found 457.0915; 1H 
NMR (300 MHz, CDCl3) δ 7.88 (dd, J = 8.0, 1.5 Hz, 1H, H-1), 7.00-7.51 (m, 11H, 11 x 
ArH), 5.85 (d, J = 16.5 Hz, 1H, NCH2), 5.31-5.46 (m, 1H, CHCH3), 5.04 (d, J = 16.5 Hz, 1H, 
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NCH2), 4.63-4.78 (m, 1H, CH2CH), 3.49 (dd, J = 13.5, 7.0 Hz, 1H, CH2CH), 2.86 (dd, J = 
13.5, 7.5 Hz, 1H, CH2CH), 1.37 (dd, J = 6.5, 1.5 Hz, 3H, CH3); 13C NMR (75 MHz, CDCl3) 
δ 193.2 (C, C-11), 171.4 (C), 156.6 (C), 144.3 (C), 136.4 (C), 135.5 (CH), 132.0 (C), 131.3 
(CH), 130.5 (CH), 129.0 (2 x CH), 128.6 (CH), 128.1 (CH), 127.7 (CH), 126.9 (2 x CH), 
123.0 (CH), 122.2 (CH), 120.4 (C), 119.0 (C), 117.7 (CH), 115.4 (CH), 69.7 (C, C-10b), 50.1 






The investigations presented in this thesis were directed at developing a new synthetic route 
to perophoramidine and the communesin group of natural products.  These investigations 
focused mainly on the rearrangements in the indolo[2,3-b]quinoline system.  It was 
discovered that the relative rates of the Claisen rearrangement and subsequent aza-Cope 
rearrangement of 11-allyloxyindolo[2,3-b]quinolines could be controlled through the 
positioning of a substituent on either N-5 or N-6 of this ring system.  When the substituent 
was placed on N-6 it was found that the rate of the aza-Cope rearrangement is greater than 
the rate of the Claisen rearrangement and the intermediate compound does not accumulate.  
Conversely, when the substituent is placed on N-5 the situation is reversed so that the Claisen 
rearrangement is faster than the aza-Cope rearrangement and the intermediate accumulates in 
the reaction mixture.  By controlling the rates of these consecutive rearrangements in this 
way it was possible to prepare compounds containing the desired C-10b quaternary centre in 
high yield.   
 
This is a truly novel approach to synthesising perophoramidine and the communesins.  
Furthermore, whilst the dearomatisation of aromatic systems using Claisen rearrangements 
has occasionally been applied to natural product synthesis,47-49,120-122 such control of a two 
step process by altering the degree of aromatic stabilisation is, to the best of our knowledge, 
without precedent in natural product synthesis.   
 
Through the use of model studies conducted on one of the substrates prepared using the 
Claisen rearrangement, it was shown that the adjacent quaternary centre at C-11 could also be 
successful constructed.  This further demonstrated that this synthetic methodology is 
applicable to the synthesis of perophoramidine and the communesins.  Through these studies 
a significant body of information was generated that will be used in the design of synthetic 
routes to perophoramidine and the communesins.  Furthermore, the intermediate (S)-281 was 
prepared that can be used directly as part of an asymmetric synthesis of the communesin 
natural products.   
 
In general, the aim of the research described in this thesis was to develop a new method for 
the construction of the vicinal all-carbon quaternary centres contained in the natural products 
perophoramidine and the communesins.  In conclusion the aims of this research have been 





The results presented in this thesis enable the development of new synthetic projects.  Many 
of the investigations reported in this thesis have been conducted on model compounds and 
the chemistry that has been developed will be applied to the synthesis of perophoramidine 
(17) and the communesins by using the appropriately substituted indolo[2,3-b]quinoline ring 
systems.  Indeed, such synthetic projects have already been initiated.   
 
With regard to a communesin synthesis, it is intended that the ketone of (S)-282 with by 
converted to the C-11 quaternary centre by using the methods described in Chapter 4.  The 
Br-10 substituent will be used to construct the isoprene motif by using, for example, a Heck 
reaction with methyl acrylate.  This would give the correct number of carbon atoms for the 
isoprene motif and the necessary functionality for construction of the azapine ring.   
 
Synthetic studies directed at a perophoramidine will use the appropriate halogen substituted 
ring system (see appendix 2) and it is intended that the methods involving the formation and 
alkylation of the C-11 nitrile described in Chapter 4 will be used in this synthesis.   
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The computational investigations described in this section were conducted by Prof. Douglas 
Philp.   
 
In order to better understand the differences in chemical behaviour between the two systems 
90 and 129 the rearrangement sequences for both compounds were investigated at the 
B3LYP/6-31G(d,p) level of theory.  Initially, lowest energy conformations of 90, 91, 116 
were located using molecular mechanics calculations.  Guess structures for the transition 
states linking 90 and 91 and 91 and 116 were then generated by the linear synchronous transit 
method and refined using the AM1 method.  These crude guesses were then used as input 
structures for the DFT calculations.  All of the transition states located for the two 
rearrangements have the classical chair-like structure.  Vibrational frequency analysis and 
intrinsic reaction coordinate (IRC) calculations verified that all of the transition state 
structures located were valid and energies for each species on the reaction pathways were 
extracted by standard methods. 
 
The calculated barrier for the conversion of 90 into 91 is 27.3 kcalmol-1 (Figure 31).  
Significantly, intermediate 91 is calculated to be 6.7 kcalmol-1 higher in energy than 90.  The 
computed barrier for the conversion of intermediate 91 into 116 is significantly lower (23.0 
kcalmol-1) than that for the first rearrangement.  These calculations are consistent with the 
efficient conversion of 90 to 116 via intermediate 91 with the first step being rate limiting so 
as 91 would never accumulate in the reaction mixture as a result of the relatively fast second 
rearrangement.   
Appendix 1 166
 
Figure 31. Calculated energy barriers (B3LYP/6-31G(d,p)) for the conversion of 90 to 91 and the conversion 
of 91 to 116.  
 
The reaction sequence 129 to 130 to 139 was also investigated at the B3LYP/6-31G(d,p) 
level of theory using the methodology outlined above.  As before, all of the transition states 
located for the two rearrangements have the classical chair-like structure and vibrational 
frequency analysis and intrinsic reaction coordinate (IRC) calculations verified that all of the 
transition state structures located were valid and energies for each species on the reaction 
pathways were extracted by standard methods. 
 
The calculated barrier for the conversion of 129 into 130 is 25.2 kcalmol-1 and the process is 
now essentially thermoneutral, with 130 being just 0.3 kcalmol-1 higher in energy than 129. 
(Figure 32).  The computed barrier for the conversion of 130 into 139 (26.8 kcalmol-1) is 




Figure 32. Calculated energy barriers (B3LYP/6-31G(d,p)) for the conversion of 129 to 130 and the 
conversion of 130 to 139. 
 
A comparison of the free energies of all of the compounds (90, 91, 116, 129, 130 and 139) is 
instructive (Figure 33).  Taking 90 as the zero point, both 91 and 130 have relatively similar 
energies (+6.7 and +10.4 kcalmol-1, respectively), as do the two N-allyl compounds 116 and 
139 (+4.2 and +2.7 kcalmol-1, respectively). By contrast, 90 is calculated to be 10.1 kcalmol-1 
more stable than 129.  This is consistent with the rationalisation that it is the predominantly 
the difference in ground state energy between 90 and 129 that causes the differences in 





Figure 33. A comparison of the free energies of all of the compounds, taking 90 as the zero point, supports 
the idea that it is the difference in ground state energy between 90 and 129 that accounts for the 
differences in chemical behaviour.   
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Appendix 2: The start of a perophoramidine synthesis 
 
 
A synthesis of perophoramidine (17) has been initiated by Dr Edward Makiyi using the 
chemistry described in this thesis (Scheme 104).  The synthesis starts with the synthesis of 
5,7-dichlorindole (283) from 2,4-dichloro-1-nitrobenzene (284) according to the literature 
procedure.123  5,7-Dichloroindole (283) was then coupled with 285 before displacement of 
the fluorine atom, which takes place in preference to displacement of the bromine atom, in 
286 with N-benzylaniline to afford 287.  Closure of the indolo[2,3-b]quinoline-11-one ring 
system of 288 was then accomplished by treatment of 287 with N-chlorosucinimide in a 
procedure similar to that described frequently throughout this thesis.  In this synthesis, by 
forming the C-10b-C-11 bond prior to the N-5-C-5a bond it was possible to avoid potential 
problems of regioselectivity that would have arisen if the indolo[2,3-b]quinoline-11-one ring 
system had been formed using the chemistry previously described.  Formation of the C-10b 
quaternary centre in 289 was then achieved using the same reaction sequence that had been 
used in the model system, via chloride 290.  It is interesting to note that the Claisen 
rearrangement in this sequence takes place at room temperature and no heating is required to 





































































Scheme 104. A perophoramidine synthesis has been initiated using the chemistry developed in this thesis.  
DMP = N,'N-dimethylpiperazine, NCS = N-chlorosucinimide, TCA = trichloroacetic acid. 
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7.27.47.67.88.08.28.48.6 ppm 6.16.26.36.46.5 ppm 4.85.05.25.45.6 ppm
 
 

























































7.27.47.67.88.0 ppm 5.05.25.45.6 ppm 2.42.52.62.72.82.9 ppm
 



















































7.07.27.47.67.8 ppm 4.44.54.64.74.84.95.05.1 ppm 2.22.42.62.83.0 ppm
 


























































7.07.17.27.37.4 ppm 4.85.05.25.4 ppm 2.22.42.62.8 ppm
 




























































7.17.27.37.47.5 ppm 5.05.25.4 ppm 3.13.23.33.4 ppm 2.22.32.4 ppm 1.15 ppm
 







































Appendix 4: Crystallographic Data 
 
 
Crystal data and structure refinement for 6-allyl-5-methyl-5H-indolo[2,1-b]quinazolin-
12-one (138) 
 
Identification code  nvnw3 
Empirical formula  C19H16N2O 
Formula weight  288.34 
Temperature  93(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 11.332(3) Å α = 90°. 
 b = 17.217(4) Å β = 107.218(7)°. 
 c = 7.5306(19) Å γ = 90°. 
Volume 1403.4(6) Å3 
Z 4 
Density (calculated) 1.365 Mg/m3 
Absorption coefficient 0.086 mm-1 
F(000) 608 
Crystal size 0.2000 x 0.0300 x 0.0300 mm3 
Theta range for data collection 2.22 to 25.31°. 
Index ranges -13<=h<=13, -16<=k<=20, -7<=l<=9 
Reflections collected 8730 
Independent reflections 2532 [R(int) = 0.0589] 
Completeness to theta = 25.00° 98.9 %  
Absorption correction Multiscan 
Max. and min. transmission 1.0000 and 0.9872 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2532 / 0 / 201 
Goodness-of-fit on F2 1.055 
Final R indices [I>2sigma(I)] R1 = 0.0510, wR2 = 0.1329 
R indices (all data) R1 = 0.0593, wR2 = 0.1400 




Crystal data and structure refinement for 5,10b-dihydro-10b-allyl-5-methyl-10bH-
indolo[2,3-b]quinolin-11-one (130) 
 
Identification code  nvnw2 
Empirical formula  C19H16N2O 
Formula weight  288.34 
Temperature  93(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 9.803(2) Å α= 69.857(9)°. 
 b = 11.370(3) Å β= 76.385(9)°. 
 c = 14.533(3) Å γ = 75.170(11)°. 
Volume 1450.7(6) Å3 
Z 4 
Density (calculated) 1.320 Mg/m3 
Absorption coefficient 0.083 mm-1 
F(000) 608 
Crystal size 0.20 x 0.15 x 0..15 mm3 
Theta range for data collection 3.03 to 25.34°. 
Index ranges -11<=h<=11, -7<=k<=13, -17<=l<=17 
Reflections collected 8213 
Independent reflections 4769 [R(int) = 0.0517] 
Completeness to theta = 25.00° 91.7 %  
Absorption correction Multiscan 
Max. and min. transmission 1.0000 and 0.3123 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4769 / 0 / 400 
Goodness-of-fit on F2 1.068 
Final R indices [I>2sigma(I)] R1 = 0.0663, wR2 = 0.1551 
R indices (all data) R1 = 0.0866, wR2 = 0.1712 







Crystal data and structure refinement for 5,10b-dihydro-10b-allyl-5-benzyl-10bH-
indolo[2,3-b]quinolin-11-one (161) 
 
Identification code  nvnw11 
Empirical formula  C25H20N2O 
Formula weight  364.43 
Temperature  93(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 8.8504(11) Å α = 89.003(9)°. 
 b = 9.4200(13) Å β = 74.988(6)°. 
 c = 11.6217(15) Å γ = 84.933(9)°. 
Volume 932.2(2) Å3 
Z 2 
Density (calculated) 1.298 Mg/m3 
Absorption coefficient 0.080 mm-1 
F(000) 384 
Crystal size 0.2000 x 0.1000 x 0.0500 mm3 
Theta range for data collection 2.17 to 25.34°. 
Index ranges -10<=h<=10, -9<=k<=11, -13<=l<=12 
Reflections collected 6101 
Independent reflections 3209 [R(int) = 0.0252] 
Completeness to theta = 25.00° 94.8 %  
Absorption correction Multiscan 
Max. and min. transmission 1.0000 and 0.8433 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3209 / 0 / 255 
Goodness-of-fit on F2 1.027 
Final R indices [I>2sigma(I)] R1 = 0.0415, wR2 = 0.1000 
R indices (all data) R1 = 0.0485, wR2 = 0.1066 
Extinction coefficient 0.030(7) 





Crystal data and structure refinement for rac-(10bS,11S)-10b-allyl-5-methyl-5,11-
dihydro-10bH-indolo[2,3-b]quinoline-11-ol (186) 
 
Identification code  nvnw14 
Empirical formula  C19H18N2O 
Formula weight  290.35 
Temperature  93(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P-1 
Unit cell dimensions a = 10.5564(10) Å α = 108.091(3)°. 
 b = 11.5496(13) Å β = 95.188(2)°. 
 c = 12.9057(15) Å γ = 90.667(2)°. 
Volume 1488.3(3) Å3 
Z 4 
Density (calculated) 1.296 Mg/m3 
Absorption coefficient 0.081 mm-1 
F(000) 616 
Crystal size 0.1300 x 0.1000 x 0.1000 mm3 
Theta range for data collection 1.67 to 25.34°. 
Index ranges -12<=h<=12, -13<=k<=13, -15<=l<=13 
Reflections collected 9720 
Independent reflections 5124 [R(int) = 0.0191] 
Completeness to theta = 25.00° 94.7 %  
Absorption correction Multiscan 
Max. and min. transmission 1.0000 and 0.9424 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5124 / 2 / 408 
Goodness-of-fit on F2 1.028 
Final R indices [I>2sigma(I)] R1 = 0.0390, wR2 = 0.0916 
R indices (all data) R1 = 0.0458, wR2 = 0.0977 







Crystal data and structure refinement for rac-(10bS,11S)-10b-allyl-5-methyl-5,11-
dihydro-10bH-indolo[2,5-b]quinolin-11-spiro-2'-oxirane (191) 
 
Identification code  nvnw6 
Empirical formula  C20H18N2O 
Formula weight  302.36 
Temperature  93(2) K 
Wavelength  0.71073 Å 
Crystal system  Rhombohedral 
Space group  R-3 
Unit cell dimensions a = 24.708(4) Å α = 90°. 
 b = 24.708(4) Å β = 90°. 
 c = 13.524(2) Å γ = 120°. 
Volume 7150.0(19) Å3 
Z 18 
Density (calculated) 1.264 Mg/m3 
Absorption coefficient 0.079 mm-1 
F(000) 2880 
Crystal size 0.150 x 0.100 x 0.030 mm3 
Theta range for data collection 2.86 to 25.34°. 
Index ranges -23<=h<=29, -25<=k<=29, -13<=l<=16 
Reflections collected 13581 
Independent reflections 2823 [R(int) = 0.0368] 
Completeness to theta = 25.34° 97.2 %  
Absorption correction Multiscan 
Max. and min. transmission 1.0000 and 0.6569 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2823 / 0 / 210 
Goodness-of-fit on F2 1.064 
Final R indices [I>2sigma(I)] R1 = 0.0712, wR2 = 0.2014 
R indices (all data) R1 = 0.0800, wR2 = 0.2129 







Crystal data and structure refinement for rac-(10bR,11R)-10b-allyl-11-hydroxymethyl-
5-methyl-5,11-dihydro-10bH-indolo[2,5-b]quinoline (192) 
 
Identification code  nvnw4 
Empirical formula  C20H20N2O 
Formula weight  304.38 
Temperature  93(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 8.121(2) Å α = 90°. 
 b = 11.403(2) Å β = 90°. 
 c = 17.486(5) Å γ = 90°. 
Volume 1619.2(7) Å3 
Z 4 
Density (calculated) 1.249 Mg/m3 
Absorption coefficient 0.078 mm-1 
F(000) 648 
Crystal size 0.1000 x 0.0300 x 0.0100 mm3 
Theta range for data collection 2.13 to 25.35°. 
Index ranges -9<=h<=6, -10<=k<=13, -20<=l<=18 
Reflections collected 10586 
Independent reflections 2923 [R(int) = 0.0677] 
Completeness to theta = 25.35° 99.0 %  
Absorption correction Multiscan 
Max. and min. transmission 1.0000 and 0.5286 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2923 / 1 / 215 
Goodness-of-fit on F2 1.071 
Final R indices [I>2sigma(I)] R1 = 0.0832, wR2 = 0.2077 
R indices (all data) R1 = 0.1104, wR2 = 0.2310 
Absolute structure parameter -4(4) 
Extinction coefficient 0.022(6) 






Crystal data and structure refinement for rac-(10bR,11S)-10b-allyl-11-hydroxymethyl-
5-methyl-5,11-dihydro-10bH-indolo[2,5-b]quinoline (195) 
 
Identification code  nvnw5 
Empirical formula  C20H20N2O 
Formula weight  304.38 
Temperature  93(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  Pbca 
Unit cell dimensions a = 12.742(4) Å α = 90°. 
 b = 14.828(3) Å β = 90°. 
 c = 16.748(4) Å γ = 90°. 
Volume 3164.4(14) Å3 
Z 8 
Density (calculated) 1.278 Mg/m3 
Absorption coefficient 0.079 mm-1 
F(000) 1296 
Crystal size 0.2000 x 0.1000 x 0.0200 mm3 
Theta range for data collection 2.43 to 25.31°. 
Index ranges -11<=h<=15, -14<=k<=17, -19<=l<=19 
Reflections collected 18917 
Independent reflections 2869 [R(int) = 0.0633] 
Completeness to theta = 25.31° 99.5 %  
Absorption correction Multiscan 
Max. and min. transmission 1.0000 and 0.4324 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2869 / 1 / 215 
Goodness-of-fit on F2 1.089 
Final R indices [I>2sigma(I)] R1 = 0.0543, wR2 = 0.1317 
R indices (all data) R1 = 0.0630, wR2 = 0.1380 
Extinction coefficient 0.0048(11) 






Crystal data and structure refinement for rac-(10bR,11S)-10b,11-diallyl-5-methyl-5,11-
dihydro-10bH-indolo[2,5-b]quinoline-11-carboxylic acid methyl ester (203) 
 
Identification code  nvnw7 
Empirical formula  C24H24N2O2 
Formula weight  372.45 
Temperature  93(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/n 
Unit cell dimensions a = 7.9672(14) Å α = 90°. 
 b = 14.623(3) Å β = 94.361(6)°. 
 c = 16.505(3) Å γ = 90°. 
Volume 1917.2(6) Å3 
Z 4 
Density (calculated) 1.290 Mg/m3 
Absorption coefficient 0.082 mm-1 
F(000) 792 
Crystal size 0.100 x 0.100 x 0.100 mm3 
Theta range for data collection 3.05 to 25.35°. 
Index ranges -7<=h<=9, -17<=k<=17, -15<=l<=19 
Reflections collected 10822 
Independent reflections 3315 [R(int) = 0.0500] 
Completeness to theta = 25.35° 94.3 %  
Absorption correction Multiscan 
Max. and min. transmission 1.0000 and 0.5182 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3315 / 0 / 256 
Goodness-of-fit on F2 1.052 
Final R indices [I>2sigma(I)] R1 = 0.0434, wR2 = 0.0941 
R indices (all data) R1 = 0.0549, wR2 = 0.1001 







Crystal data and structure refinement for rac-(10bR,11S)-10b-allyl-11-hydroxymethyl-
5-methyl-5,11-dihydro-10bH-indolo[2,5-b]quinoline-11-carboxylic acid methyl ester 
(204) 
 
Identification code  nvnw9 
Empirical formula  C22H22N2O3 
Formula weight  362.42 
Temperature  93(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 10.338(5) Å α = 90°. 
 b = 10.644(5) Å β = 90°. 
 c = 16.851(8) Å γ = 90°. 
Volume 1854.3(15) Å3 
Z 4 
Density (calculated) 1.298 Mg/m3 
Absorption coefficient 0.087 mm-1 
F(000) 768 
Crystal size 0.1000 x 0.0500 x 0.0500 mm3 
Theta range for data collection 2.26 to 25.37°. 
Index ranges -12<=h<=12, -12<=k<=12, -20<=l<=20 
Reflections collected 18221 
Independent reflections 3349 [R(int) = 0.0654] 
Completeness to theta = 25.00° 98.6 %  
Absorption correction Multiscan 
Max. and min. transmission 1.0000 and 0.8279 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3349 / 1 / 252 
Goodness-of-fit on F2 1.093 
Final R indices [I>2sigma(I)] R1 = 0.0589, wR2 = 0.1315 
R indices (all data) R1 = 0.0651, wR2 = 0.1362 
Absolute structure parameter 1.6(16) 
Extinction coefficient 0.0085(18) 





Crystal data and structure refinement for 5,10b-dihydro-10b-allyl-5-benzyl-10-bromo-
10bH-indolo[2,3-b]quinolin-11-one (258) 
 
Identification code  nvnw10 
Empirical formula  C25H19BrN2O 
Formula weight  443.33 
Temperature  93(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C2/c 
Unit cell dimensions a = 30.457(10) Å α = 90°. 
 b = 8.162(2) Å β = 122.791(12)°. 
 c = 18.382(5) Å γ = 90°. 
Volume 3841(2) Å3 
Z 8 
Density (calculated) 1.533 Mg/m3 
Absorption coefficient 2.160 mm-1 
F(000) 1808 
Crystal size 0.030 x 0.030 x 0.010 mm3 
Theta range for data collection 2.62 to 25.35°. 
Index ranges -34<=h<=36, -9<=k<=9, -18<=l<=21 
Reflections collected 10780 
Independent reflections 3401 [R(int) = 0.1102] 
Completeness to theta = 25.00° 97.6 %  
Absorption correction Multiscan 
Max. and min. transmission 1.0000 and 0.8220 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3401 / 0 / 263 
Goodness-of-fit on F2 1.095 
Final R indices [I>2sigma(I)] R1 = 0.0569, wR2 = 0.0731 
R indices (all data) R1 = 0.0963, wR2 = 0.0815 







Crystal data and structure refinement for (S)-(-)-5-benzyl-10-bromo-10b-(E-but-2-
enyl)-5H-indolo[2,3-b]quinolin-11-one ((S)-282) 
 
Identification code  nvnw13 
Empirical formula  C26H21BrN2O 
Formula weight  457.36 
Temperature  93(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P1 
Unit cell dimensions a = 8.7486(17) Å α = 101.33(3)°. 
 b = 9.3067(19) Å β = 99.93(3)°. 
 c = 13.714(3) Å γ = 90.56(3)°. 
Volume 1077.4(4) Å3 
Z 2 
Density (calculated) 1.410 Mg/m3 
Absorption coefficient 1.928 mm-1 
F(000) 468 
Crystal size 0.1000 x 0.1000 x 0.0800 mm3 
Theta range for data collection 2.23 to 25.28°. 
Index ranges -10<=h<=10, -11<=k<=7, -16<=l<=16 
Reflections collected 6436 
Independent reflections 4997 [R(int) = 0.0640] 
Completeness to theta = 25.00° 93.3 %  
Absorption correction Multiscan 
Max. and min. transmission 1.0000 and 0.6056 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4997 / 3 / 545 
Goodness-of-fit on F2 1.003 
Final R indices [I>2sigma(I)] R1 = 0.0621, wR2 = 0.1269 
R indices (all data) R1 = 0.0775, wR2 = 0.1376 
Absolute structure parameter -0.005(14) 
Extinction coefficient 0.022(2) 
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